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1.1. Feline immunodeficiency virus (FIV) 
1.1.1.  Classification 
Feline immunodeficiency virus (FIV) is a member of the family Retroviridae. 
Retroviruses are characterized by the presence of a viral transcriptase, and the 
integration of the viral genome into the host cell chromatin by a viral integrase. The 
name retrovirus refers to the reverse flow of information from the RNA genome to a 
DNA intermediate (provirus) during the viral life cycle. These viruses have 80-100 nm 
sized enveloped particles that contain a genome of 7-12 kb. 
Historically, three groups of retroviruses were established; the oncoviruses, 
lentiviruses and spumaviruses. The oncoviruses include viruses that can easily 
immortalize or transform host cells. Lentiviruses have a slow onset of disease and are 
associated with neurological and immunosuppressive disease. Spumaviruses cause a 
distinct cytopathological effect and do not seem to cause clinical disease. The 
oncoviruses were further subclassified based on morphology into B-, C- and D-type 
particles (Vogt, 1997). Five types of retroviral particles can be distinguished as shown 
in Figure 1. First, A-type particles; nonenveloped cytoplasmatic particles with the 
appearance of a doughnut, represent the immature cores for B- and C-type particles. 
They are immature because their gag polyprotein is not proteolytically processed, and 
hence the typical condensed core of electrondense material is absent. The condensed 
core of mature particles is round or slightly angular in shape and lies centered (C-type) 
or eccentric (B-type) in the viral particle. D-type oncoviruses have a bar or rod shaped 
core. The fifth group are the lentiviruses that have a typical cone shaped core.  
Following the latest report of the International Committee on Taxonomy of Viruses 
(ICTV), the family of the retroviruses is divided into two subfamilies; the former 
oncoviruses and lentiviruses are combined in the Orthoretrovirinae, while the 
Spumaretrovirinae remain separated. The viral particles of the Orthoretrovirinae 
carry two copies of linear, positive sense, single stranded RNA that is reverse 
transcribed during infection of a susceptible cell. Spumaretrovirinae, on the other 
hand, carry a double stranded DNA molecule as genome since reverse transcription 
takes place as a late step in the viral life cycle. The Orthoretrovirinae are further 
subdivided as defined by genetic evolutionary relatedness and complexity of the 
genome. This has led to the creation of six subgroups; alpha-, beta-, gamma-, delta-, 
and epsilon-retroviruses (the former oncoviruses), and lentiviruses (Table 1).  
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Together with its notorious cousin, the human immunodeficiency virus (HIV), FIV 
belongs to the genus lentivirus. Other retroviruses known to infect cats, are feline 
leukemia virus (FeLV) belonging to the genus Gammaretroviruses, and feline foamy 
virus (FFV) in the subfamily Spumaretrovirinae. FIV was first isolated in 1987 by 
Pedersen and colleagues, from FeLV negative cats that displayed an immunodeficiency 
syndrome similar to AIDS in humans (Pedersen et al., 1987).  
Figure 1: Electron micrographs of retroviral particles (courtesy of Gonda MA). (A) A-Type: 
intracisternal A particles in the endoplasmatic reticulum. (B) B-Type: Mouse mammary tumor virus (top, immature 
intracytopasmatic A-type particles; middle, budding particles; bottom, mature extracellular particle). (C) C-type 
with round core: Murine leukemia virus (top, budding; bottom, mature extracellular particles). (D) C-type with 
angular core: Avian leukosis virus (top, budding; bottom, mature extracellular particles). (E) D-type: Mason-Pfizer 
monkey virus (top, immature intracytopasmatic A-type particles; middle, budding particles; bottom, mature 
extracellular particle). (F) Lentivirus: Bovine immunodeficiency virus (top, budding; bottom, mature extracellular 
particles). (G) Spumavirus: Bovine syncytium virus (top, budding; bottom, mature extracellular particles). Adapted 
from (Vogt, 1997). 
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Table 1: Classification of the Retroviridae family based on the last report of the International 
Committee on Taxonomy of Viruses (ICTV). 
Family Subfamily Genus Species 
Retroviridae 
Orthoretrovirinae 
Alpharetrovirus Avian leukosis virus 
Betaretrovirus Mouse mammary tumor virus 
Gammaretrovirus Feline leukemia virus 
Deltaretrovirus Bovine leukemia virus 
Epsilonretrovirus Walleye dermal sarcoma virus 
Lentivirus Feline immunodeficiency virus 
Human immunodeficiency virus 
Simian immunodeficiency virus 
Caprine arthritis and encephalitis virus 
Maedi-Visna virus 
Spumaretrovirinae 
Spumavirus Feline foamy virus 
1.1.2.  FIV genome 
Members of the Retroviridae all share a similar genetic make-up, four large open 
reading frames (ORF). These ORF encode for structural and enzymatic proteins, 
important for the formation of new virus particles. Figure 2 represents the generalized 
retroviral DNA provirus and mRNA genome, and the FIV genome constellation. 
Starting from the 5’ end, the first gene in the genome is the group specific antigen 
(gag) gene. This gene encodes the Gag polyprotein that encompasses the matrix 
protein (MA), capsid protein (CA) and nucleocapsid protein (NC). The polymerase 
(pol) gene is located next to the gag gene. This gene encodes for a polyprotein with 
several enzymatic functions. For FIV, the pro gene, encoding the viral protease, is part 
of the pol ORF. Hence, the FIV Pol polyprotein contains the protease (PR), reverse 
transriptase (RT), deoxyuridine-phosphatase (DU) and the integrase (IN). The fourth 
and last ORF contains the envelope (env) gene, that consists of two parts; the surface 
protein (SU) and the transmembrane protein (TM) (Talbott et al., 1989). Depending 
on the subfamily and genus, retroviruses may contain additional ORF, positioned 
around the env gene, that encode for “accessory” proteins. Accessory proteins are 
involved in regulation of syntheses and processing of the virus, and combating host 
restriction factors. The FIV genome also codes three such viral accessory proteins; Vif 
(Felber et al., 1989; Talbott et al., 1989), OrfA (Talbott et al., 1989) and Rev (Brown et 
al., 1991; Kiyomasu et al., 1991). The presence of these accessory proteins places the 
FIV genome in the group of complex retroviral genomes.  
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The Gag polyprotein and Gag-Pol chimeara are translated from a full length unspliced 
mRNA. The Gag-Pol polyprotein is translated after a ribosomal frameshift (FS) at the 
end of the gag gene, shifting the ribosome back one codon into the pol ORF 
(Morikawa & Bishop, 1992). The envelope protein is translated from a singly spliced 
mRNA molecule, after recombination of the primary splice donor site (SD) with the 
major splice acceptor site (SA).  
Figure 2: Genetic organization of the generalized retrovirus. The proviral DNA (top) that is inserted into 
the host cell chromatin, with long terminal repeats (LTRs) composed of U3, R and U5 elements at each end. The 
four major open reading frames gag, pro, pol and env are located at invariable positions in the retroviral genome. 
Accessory genes are located after the pol and/or env gene. The primary mRNA transcript is shown in the middle. 
The mRNA is capped at the 5’ end and polyadenylated at the 3’ end, with the R sequence encompassing the 
polyadenylation (PA) signal. The untranslated leader region contains the major splice donor (SD) site. The viral 
genome contains several splice acceptor sites (SA), with the most important one proximal to the env gene. The pro 
and pol genes are generally translated after a ribosomal frame shift (FS) in gag. The 5’ end holds the encapsidation 
sequence that interacts with the gag gene product for genome packaging into the viral particle. In the FIV mRNA 
genome (bottom), pro is part of the pol open reading frame, in ORF-1 from gag. The env region contains several 
accessory genes, vif, orf A, and rev. The rev gene has two exons, one in front of and one after the env gene, with the 
second exon overlapping the 3’ LTR region.  
The genes in the DNA intermediate provirus are bracketed by the long terminal 
repeats (LTR) (Temin, 1981). These LTR are identical sequences that can be divided 
into three elements, and are created during reverse transcription. The unique region 3’ 
(U3), derived from the sequence unique to the 3’ end of the viral RNA. The repeat (R) 
is derived from a sequence repeated at both ends of the RNA, and U5 is derived from 
the sequence unique to the 5’ end of the viral RNA. Transcription initiation motifs are 
located at the boundary between U3 and R, and the site of polyadenylation (PA) at the 
boundary between R and U5. The U3 contains most of the transcriptional control 
elements of the provirus, which include promoter and enhancer sequences, responsive 
Chapter 1 
7 
to cellular transcriptional activator proteins. The viral mRNA genome is packaged into 
virions via the encapsidation sequence that interacts with viral nucleocapsid proteins, 
located proximal to the 5’ end. The mRNA molecules encoding the accessory proteins 
are all multiple spliced variants.  
1.1.3.  FIV subtyping  
FIV is divided into five different clades (A to E), which vary in prevalence by 
geographic location (Yamamoto et al., 2007). These clades are based on phylogenetic 
analyses of several variable regions (3 to 5) in the env gene. The intra-clade diversity at 
the nucleotide level in these variable regions range from 2.5 to 15%. A new clade arises 
when a sequence shows more than 20% genetic distance from other clades (Kakinuma 
et al., 1995; Sodora et al., 1994). While clade A strains are found worldwide, other 
clades indicate a separate evolution of FIV viruses in geographical isolated locations. 
For example, subtype E has only been found in South-America and subtype D is 
confined to Japan (Kakinuma et al., 1995; Pecoraro et al., 1996). Several reports have 
been made of env sequences clustering into new FIV clades, these were designated “F” 
(Duarte & Tavares, 2006; Hayward et al., 2007; Weaver et al., 2004) or “New 
Zealand-Unknown” (NZ-U) (Hayward et al., 2007). A cat can be infected with multiple 
FIV strains. In places where multiple subtypes circulate, this can give rise to 
recombinant viruses. Recombination can occur either between gene regions giving rise 
to, for example, A/C subtypes; or within single gene regions, forming for instance A/B 
envelope protein chimaeras (Hayward & Rodrigo, 2008).  
1.1.4.  FIV gene products and virion architecture  
The structure of the FIV virion is determined by the protein products of the gag, pol, 
and env gene. In addition, the virion contains several accessory proteins. First, the 
different FIV proteins will be discussed, in the order of their presence in the viral 
genome. Next, their interactions within the FIV virion will be presented. 
1.1.4.1. Gag polyprotein 
The Gag polyprotein is the product of the gag gene. The FIV Gag polyprotein 
comprises the major structural proteins, matrix, capsid, and nucleocapsid. 
Furthermore, it also contains a p2 protein, important for virion egress, as will be 
discussed later. Expression of the Gag polyprotein can induce the production of virus-
like particles without the need for other viral proteins (Manrique et al., 2001). The 
polyprotein is cleaved very late in virus assembly; hence important functions of the 
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different components (MA, CA and NC) are inevitably associated with the function of 
the full Gag polyprotein.  
The Gag polyprotein is targeted to the plasma membrane by myristolyation and a 
stretch of basic residues in the matrix (MA) protein, common among retroviruses 
(Brown et al., 2015; Elder et al., 1993; Henderson et al., 1983; Li et al., 2013; Schultz & 
Oroszlan, 1983). The interaction with phospholipids of the cellular plasma membrane 
is essential for viral replication. It was recently shown that unlike other lentiviral 
matrix proteins, the FIV matrix protein is capable of dimerization, thus aiding the 
multimerization of the Gag polyprotein (Serrière et al., 2013b), a function usually 
reserved for the capsid protein. Apart from interaction with the plasma membrane, the 
matrix protein is also important for proper incorporation of the viral envelope protein 
into the viral particle (Celma et al., 2007).  
The biggest portion of the Gag polyprotein is reserved for the capsid (CA) protein. 
The capsid protein is highly immunogenic and conserved among different FIV strains. 
It is therefore an important indicator for rapid diagnostic methods. The capsid protein 
induces multimerization of the gag polyprotein (Serrière et al., 2013a) and constitutes 
the viral capsid that holds the viral genome and products of the pol gene. The capsid 
protein is capable of interaction with several cellular proteins. A first one is cyclophilin 
A (Lin & Emerman, 2006). The importance of this interaction remains enigmatic. 
However, it is suggested that the binding spot of cyclophilin A may also be used by 
tripartite motif 5 protein (TRIM5), a known cellular restriction factor for lentiviral 
infection (Dietrich et al., 2011b; Waters et al., 1996). Furthermore, HIV CA has been 
shown to interact with the cytoskeleton and cellular motors. This may be essential for 
transport of the viral capsid or pre-integration complex towards the nucleus.  
The FIV nucleocapsid (NC) contains the packaging signal that binds the viral 
mRNA genome and incorporates it into the viral particle (Kemler et al., 2002; 
Manrique et al., 2004; Moscardini et al., 2002). The “when and where” of this 
interaction remains unknown. However, Kemler and co-workers recently showed that 
the Gag polyprotein is able to shuttle between the cytoplasm and the nucleus, and that 
this shuttling is dependent on the NC (Kemler et al., 2012). These results raise the 
possibility that Gag cycles to the nucleus to interact with the genomic FIV mRNA.  
Apart from the above mentioned structural viral elements, the carboxyl end of the FIV 
Gag polyprotein contains the p2 protein with a late domain (L-domain) required for 
efficient virion release from infected cells (Calistri et al., 2009; Elder et al., 1993; 
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Luttge et al., 2008; Manrique et al., 2004). L-domains are short proline rich motifs in 
viral genomes that have a function in the late phase of virus assembly (Demirov & 
Freed, 2004). The FIV p2 protein contains a conserved PSAP L-domain that is able to 
bind directly to Tsg101 (Luttge et al., 2008), and is ubiquitinated by Nedd4-2 (Calistri 
et al., 2009). Tsg101 is a subunit of the endosomal-sorting complexes required for 
transport (ESCRT)-I protein. Proteins of the ESCRT machinery drive membrane 
remodeling processes, which results in membranes bending and budding away from 
the cytoplasm. They depend on ubiqitination for some of their functions (Schuh & 
Audhya, 2014).  The hijacking of the ESCRT machinery for viral release is a feature 
shared by many enveloped viruses (Votteler & Sundquist, 2013).  
1.1.4.2. Pol polyprotein 
The Pol polyprotein contains all FIV enzymes; protease, reverse transriptase, 
deoxyuridine-phosphatase, and integrase. As already mentioned in paragraph 1.1.2, 
the protease gene is part of the pol ORF in the FIV genome. Furthermore, the FIV 
genome contains an additional enzyme compared to primate lentiviruses, the 
deoxyuridine-phosphatase. The Pol polyprotein is translated after a ribosomal -1 
frameshift from the gag ORF, creating a chimaeric Gag/Pol polyprotein (Morikawa & 
Bishop, 1992).  
The viral protease (PR) is indispensible in the viral life cycle. When the Gag and 
Gag/Pol polyproteins assemble, the protease dimerizes and becomes active. After 
dimerization, the enzyme autocleaves, and cleaves the Gag and Gag/Pol polyproteins, 
hereby inducing virion maturation (Elder et al., 1993). Cleavage of the Gag/Pol 
polyprotein activates the other enzymes carried within the virion. 
The reverse transcriptase (RT) converts the viral mRNA genome to a double 
stranded DNA intermediate, and is key to retroviral replication. The enzyme has two 
enzymatic functions; an RNA-dependent DNA polymerase activity (North et al., 1990) 
and an RNase H activity. The enzyme exists as a heterodimer with a full (66 kDa) and 
a truncated form (54 kDa) of the RT protein. The truncated form lacks the RNase H 
activity, and differs structurally from the full form (Elder et al., 1992), but is 
indispensable for the function of the enzyme (Amacker et al., 1995).  
Like other non-primate lentiviruses, the FIV genome encodes for a deoxyuridine-
phosphatase (DU), an enzyme that degrades deoxyuridine triphosphate to prevent 
the misincorporation of uracil into the viral DNA intermediate (Elder et al., 1992). FIV 
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viruses lacking DU can still infect cells, but show a higher mutation rate in cells that 
are not actively dividing (Lerner et al., 1995).  
After conversion of the viral RNA genome into dsDNA, the genome is integrated into 
the host cell chromatin by the viral integrase (IN). The enzyme contains at least 
three active domains; one to bind and process the viral genome, a non specific DNA 
binding domain to interact with the host cell DNA, and a catalytic site to perform 
ligation between the viral and host DNA (Shibagaki et al., 1997).  
1.1.4.3. Envelope protein 
FIV contains only one glycosylated envelope protein on the viral envelope. This 
envelope protein is composed of two parts, the surface (SU) protein and the 
transmembrane (TM) protein (Stephens et al., 1991; Verschoor et al., 1993), and exists 
as a trimer on the viral envelope. The transmembrane part is anchored to the viral 
envelope by interaction with the MA that lies just underneath the lipid bilayer. At the 
luminal side, SU is associated with TM but they are not covalently linked. 
Figure 3 gives a prediction of the FIV envelope protein structure. The envelope 
contains eight regions that are prone to a high mutation rate, and are highly variable 
when compared between different strains; they are called the variable loops (V). Six of 
these regions can be found on SU (V1 to 6) and the other three on TM (V7 to 9) 
(Pancino et al., 1993). Variable region four and five are speculated to be important for 
the initial binding to the cell surface, by interacting with CD134, the primary receptor 
of FIV (Elder et al., 2010; Shimojima et al., 2004). This interaction induces a 
conformational change that reveals the secondary receptor (CXCR4) binding epitope 
in the V3 region. After binding of the viral receptors, the fusion peptide located on TM 
can extend into the plasma membrane of the host cell and induce fusion with the viral 
envelope (Hosie et al., 2009). This action releases the viral capsid into the cytoplasm 
of the host cell.  
 
 
Figure 3 (next page): Predicted structure of the mature FIV envelope protein, cleaved into the 
surface (SU) and transmembrane part (TM). The two parts are non-covalently linked, and the mature Env 
proteins exist as timers on the virion surface. TM spans the viral envelope once. When comparing the genetic 
sequences of the env gene, SU contains 6 variable regions (V1 to 6), and TM contains 3 (V7 to 9). Every dot 
represents an amino acid, and the consensus glycosylation sites are indicated with forks. Adapted from (de Parseval 
et al., 2006; Pancino et al., 1993).  
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1.1.4.4. Accessory proteins 
The FIV genome encodes several so called “accessory” proteins. These viral proteins 
are not per se involved in the structural make-up of the virion, but are important for 
virulence, infectivity and counteracting host restriction factors (Inoshima et al., 1998a; 
Troyer et al., 2013). The FIV genome contains three known accessory proteins, Rev, 
Vif and OrfA. Both the vif and orfA gene are located in front of the env gene. The rev 
gene, on the other hand, has two exons, one in front of env, and one after env, 
extending into the U3 region. All three proteins exert part of their function in the 
nucleus of the infected cell (Brown et al., 1991; Chatterji et al., 2000; Gemeniano et 
al., 2004). 
Rev or “regulator of expression of virion proteins” is responsible for transport 
of viral mRNA from the nucleus into the cytoplasm. This way, viral mRNA that is not 
fully spliced can leave the nucleus and code for the Gag, Gag-Pol and Env polyproteins, 
hence inducing productive replication (Kiyomasu et al., 1991). The egress of unspliced 
viral RNA from the nucleus is also important for the incorporation of the full mRNA 
genome into newly formed viral particles. The Rev protein binds to the rev responsive 
element (RRE), a secondary RNA structure formed in the env gene (Brown et al., 1991; 
Na et al., 2010). 
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Vif, short for “viral infectivity factor” is found in all lentiviruses and counteracts 
the activity a cellular viral restriction factor; the apolipoprotein B mRNA editing 
enzyme, catalytic polypeptide-like 3 (APOBEC3) family. Vif can recruit an E3 ubiquitin 
ligase to APOBEC and label it for degradation by the proteasome (Gu et al., 2016; 
Zielonka et al., 2010). Vif is essential for cell-free infectivity (Tomonaga et al., 1992), 
and productive infection of PBMC and monocyte-derived macrophages (Lockridge et 
al., 1999). FIV mutants defective for Vif failed to replicate efficiently in cats (Inoshima 
et al., 1998b). It has been described that Vif localized to the nucleus of FIV infected 
cells, but it’s function here is unknown (Chatterji et al., 2000).  
Open reading frame A (OrfA) is a multifunctional protein present only in the FIV 
genome. FIV viruses lacking OrfA show no or a reduced replication efficiency in 
peripheral blood mononuclear cells (PBMC) in vitro and in vivo (Dean et al., 1999; Na 
et al., 2010; Pistello et al., 2002; Tomonaga et al., 1993a). The protein is important for 
viral particle formation and viral infectivity (Brunner & Pedersen, 1989). In the 
nucleus, OrfA can transactivate viral mRNA transcription through elements in the LTR 
(Chatterji et al., 2002; de Parseval & Elder, 1999), and is able to induce a cell cycle 
arrest in the G2 phase (Gemeniano et al., 2004). Furthermore, OrfA can downregulate 
cell surface expression of the primary FIV receptor, CD134, causing accumulation of 
the receptor in the Golgi apparatus (Hong et al., 2010). 
1.1.5.  Virion architecture 
FIV particles are characterized by a spherical phospholipid bilayer (envelope) and a 
cone shaped core, typical for lentiviruses. Figure 4 represents the FIV virion 
architecture. The FIV virions are approximately 90 to 120 nm in size. On the bilayer 
envelope the virus carries one glycosylated envelope protein that is important for host 
cell recognition. This envelope protein extends through the lipid envelope, and 
interacts with the viral matrix protein which anchors it to the virion. The cone shaped 
core is composed of the capsid protein, and contains the nucleocapsid protein that 
stabilizes two copies of the FIV mRNA genome. Besides these structural elements, the 
viral particle carries the viral enzymes important for virion maturation (PR), for 
integration of the DNA provirus into the cellular chromatin after infection (RT and 
IN), and for prevention of high mutation rate during reverse transcription (DU). It is 
still a matter of debate if the FIV virion contains all the accessory proteins (Vif, Rev 




Figure 4: Feline immunodeficiency virus architecture. In red, the products of env ORF, the envelope 
protein that is expressed as a trimer on the lipid bilayer. In blue, products of the Gag polyprotein after proteolytic 
cleavage. The matrix protein lies just underneath the envelope and interacts with the envelope protein. The capsid 
protein is the major constituent of the viral core that contains two copies of the viral mRNA genome. The genome is 
stabilized by the nucleocapsid protein, and is associated with the reverse transcriptase, integrase and the 
deoxyuridinefosfatase. The viral protease is important for virion maturation after budding from the infected cell. In 
addition, the virion may also contain the accessory proteins OrfA, Vif and Rev. 
1.1.6.  Replication cycle 
Retroviruses have a complex replication cycle (Fig. 5). The viral mRNA genome is first 
transcribed into a DNA intermediate that is subsequently integrated into the host cell 
chromatin, giving rise to the so called “provirus”. After creation of the provirus, the 
virus completely depends on the host cell transcription and translation machinery for 
the production of new viral genomes and proteins, and hence the formation of new 
FIV virions. The different steps are discussed in more detail in the following sections.  
1.1.6.1. Entry 
FIV enters the cell through the interaction between the envelope SU protein and two 
receptors. These receptors are: CD134, an activation marker of the tumor necrosis 
factor-receptor superfamily, and CXCR4, a CXC-chemokine receptor (Joshi et al., 
2005; Shimojima et al., 2004). The interaction between SU and CD134 changes the 
conformation of SU and opens the cryptic CXCR4 binding loop. After binding with 
CXCR4, SU dissociates from the envelope TM protein, and the fusion peptide located 
on TM can now insert into the host cell plasma membrane (Hosie et al., 2009). Next, 
the viral envelope and the host cell plasma membrane fuse, releasing the viral capsid 
into the cytoplasm. Today, there is still debate if fusion of the HIV viral and cellular 
membranes truly takes place at the plasma membrane and/or if the virus is 
endocytosed first (Melikyan, 2014). For FIV, on the other hand, no information exists.  
Chapter 1 
14 
Figure 5: Steps in the FIV lifecycle. FIV enters the cell by sequential interaction between FIV SU and CD134 
and CXCR4, respectively (1). Next SU is shed and the fusion peptide on TM inserts into the plasma membrane (2), 
causing fusion of the viral envelope and the cell membrane (3). The viral capsid is released into the cytoplasm and 
reverse transcription is initiated (4), converting the FIV mRNA genome into a dsDNA intermediate. The pre-
integration complex docks at the nucleus (5) and viral dsDNA genome is transported across the nuclear pore. The 
viral IN inserts the viral genome into the host cell DNA (6). Now the cellular machinery is responsible for 
transcription and translation of the viral proteins (7). The Gag and Gag/Pol polyproteins assemble at the plasma 
membrane and recruit Env (8). After budding with help of the cellular ESCRT family (9), the virion matures by 
proteolytic cleavage of Gag, giving rise to the typical capsid core (10).  
1.1.6.2. Uncoating and reverse transcription 
The “when and where” of lentiviral particle uncoating remains a black box, and is also 
relevant in the debate about the manner of viral entry. In a first model, the viral capsid 
disassembles immediately after fusion. In another model, the viral capsid remains 
intact at least until reverse transcription is initiated, and gradually uncoats during 
transport towards the nucleus. The third model proposes that the capsid remains 
intact until it reaches the nuclear membrane, and uncoating takes place at the nuclear 
pore after completion of reverse transcription (Arhel, 2010). Recent studies on HIV 
favor the third model, in which premature uncoating is prevented to facilitate reverse 
transcription, and to permit passage to the nucleus without the activation of DNA 
sensing innate immune responses (Ambrose & Aiken, 2014). 
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As mentioned before, the mRNA viral genome has all the characteristics of a cellular 
mRNA molecule, with a 5’ guanine cap and a polyadenylated 3’ end. Like other 
polymerases, the FIV RT requires a primer for initiation of transcription. The 5’ end of 
the viral genome is primed with a partially unwound cellular transfer RNA (tRNA) that 
is bound to the primer binding site (PBS) (Fig. 6A). From this primer, minus-strand 
DNA is synthesized until the 5’ end of the genome is reached. This short fragment of 
DNA intermediate is called the minus-strand strong-stop DNA (-sssDNA). Due to the 
RNase H activity of the FIV RT the viral RNA in the RNA/-sssDNA duplex will be 
degenerated. Now the first strand transfer takes place, annealing the repeat (R) region 
in the -sssDNA to the 3’ R sequence on the viral mRNA template (Fig. 6B). This event 
creates the LTR sequence, comprising the U3, R, and U5 region, respectively. The 
minus-strand synthesis now resumes, accompanied by RNase H digestion of the RNA 
template. Initiation of the plus-strand synthesis starts from two short polypurine tract 
(PPT) sequences, the 3’ PPT and the central PPT, that are more or less resistant to 
RNase H degradation. At these places a RNA primer remains bound to the minus-
strand DNA. The generation of the plus-strand is halted when a portion of the minus-
strand primer tRNA is reverse-transcribed, this yields the plus-strand strong-stop 
DNA (+sssDNA). The remaining tRNA primer is removed by RNase H activity. A 
second strand transfer occurs, annealing the plus-strand and minus-strand PBS (Fig. 
6C). Synthesis is completed with each DNA strand serving as a template for the other 
strand. Final elongation of the minus-strand displaces the portion of the minus-strand 
from which the plus strand was copied (5’ LTR). Elongation of the +sssDNA stops at 
the central termination sequence, and leads to a discrete plus-strand displacement in 
the centre of the genome of the plus-strand initiates at the cPPT. The final product is a 
blunt-ended linear double stranded DNA molecule. Since the viral genome is provided 
in duplicate in the virion, strand transfer events can occur intramolecular or 
intermolecular. Existence of dual subtype viruses proves that the RT can even switch 
strands during elongation.  
1.1.6.3. Genome integration 
After reverse transcription, the pre-integration complex (PIC) needs to get access to 
the nucleus in order to integrate the viral genome into the host cell chromatin. 
Lentiviruses are capable of actively transporting their PIC across the nuclear pore 
complex (NPC) and can therefore infect non-dividing cells. The precise composition of 
the PIC is not known today. However, several viral and cellular proteins have been 
identified to be involved in successful integration (reviewed in (Matreyek & Engelman, 
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2013)). While both the viral integrase and matrix protein contain a nuclear localization 
signal (NLS), the viral capsid protein is now being viewed as an important factor for 
nuclear transport. It is speculated that CA interacts with cellular proteins for docking 
and transport across the NPC. It is therefore unlikely that uncoating of the viral capsid 
occurs passively, as already described before. After transport, the lentiviral integrase 
interacts with cellular nuclear factors that bind to active transcription units, and 
tethers the PIC to the chromatin. One of the most intensively studied is lens 
epithelium derived growth factor (LEDGF/p75) (Christ & Debyser, 2013; Kang et al., 
2006). The integration itself occurs in two catalytic steps. First the viral LTRs are 
processed by removing dinucleotides adjacent to a highly conserved “CA” dinucleotide 
from the 3’ strand on both sides. This exposes a 3’ hydroxyl group that is used to attack 
the target DNA during the second step, the joining reaction, in which the viral genome 
is inserted into the cellular DNA (Engelman et al., 1991; Vink et al., 1991). Nicks that 
remain in the DNA after the insertion are repaired by the cellular base excision repair 













Figure 6 (next page): Steps in the retroviral reverse transcription process. (A) The first step in the 
process, creation of the minus-strand strong-stop DNA (-sssDNA). (B) The -sssDNA is then transferred for further 
synthesis of the minus-strand and creation of the +sssDNA. (C) Second transfer of the minus-strand DNA to 
dimerize with the PBS on the +sssDNA, and completion of the reverse transcription. The full description of the 





1.1.6.4. Viral transcription and translation 
After integration of its genome in the host cell chromatin, FIV uses the cellular 
machinery to replicate. The TATA-box is the core promoter element in the viral 
promoter and initiates basal transcription of the viral genome. Apart from the TATA-
box, a number of regulatory control elements are located in the LTRs. Some of these 
sites are conserved between FIV isolates, like AP-4, AP-1 and ATF/CREB sites 
(Sparger et al., 1992; Talbott et al., 1989). Some viruses may also contain additional 
sites to bind transcription factors (TF) like NF-κB, NF-1, C/EBP and LBP-1 (Sparger et 
al., 1992; Thompson et al., 1994). These TF binding sites make the transcription of 
FIV sensitive to cellular activation signals. As already mentioned before, the FIV OrfA 
protein can transactivate viral mRNA transcription through elements in the LTR 
(Chatterji et al., 2002; de Parseval & Elder, 1999).  
Transcription of the FIV provirus generates a viral mRNA molecule that has all the 
features of a cellular mRNA molecule. The host cell nuclear transport system has a 
preference for fully spliced mRNA that no longer contains splice acceptor sites, which 
indicate intron structures. Like other lentiviruses, the FIV genome contains a major 
splice donor site proximal to the 5’ LTR (Fig. 2). Downstream, multiple splice acceptor 
site can be found for creation of differently spliced viral mRNAs that code for different 
viral proteins (Tomonaga et al., 1993b). The first mRNA to be exported is fully spliced 
and encodes the Rev protein. Rev is responsible for the efficient transport of unspliced 
(genomic, and encoding Gag and Pol) and singly spliced (for Env, Vif and OrfA) viral 
RNA, from the nucleus to the cytoplasm (Kiyomasu et al., 1991).  
Translation of viral proteins starts after transport of the (spliced) viral mRNA from the 
cellular nucleus. FIV uses the host cell machinery for translation. While Env is 
translated by ribosomes on the rough endoplasmic reticulum, the other proteins are 
translated by free ribosomes. The Gag and Gag/Pol polyprotein are both translated 
from a non-spliced mRNA. The Gag/Pol chimaeras are created after a ribosomal 
frameshift of -1 codon on a slippery region at the 3’ end of the gag gene. This 
frameshift occurs in approximately 5% of the translational events.  
1.1.6.5. Assembly and budding 
FIV is an enveloped virus and obtains its bilipid layer from the budding site before 
entering the extracellular space. Lentiviruses assemble at the plasma membrane in 
lymphocytes, but they may also use an (membrane connected) intracellular 
compartment like multi vesicular bodies in macrophages (Benaroch et al., 2010; Joshi 
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et al., 2009; Ono & Freed, 2004). The Gag polyprotein seems to be choreographer of 
the assembly and budding of retroviruses. A lot of the functions that were described 
for the Gag polyprotein under heading 1.1.3.1 come into action here. The matrix 
protein interacts with particular lipids in the membranes (Ono et al., 2004; Waters et 
al., 1996) and assures anchoring to the lipid membrane via a myristyl moiety. The 
spatial lattice of the multimeric MA allows for interaction with the cytoplasmic tail of 
the Env protein (Affranchino & González, 2014; Celma et al., 2007; Manrique et al., 
2001). Between the Gag polyproteins, some chimaeric Gag/Pol polyproteins are 
inserted, ensuring the incorporation of the viral enzymes into the viral particle. The 
NC and MA protein interact with the genomic viral mRNA (Kemler et al., 2002). 
However the “when and where” of this interaction is not known yet. Budding of the 
virion is driven by members of the cellular ESCRT machinery through interaction with 
the p2 protein located in the C-terminal part of Gag (Calistri et al., 2009; Luttge et al., 
2008). The cellular proteins drive the membrane remodeling and the constriction of 
the cellular membrane to result in a free FIV virion.  
1.1.6.6. Maturation 
During or shortly after budding, the FIV particle matures by cleavage of the Gag/Pol 
and Gag polyproteins into their separate components. The maturation event starts by 
dimerisation of the PR subunits in the Gag/Pol protein. The dimerisation of PR creates 
active enzymatic site, and the functional protease is released by autoproteolysis 
(Kräusslich, 1991; Laco et al., 1997). Although the precise timing of the proteolytic 
event is not known, it is essential for the formation of infectious particles (Kräusslich, 
1991). The cleavage releases the structural elements MA, CA and NC, of which CA will 
create the typical conical core, and creates the separate viral enzymes PR, IN, RT and 
DU.  
1.1.7. Pathogenesis 
FIV is transmitted through biting incidents between cats. Territorial behavior puts 
male free roaming cats at a higher risk for contraction of FIV compared to female cats 
(Tompkins et al., 2008). Virus or FIV infected cells present in the saliva enter the bite 
wound and eventually get drained to the lymph nodes. FIV infects a range of immune 
cell lineages; T- and B-lymphocytes, and cells of the myeloid lineage, including 
monocytes, macrophages and astrocytes (Brown et al., 1991; English et al., 1993; 
Lerner et al., 1995). It is unclear if infiltrating immune cells at the entry wound can 
become infected before draining to the lymph nodes.  
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The clinical acute phase starts 4-8 weeks p.i., and peaks at 8-12 weeks. The cat may 
present some flu-like symptoms, mild anorexia, and neutropenia which may last from 
days to several weeks, and a generalized lymphadenopathy that can last up to 9 
months (Pedersen et al., 1989). During this acute phase, the immune system 
successfully counteracts the viral replication, and viral titers in the blood become 
almost undetectable (Fig. 7). After an initial decline in CD4+ T-cell numbers due to 
FIV replication and bystander apoptosis, there is a partial restoration once antibodies 
and cytotoxic T-cells control the infection. There is a steep decrease in the number of 
infected CD4+ T-cells, but a shift of infection to macrophages. Unfortunately, the 
infection is not cleared and the disease course enters an asymptomatic phase which 
can last for years, depending on the age of the cat, pathogenicity of the infecting FIV 
strain, and exposure to secondary infections (Lerner et al., 1995). Some cells that were 
infected early during infection may become latently infected, with the viral genome 
incorporated in the cellular chromatin, but no productive viral replication. Latently 
infected cells may become activated, which can induce FIV replication (McDonnel et 
al., 2012). Recent information showed that ongoing viral replication occurs in the 
lymph nodes, while this is hampered in blood circulating cells (Eckstrand et al., 2016). 
This means that the FIV infection is persistent as well. The ongoing low-level FIV 
replication during the asymptomatic phase over time induces a dysregulation of the 
immune system and a decline in the CD4+ T-cell count. Over the course of time, this 
results in a peripheral general lymphadenopathy (PGL) and development of the AIDS 
related complex (ARC). Cats develop leukopenia due to declining T-cell numbers an 
may develop other leukocyte depletions as well (Shelton et al., 1990). Cats present 
weight loss and some chronic infections, usually in the mouth, airways and eyes 
(Lerner et al., 1995; Pedersen et al., 1989). Within 18 months the cat will develop full 
blown feline AIDS, that is characterized by a rise in the FIV plasma viral load, further 
CD4+ T-cell decline (Fig. 7), and failure to generate an immune response against 
secondary and opportunistic infections. Some cats may develop neurological 
symptoms related with FIV infection in the brain (Phillips et al., 1994; Prospéro-
García et al., 1994), or blood neoplasms (Beatty et al., 1998; Steigerwald et al., 1999). 
Up till now, no antiretroviral therapy is available, and cats are treated symptomatically 
for concomitant infections. Most cats succumb to severe anorexia due to a chronic 
stomatitis and gingivitis, and failure to clear secondary infections.  
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Figure 7: FIV disease course. Adapted from (Lecollinet & Richardson, 2008).  
1.1.7.1. Pathogenesis of lentiviruses in other mammalian hosts 
The genus lentivirus contains eight viruses that can infect only their specific 
mammalian host, and persist through life. All viruses in this group are transmitted 
through contact with one or more body fluids from infected individuals. The main 
targets of lentiviruses are monocytes/macrophages and lymphocytes, both important 
cells of the immune system. Pathogenesis caused by lentiviruses can be divided into 
roughly two groups. The first group contains the small ruminant lentiviruses, caprine 
arthritis and encephalitis virus (CAEV) and maedi-visna virus (MVV), that mainly 
infect goat and sheep respectively, but can also cross between these species. These 
animals represent with symptoms of chronic inflammation in specific tissues. Another 
member of the first group is equine infectious anemia virus (EIAV), that infects all 
members of the Equidae family; horses, ponies, donkeys, mules, and zebras. EIAV 
causes recurrent episodes of diseases with high fever, anemia and wasting symptoms 
as the most important signs. The members of this first group of lentiviruses only infect 
macrophages and not lymphocytes.  
The second group contains the immunodeficiency viruses infecting humans (HIV-1 
and HIV-2), non-human primates (SIV), felines (FIV), and bovines (BIV). These 
viruses infect both monocytes/macrophages and lymphocytes. They cause a severe 
dysregulation of the immune system, leading to an acquired immunodeficiency. Non-
human primates and bovines have adapted to infection with their respective 
lentiviruses, and infection causes no or little disease. Also in felines, FIV only causes 
disease among domestic cats. Wild cats have their own FIV strains, and infected 
individuals show no signs of disease. The human viruses, HIV-1 and HIV-2, are 
believed to originate from SIV infecting chimpanzees and sooty mangabey 
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respectively, in relatively recent events. While causing no disease in their natural host, 
crossing of the species barrier allowed these viruses to be pathogenic in their new host. 
Since HIV is new virus in humans, we are poorly adapted to fight and restrict the 
disease caused by these viruses.  
Table 2: Overview of pathogenesis of lentiviruses in different mammalian hosts. 



























HIV 1 human 
body fluid 
contact 
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HIV 2 human 
body fluid 
contact 
+ + slow 
















FIV is often proposed as a natural occurring small animal research model for HIV 
because of many similarities in pathogenesis. As described above,  FIV infection causes 
a short acute phase, followed by a long asymptomatic phase that progresses into a 
terminal phase characterized by immunologic decompensation, increase in plasma 
viral load, and clinical symptoms of immunodeficiency with opportunistic infections. 
All these phases of disease are also evident in HIV infected humans. Lymphoid tissue 
alterations are similar with those found in HIV infected humans and neurological 
manifestations are also evident. HIV and FIV share the general retroviral genome 
make-up, containing the large open reading frames gag, pro, pol and env. However, 
FIV lacks vpr, vpu, and nef accessory genes that are present in HIV. The accessory 
genes vif and rev are shared, but FIV has an additional ORF called orfA. Another 
difference is the broader cellular tropism of FIV. Unlike HIV, FIV is able to infect B-
lymphocytes (Shimojima et al., 2004). Thus although the general pathogenesis and 
clinical manifestations seem similar for both viruses, underlying mechanism might be 
different due to important differences in cell tropism and genetic make-up. 
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1.1.8.  Immune response 
During the acute phase of FIV infection a vigorous immune response is generated 
leading to a steep decline in viral plasma load. The next section will discuss the innate 
restriction factors against retroviruses, and the response by the adaptive immune 
system against FIV in particular.  
1.1.8.1. Cellular restriction factors 
Mammalian cells have an innate defense against retroviruses that act on various steps 
of the virus replication cycle (Fig.8). Upon entry, the viral capsid can be bound by 
tripartite motif-containing protein 5 (TRIM5). TRIM5 is an ubiquitin ligase that can 
target the capsid protein for degradation by the proteasome. Binding of TRIM5 to the 
viral capsid accelerates the uncoating of the viral capsid, hindering reverse 
transcription and integration of the viral genome. However, due to a truncation in 
feline TRIM5, there is no restriction in felids against FIV (McEwan et al., 2009).  
Upon reverse transcription of the RNA molecule harboring the viral genome, the 
single stranded DNA intermediate can be attacked by members of the apolipoprotein B 
mRNA editing enzyme, catalytic polypeptide-like 3 (APOBEC3) family. These cellular 
proteins are incorporated into the virion, and exert their activity in the next replication 
round. APOBEC3 is a cytidine deaminase that catalyzes the deamination of cytidine 
(C) to uridine (U) in the single stranded DNA substrate. This C to U substitution can 
cause extensive and inactivating levels of FIV genome hypermutation. Different 
members of the feline APOBEC3 proteins are active against the different feline 
retroviruses (Münk et al., 2008). 
In non-cycling cells like dendritic cells, monocytes and macrophages, SAM domain 
and HD domain-containing protein 1 (SAMHD1) is starving the viral reverse 
transcriptase from nucleotides. Hydrolyzation of the intracellular deoxynucleoside 
triphosphates (dNTPs) by SAMHD1 lowers their concentrations below those required 
for the synthesis of the viral DNA by reverse transcriptase (Laguette et al., 2011; 
Lahouassa et al., 2012). Furthermore, SAMHD1 has an RNAse function that may 
degrade viral RNA (Ryoo et al., 2014). According to Gramberg and colleagues, 
SAMHD1 may also be active against FIV (Gramberg et al., 2013). 
While all restriction factors described above work on elements early in the viral life 
cycle, tetherin, also known as bone marrow stromal cell antigen 2 (BST2), plays a 
role at the very end of the replication process. Tetherin is a plasma membrane protein, 
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and expression is upregulated following an interferon (IFN) signal. It inhibits spread 
of newly formed viral particles by tethering them to the plasma membrane of infected 
cells post budding or release (Neil et al., 2008). It remains unclear is feline tetherin if 
also effective against FIV spread (Dietrich et al., 2011a).  
Figure 8: Schematic representation of cellular restriction factors against FIV infection and 
countermeasures of FIV. Upon release of the viral capsid in the cell, TRIM5 ubiquitin (Ub) ligases can target 
the FIV capsid protein for degradation by the proteasome. APOBEC3 is incorporated into virion during replication 
and executes its function when reverse transcription is initiated. It attacks the cytidines in the DNA intermediate 
introducing extensive mutations of the viral genome. FIV Vif can recruit ubiquitin ligases to APOBEC, targeting the 
protein for degradation. SAMHD1 lowers the amount of available nucleotides inside the cell, hindering reverse 
transcription. Furthermore, it has an RNAse function that can attack the viral RNA genome. When FIV is able to 
infect and replicate, virus release can still be inhibited by expression of the cellular protein tetherin, which can 
anchor newly produced virions to the plasma membrane. 
1.1.8.2. Adaptive immune response 
Seroconversion occurs 1 to 6 weeks after infection, depending on several factors like 
initial viral load, route of inoculation, virus strain, and host-dependent factors 
(Burkhard et al., 2001; Calzolari et al., 1995; Grant et al., 2009; Podell et al., 1997). 
The first antibodies are generated against structural elements of the FIV virion, the 
Env protein and viral core (MA, CA, and NC) proteins. Later, antibodies against the 
reverse transcriptase can be detected as well. Potentially neutralizing antibodies arise 
after 5 to 6 weeks (Tozzini et al., 1993). Antibody titers are maintained throughout the 
infection. A hypergammaglobulinemia comprising antibodies against non-FIV 
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antigens can be detected in FIV infected cats due to non-specific stimulation of B-cells 
(Pedersen et al., 2001).   
CD8+ T-cells can inhibit FIV replication by non-cytolytic and cytolytic activity. CD8+ 
T-cells produce unknown soluble factor(s) in the acute phase of FIV infection (within 1 
week of p.i.) that inhibit post-integration steps of the viral lifecycle (Flynn et al., 1999; 
Flynn et al., 2002; Hohdatsu et al., 1998). FIV specific cytotoxtic CD8+ T-lymphocytes 
(CTL) can be detected 4 to 6 weeks p.i. (Bucci et al., 1998; Zielonka et al., 2010) and 
remain present during the FIV disease course. Shimojima and co-workers also 
reported an increase in a specific subset of CD8+ cells and phenotypic changes of these 
cells post-FIV-infection (Shimojima et al., 1998; Shimojima et al., 2003). Natural 
killer (NK) cells, on the other hand, are defective in killing FIV infected cells (Hanlon 
et al., 1993; Zaccaro et al., 1995). 
1.1.9.  Immune evasion and dysregulation 
To establish a lifelong infection, retroviruses have developed several immune evasive 
mechanisms. Information about FIV immune evasion is limited, but strategies known 
to be employed by FIV will be discussed in more detail below. Because FIV infects cells 
of the immune system, a profound immune dysregulation develops as the disease 
progresses. The most important processes leading to the final stage of acquired 
immunodeficiency will also be reviewed.  
1.1.9.1. FIV immune evasion 
FIV replication can spread to a larger cellular machinery using formation of syncytia. 
Interaction between cell surface expressed Env and the FIV receptors on an interacting 
cell can induce fusion of the cellular membranes (Pedersen et al., 1987).  
The retroviral RNA genome can mutate quickly under impulse of replication 
restraining factors, like the mounted immune response or antiretroviral therapy, 
leading to escape mutants. Like HIV, the FIV env gene allows large sequence 
variation in the hypervariable regions as described in 1.1.4.3. This sequence variation 
leads to the emergence of different FIV clades with little cross-protection (Westman et 
al., 2016), allowing for infection with multiple FIV viruses, and making it difficult to 
generate effective vaccines (Carpenter et al., 1998). FIV Env even allows the 
generation of quasispecies with reduced need for primary receptor binding (Hartmann 
et al., 2012).  
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Most lentiviruses contain a number of accessory proteins important for virulence, 
infectivity, and immune evasion. FIV contains 3 known accessory proteins, Rev, Vif 
and OrfA (discussed in detail sub 1.1.4.4.). The latter two contain immune evasive 
properties. FIV Vif, like Vif of human and primates immunodeficiency viruses, has an 
anti-APOBEC3 function. Vif can recruit an E3 ubiquitin ligase to APOBEC and label it 
for degradation by the proteasome (Gu 2016). The lower cellular concentrations of 
APOBEC reduce the likelihood that APOBEC is incorporated in the virion, and will be 
able to execute its function in the next replication round. OrfA is unique for FIV, and 
has functions overlapping those of accessory proteins that are known for other 
lentiviruses. For instance, OrfA downregulates CD134 (FIV primary receptor) 
expression on the cell surface, similar to Nef for HIV. Sündstrom and colleagues 
reported that expression of OrfA downregulated the expression of genes important for 
the ubiquitination-proteasome system, thereby possibly hindering destruction of viral 
proteins (Sundstrom et al., 2008). The relevance of these findings, however, are yet to 
be proven.  
1.1.9.2. FIV induced immune dysregulation 
Early after the discovery of FIV it was noticed that immune cells of FIV infected cats 
showed a reduced ability to proliferate in response to primary and memory antigens, 
and mitogenic agents (Bishop et al., 1992a; b; Torten et al., 1991). Furthermore, FIV 
positive cats have an unremitting polyclonal hypergammaglobulinemia (Pedersen et 
al., 2001), and an increase in phenotypically activated CD8+ T-cells (Shimojima et al., 
1998; Shimojima et al., 2003) and regulatory T-cells (Treg) (Vahlenkamp et al., 
2004b). Therefore, it can be stated that FIV infection induces a dysregulation of the 
immune system. The dysregulation is characterized by: (1) a reduced activity of innate 
immunity, (2) immunologic anergy and apoptosis, and (3) an inappropriate activation 
of certain immune cells.  
Several mechanisms have been proposed to contribute to the observed immune 
dysregulation. First, FIV infected cats show a distorted cytokine balance. FIV infected 
cats show a constitutive increase of IL10, IFNγ and TNFα, but decreased IL2 and IL12 
levels in the lymph nodes. In response to challenge of the immune system with a 
secondary agent, these cats fail to mount an adequate immune response, with 
depressed IL2, IL6, IL12 and IFNγ levels compared to control cats (Dean et al., 2006; 
Levy et al., 1998). Inversion of the IL10/IL12 balance may suppress Th1 cells to 
generate a cell-mediated immune response. Second, Treg cells are activated early in 
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FIV infection, as a direct effect of FIV infection in these cells (Mexas et al., 2008; 
Miller et al., 2013). FIV preferentially replicates in Treg cells due to high CXCR4 
expression, and elevated activation of the proviral LTR (Joshi et al., 2005). Treg cells 
of FIV infected cats inhibit IL2 production and proliferation of CD4+ T-cells, hence 
inducing immunologic anergy (Meng et al., 2014) and induce anergy in CD8+ cells 
(Fogle et al., 2010). In addition, chronic stimulation of immune cells with FIV antigens 
can lead to the upregulation of B7 and CTLA-4 on T-cells. B7 is the counterpart of both 
CD28 and CLTA-4, while CD28 enhances T-cell survival, the elevated expression of 
CTLA-4 induces apoptosis. The upregulation of B7 and CTLA-4 correlates with 
spontaneous T-cell apoptosis in lymph nodes of FIV infected cats (Tompkins et al., 
2002; Vahlenkamp et al., 2004a). The massive apoptosis of immune cells may account 
for the destruction of the lymph node structure in advanced stages of FIV infection 
(Matsumura et al., 1994; Rideout et al., 1992) and the steady decline of CD4+ T-cell 
numbers. These phenomena over time increase the observed immune dysfunction, 
leading to the acquired immunodeficiency of FIV infected cats.  
Keeping FIV negative cats indoors is the only preventive measure owners can take. A 
lot of FIV research has focused on the development of a FIV vaccine, with development 
of a commercial dual subtype vaccine as a result. The vaccine, called Fel-O-Vax FIV® 
(Boehringer Ingelheim), contains inactivated cells infected with a Japanese FIV 
subtype D strain (Shizuoka) and an American FIV subtype A strain (Petaluma). 
However, vaccination against FIV is not recommended in Europe (Hosie et al., 2009). 
Safety concerns have been raised since there are several reports of vaccine-mediated 
enhancement of disease (Lecollinet & Richardson, 2008). Furthermore, cross-
protection against European isolates is still under discussion (Dunham et al., 2006). 
In Australia and New Zealand the vaccine is in use, recently an Australian study assed 
the protective rate of the vaccine in the field using 139 vaccinated cats and 301 un-
vaccinated controls. They registered 5 vaccine-breakthroughs, as well as two infection 
cases in vaccinated cats with missing follow-up vaccinations. There was no difference 
in FIV prevalence between the vaccinated and un-vaccinated group of cats, raising 
doubts about the efficacy of the Fel-O-Vax vaccine in the field (Westman et al., 2016).  
1.1.10.  FIV disease prevention and control 
FIV infected cats usually do not develop severe symptoms until 4-6 year after 
infection. Cats presenting with chronic gingivostomatitis, chronic rhinitis, weight loss, 
lymphadenopathy, immune-mediated glomerulonephritis, unusual or severe parasitic 
Chapter 1 
28 
skin disease, or blood tumors should alert the clinician to the possibility of FIV 
infection. FIV infection can be checked with a commercial point-of-care SNAP test. 
Several test are on the market, and some are available as a combo test for both feline 
retroviruses; FIV and FeLV. In an FIV SNAP test, a drop of blood is applied to 
chromatographic paper that contains FIV antigen. If the cat has antibodies against 
FIV, the test will return a positive result. It is advised to confirm positive SNAP test 
results in low-risk groups by western blot (Hosie et al., 2009).  
FIV-infected cats are usually not treated as long as no symptoms are present. Owners 
are advised to keep seropositive cats indoors to avoid spread of FIV and contraction of 
other diseases. Male cats should be neutered to avoid fighting when held in a multi-cat 
household. Regular health checks are advised to allow early intervention for 
developing problems. In case of sickness longer or more aggressive treatment than 
usual may be needed. Supportive treatment can be given when chronic problems like 
gingivostomatitis develop (Hosie et al., 2009). Specific anti-FIV drugs do not exist, 
and antiviral therapy against FIV is not generally used in veterinary practice. However, 
some clinical trials have been performed with antiretroviral drugs developed against 
HIV. One of the first nucleoside analogue reverse transcriptase inhibitors that was 
developed against HIV, 3’-azido-2’,3’-dideoxythymidine (AZT, Zidovudine) has been 
used successful in inhibiting FIV replication and improving immunological and 
clinical status of FIV-infected cats (Arai et al., 2002; Hartmann et al., 1992). Caution 
is needed when using this drug, since development of resistance has been reported, 
and AZT my cause non-regenerative anemia (Medeiros et al., 2016; Zhu et al., 1996). 
Other anti-HIV drugs, like Tenofovir and Plerixafor have been tested and seemed 
effective against FIV but no recommendations for use have been made (Hartmann et 
al., 2012; Taffin et al., 2015; Vahlenkamp et al., 1995).  
1.2. Lymphoid tissues 
The role of lymphoid tissues in the FIV and HIV pathogenesis is a hot topic in current 
lentiviral research. In this doctoral thesis there is also a focus on the influence of these 
tissues on FIV replication. Therefore, the following sections will give a short overview 
of the normal physiological organization and function of the primary (hematopoiesis 
and development of immune cells) and secondary  lymphoid organs (orchestration of 
the immune system), and the changes in these organs induced by FIV infection.  
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1.2.1.  Primary lymphoid organs 
1.2.1.1. Bone marrow 
There are two types of bone marrow, the red and the yellow bone marrow. The red 
bone marrow is the major site of hematopoiesis, while the yellow bone marrow is fatty 
with little to no hematopoiesis. Hematopoietic stem cells (HSC) in the red bone 
marrow provide lymphoid and myeloid progenitor cells, based on the demand of the 
body (Fig. 9). The progenitors are supported by a network of reticular stromal cells 
that produce extracellular matrix components, cytokines, growth factors and 
hormones to stimulate mitosis and early differentiation of HSC. The yellow bone 
marrow lost the hematopoietic function but still contains multipotent mesenchymal 
stem cells that can differentiate into hematopoietic supportive stromal cells, 
fibroblasts, myoblasts, adipocytes, chondrocytes and osteocytes.  
In the bone marrow, mononuclear cells and megakaryocytes can become FIV infected, 
and produce FIV provirus carrying progeny cells. Tissue abnormalities seen in the 
bone marrow of FIV infected cats are lymphoid follicular hyperplasia, increase in 
number of granulocyte and monocyte precursor cells (immaturity), and excess of 
eosinophils (Beebe et al., 1992; Huisman et al., 2004; Shelton et al., 1990).  
1.2.1.2. Thymus  
The thymus is responsible for further differentiation and selection of non-self T-cells 
and natural killer (NK) cells that arrive in the thymus from the bone marrow (Rossi et 
al., 2005). The thymus has 4 major zones that have a specific cellular composition and 
chemokine profile that aid in the selection process; the subcapsular zone (SCZ), the 
cortex, the cortico-medullar junction (CMJ) and the medulla (Fig. 9) (Bunting et al., 
2011). T-cells that do not survive the selection undergo apoptosis and are removed by 
residential macrophages. Single positive naive mature T-cells leave the thymus via 
blood vessels in the medulla.  
FIV infection strikes hard in the thymus, with almost complete depletion of 
thymocytes in the cortex and concomitant involution of the cortex. The medulla, on 
the contrary, shows an increase in the number of cells due to follicular hyperplasia, 
and even the formation of germinal centers. The heavy FIV infection in the thymus 
leads to the influx of activated immune cells leading to thymitis (Huisman et al., 2004; 















































































































































































































































































































































































































































































































































































































































1.2.2.  Secondary lymphoid organs 
The secondary lymphoid organs are organized in a way to increase the likelihood that a 
naïve lymphocyte will interact with their specific antigen. Some antigens may diffuse 
freely into these organs while others are carried from the periphery and are presented 
by professional antigen presenting cells. Stimulation of the naive lymphocytes by 
antigens will induce activation and clonal expansion of these cells, and lead to an 
adaptive immune response against the source of the recognized antigen. Overall, the 
secondary lymphoid organs have an analogous structure. In a network of reticular cells 
and fibers, primary lymphoid follicles that mainly contain recirculating naive B-cells 
are surrounded by extranodular lymphoid tissue constituted of recirculating naïve T-
cells and macrophages. Upon antigen recognition, the primary lymphoid nodule may 
evolve into a germinal centre that contains lymphoblasts involved in the immune 
response. 
1.2.2.1. Lymph nodes 
Lymph nodes (Fig. 10a) are bean-like structures that are located at sites of converging 
lymphatic vessels that drain a specific tissue or area. The afferent lymphatic vessels 
carry fluid and antigen-carrying cells from the periphery into the lymph nodes. The 
lymphatic vessels end in lymphatic sinuses in the parenchyma of the lymph node and 
are lined by endothelio-like reticular cells. This lining is discontinuous and is 
connected to the lymph node reticular network. Naive lymphocytes enter the lymph 
node via blood vessels that end in high endothelial venules (HEV) (Girard & Springer, 
1995). Segregation of the T-and B-cell zones and the attraction of naive cells to the 
lymph nodes depends on a delicate interchange of signaling between immune cells and 
factors produced by different subtypes of stromal reticular cells. B-cells migrate to the 
cortex, where they concentrate into follicles populated by follicular dentritic cells of 
mesenchymal origin (Aguzzi et al., 2014; Cupedo et al., 2004). Activation of B-cells in 
the follicle will lead to the development of germinal centers with intense proliferation 
and differentiation of B-cells into plasma cells that produce antibodies. T-cells are 
concentrated within a vast network of fibroblastic reticular cells in the paracortex 
(Brown & Turley, 2015; Cyster, 2000; Seibert et al., 1995). In the medulla a mixture of 
B-cells, T-cells and antigen presenting cells (APC) can be found. The medulla contains 
numerous lymphatic sinuses that lead cells out of the lymph nodes to the efferent 
lymphatic vessels.  
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In the acute phase of FIV infection, lymph nodes are hyperplastic, and cells are 
attracted via the high endothelial venules, which show increased accumulation of 
lymphocytes in pockets located around these venules. There is an increase in number 
and size of follicles and germinal centra, which can be aberrant in shape. The 
paracortex also has an increase in the number of lymphocytes, lymphoblasts and 
macrophages (Bach et al., 1994; Huisman et al., 2004). In the AIDS phase, lymph 
nodes may show involution or may even be depleted of cells (Rideout et al., 1992).  
1.2.2.2. Spleen  
The spleen is a giant sieve for dying red blood cells, blood borne pathogens and large 
antigens. The red pulp mainly contains red blood cells and antigens, while the 
lymphoid cells are concentrated in the white pulp (Fig. 10b). Arterial blood arrives into 
cords in the red pulp, channel-like structures consisting of reticular fibers produced by 
reticular cells, that are populated with macrophages and plasma cells. From these 
cords, the blood is passed into venous sinuses, which are lined with endothelial cells, a 
discontinuous basement membrane and lopsided reticular fibers. This specialized 
endothelial lining determines the efflux of RBC from the spleen and retains aging RBC 
(Mebius & Kraal, 2005). The white pulp, on the other hand, located around arterioles, 
is a dense lymphoid tissue that lodges B- and T-lymphocytes into specific 
compartments. T-cells are concentrated around the periarteriolar lymphoid sheats, 
while B-cells reside in follicles. In cats and ruminants, the lymphatic tissue (white 
pulp) is less abundant compared to dogs and pigs, and occurs mainly as B-cell follicles 
(Landsverk & Press). The marginal zone separates the red and white pulp, and 
contains specialized macrophages, non-circulating marginal zone B-cells important for 
responses against polysaccharide antigens, and some T-cells.  
Abnormalities seen in the spleen of FIV infected cats are similar to those observed in 
the lymph nodes. There is an increase in the number and size of the follicles in the 
white pulp, an increase in the number of lymphocytes and macrophages in the 
marginal zone, and myeloid metaplasia of the red pulp (Bach et al., 1994; Huisman et 
al., 2004).  
1.2.2.3. MALT  
A lot of pathogens enter the body at the mucosa of the gastrointestinal and respiratory 
tract. The epithelial lining of these systems contains specialized epithelial cells called 
microfold (M-) cells (Fig 10c). The M-cells overlay a central follicle of B-cells 
surrounded by T-cells and dendritic cells. M-cells take up antigens by pinocytoses and 
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transport them to the sub-epithelial tissues where they encounter dendritic cells that 
process the antigen for presentation to the lymphocytes.  
FIV infected cells can be found in high numbers in the Peyer’s patches and lamina 
propria of the gut. MALT tissues, show an increase of the number and size of the 



















Figure 10 (next page): Overview of the structure of the secondary lymphoid organs. (a) Organization 
of the lymph nodes. B-cells concentrate in the primary lymphoid follicle and plasma cells are found in germinal 
centers. In the paracortex, T-cells are concentrated, while the medullar chords contain a mixture of B-cells, T-cells 
and macrophages. (b) Transection of the spleen. The red pulp mainly contains red blood cells, macrophages and 
plasma cells. Around the central arteriole, in the periarteriolar sheets, most T-cells can be found. B-cells gather in 
follicles, that may contain germinal centers. Together the periarteriolar sheets and the B-cell zones form the white 
pulp. Between the red and white pulp lies the marginal zone that contains macrophages and specialized B-cells. (c) 
Organization of mucosa associated lymphoid tissue. In the epithelial layer specialized M-cells overlay a dome of T-
cells. These T-cells surround a central follicle with B-cells that may contain a germinal centre with plasma cells.  
Location of the B-cells, T-cells and plasma cells in these tissues are colour coded in the drawings; white for B-cells, 
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Feline immunodeficiency virus (FIV) is a major cat pathogen with seroprevalences 
of up to 30% in urban areas (Yamamoto et al., 2007). It was discovered a few years 
after the human immunodeficiency virus (HIV) in cats that presented symptoms 
similar to seropositive humans with AIDS (Pedersen et al., 1989).  
FIV strains are classified into several genetically distinct clades. When starting the 
current FIV research in Belgium, no up-to-date information existed on strains 
circulating in the Benelux. In Chapter 3 FIV field strains collected from naturally 
FIV infected cats living in Belgium and The Netherlands were genotyped. Insights 
into genotypes occurring in the Benelux will allow us to select a relevant FIV strain 
for further work.  
Once FIV is contracted, it establishes a lifelong infection in its host and causes a 
severe immunodeficiency that eventually leads to death. The FIV envelope protein 
(Env) and Gag protein are major stimulators of the anti-FIV response. Although 
infected cats develop a strong antiviral response, FIV is not cleared. This implies 
that FIV successfully escapes from detection by the immune system. Chapter 4 
aims at investigating the expression of FIV Env and Gag, and the availability of 
different epitopes on these viral proteins during replication. The well characterized 
American FIV subtype A strain “FIV-PPR”, was chosen for all further experiments 
because of the close resemblance with the FIV field strains in Belgium and The 
Netherlands. Knowledge about the timing of expression of viral proteins, their 
trafficking in the cell and availability of epitopes on these proteins when exposed to 
the extracellular milieu will broaden our view on the immune-evasive strategies 
employed by FIV.  
Another aspect of the FIV pathogenesis is the absence of FIV replication in blood 
leukocytes while the disease is asymptomatic but nonetheless progressing. The hunt 
for so called “replication reservoirs” has been ongoing for many years. Recently, it 
was shown that FIV replication is active in lymphoid tissues during the 
asymptomatic phase. Chapter 5a focuses on the isolation, characterization and 
immortalization of feline mesenchymal cells from primary lymphoid tissues (bone 
marrow and thymus) and secondary lymphoid tissues (lymph nodes and spleen). 
These cells create the network essential for proper function of the lymphoid organs. 
In Chapter 5b the influence of these lymphoid organ-derived mesenchymal cells 
on FIV replication in peripheral blood mononuclear cells (PBMC) and PBMC 
sensitivity for FIV infection was examined. 
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Feline immunodeficiency virus (FIV) is a major pathogen in feline populations 
worldwide, with seroprevalences up to 26%. Virus strains circulating in domestic cats 
are subdivided into different phylogenetic clades (A to E), based on the genetic 
diversity of the V3-V4 region of the env gene. In this report, a phylogenetic analysis of 
the V3-V4 env region, and a variable region in the gag gene was made for 36 FIV 
strains isolated in Belgium and The Netherlands. All newly generated gag sequences 
clustered together with previously known clade A FIV viruses, confirming the 
dominance of clade A viruses in Northern Europe. The same was true for the obtained 
env sequences, with only one sample of an unknown env subtype. Overall, the genetic 
diversity of FIV strains sequenced in this report was low. This indicates a relatively 
recent introduction of FIV in Belgium and The Netherlands. However, the sample with 
an unknown env subtype indicates that new introductions of FIV from unknown origin 




Feline immunodeficiency virus (FIV) is a common pathogen in cat populations 
worldwide. The virus is mainly spread by biting, especially during fights between 
tomcats (Natoli et al., 2005; Yamamoto et al., 1989). It causes a dysfunction of the 
immune system, in part by directly targeting cells of the immune system, leading to a 
persistent infection (Tompkins & Tompkins, 2008). After a long asymptomatic phase, 
infection with FIV can cause an AIDS-like disease, characterized by a depletion of 
CD4+ T-cells, increase in plasma viral load and severe immune suppression. Clinical 
signs are usually not directly caused by the FIV infection, but are the result of 
secondary infections or immune hyper-stimulation. 
FIV is divided into five different clades (A to E), which vary in prevalence by 
geographic location (Yamamoto et al., 2007). These clades are based on phylogenetic 
analyses of variable regions 3 to 5 in the env gene. The intra-clade diversity in these 
regions range from 2.5 to 15% at the nucleotide level. A new clade arises when a 
sequence shows more than 20% genetic distance from other clades (Kakinuma et al., 
1995; Sodora et al., 1994). While clade A strains are found worldwide, other clades 
indicate a separate evolution of these viruses in geographical isolated locations. For 
instance, subtype E has only been found in South-America and subtype D in Japan 
(Kakinuma et al., 1995; Pecoraro et al., 1996). Several reports have been made of env 
sequences clustering into new FIV clades, these were designated “F”(Duarte & 
Tavares, 2006; Hayward et al., 2007; Weaver, 2010) or “New Zealand-Unknown” (NZ-
U) (Hayward et al., 2007). A cat can be infected by multiple FIV strains. In places 
where multiple subtypes circulate, this can give rise to recombinant viruses. 
Recombination can occur either between gene regions, giving rise to, for example, A/C 
subtypes or within single gene regions, forming for instance A/B envelope chimaeras 
(Hayward and Rodrigo 2008).  
Routine vaccination with the dual clade (A & D) vaccine (Fel-O-Vax, Boehringer 
Ingelheim) is not recommended in Europe. Safety concerns have been raised since 
there are several reports of vaccine-mediated enhancement of disease (Lecollinet & 
Richardson, 2008). This enhancement might be related to humoral factors (Siebelink 
et al., 1995) and/or by inducing memory cells that are rapidly activated upon FIV 
infection. These activated lymphocytes are an ideal target for FIV (de Parseval et al., 
2004; Gramaglia et al., 1998; Joshi et al., 2005). Furthermore, it is important to 
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mention that cross-protection against European isolates is under discussion (Dunham 
et al., 2006). 
Clades A and B are reported to circulate in Western Europe (Samman et al., 2011; 
Steinrigl et al., 2010; Yamamoto et al., 2007), but data from Belgium are lacking. 
Serological surveys in Belgium have shown an FIV prevalence of 11% in urban stray 
cats (Dorny et al., 2002) and 14% in healthy cats of six years and older (Paepe et al., 
2013). However, virus was not isolated and phylogenetic analyses were not performed. 
In the present study, env and gag sequences derived from 36 naturally infected cats 
living in Flanders and The Netherlands were phylogenetically analyzed. 
3.2. Materials and methods 
3.2.1.  Samples 
Samples were obtained from naturally infected cats living in Belgium (n=26) and The 
Netherlands (n=10). Cats were presented to the Clinic for Small Companion Animals 
of  Ghent University. All cats were privately owned and owners provided a signed 
consent. Blood samples were taken by jugular venipuncture. Genomic DNA was 
isolated from 50µl heparin-treated blood with the Quick-gDNA™ Blood Microprep kit 
(Zymo Research). 
3.2.2.  PCR and sequencing 
Sequences for variable regions in gag and env (V3-V4) were amplified, using primers 
FIV-960F and FIV-1709R for gag, and primers FIV-7224F and FIV-8000R for env 
(Iwata & Holloway, 2008; Steinrigl & Klein, 2003). All primer sequences can be found 
in Table 1. PCR was performed using Herculase II Fusion DNA polymerase (Aligent 
Technologies) in a 50 µl reaction mix containing 0.25 µM of the forward and reverse 
primer, 0.5 µl template DNA, 1 mM dNTPs, 0.5 µl polymerase and 2.5 mM MgCl2. The 
PCR product was visualized on a 1% agarose gel, excised and purified with the 
NucleoSpin® Gel and PCR Clean-up kit (Machery-Nagel GmbH & Co. KG, Düren). 
Sequencing was performed by GATC Biotech (Constance, Germany) with both forward 
and reverse primers on an ABI 3730XL Sanger sequencing platform. When sequencing 
failed, the fragment was cloned into a commercial vector (pCR®-Blunt) with the Zero 
Blunt PCR cloning kit (InvitrogenTM, life technologies) following manufacturer’s 




Table 1: Location and 5’ to 3’ sequence of primers used for sequencing the variable gag fragment 
and the V3-V4 region of the env gene (Iwata & Holloway, 2008; Steinrigl & Klein, 2003).  
Gene Location Forward primer Reverse primer  
gag 960-1709 TCA GAT GGG ATT AGA CAC CTT CTG CCA AGA GTT GC 
env 7224-8000 GTA CAG ACC CAT TAC AAA CTG CCA CTG GGT TAT ACC 
3.2.3.  Phylogenetic analysis 
Sequences were analyzed and corrected with the 4Peaks software (Mekentosj). The 
fragments for gag and the V3-V4 env fragment were aligned together with reference 
strains in the MEGA 6.06 software package (Tamura et al., 2013), using the ClustalW 
algorithm. Names and GenBank accession numbers of the used reference strains can 
be found in Supplementary Table 1. All further phylogenetic analyses were made in 
MEGA 6.06. To determine the parameter model for genetic distance calculation at the 
nucleotide level, a model test was performed in MEGA. Hence, genetic distances were 
calculated with the Tamura 3-parameter model for nucleotide sequences with a 
gamma distribution with 5 rate categories. Maximum likelihood trees were 
constructed starting from an initial neighbor-joining tree, using bootstrap analysis 
based on 1000 resamplings. 
3.2.4.  GenBank accession numbers 
Nucleotide sequences were uploaded in GenBank and accession numbers for gag and 
env sequences can be found in Table 2.  
3.2.5.  Recombination analysis 
Bootscan analysis for recombination events was performed in the SimPlot 3.5.1 
program (Lole et al., 1999). Reference sequences for the different FIV clades in the 
analysis were M25381 (Petaluma, clade A), U11820 (USIL2489_7B, clade B), 
AF474246 (BM3070, clade C), AY679785/D37811 (Shizuoka, clade D) (Steinrigl et al., 
2010). The Kimura 2-parameter model was used as a distance model, the window was 





3.3.1.  Sample details 
All cats enclosed in the study were naturally infected with FIV. Samples were collected 
from across Belgium, dominantly from the Flanders region, with only one cat in the 
Walloon region. The samples from The Netherlands were more distributed across the 
whole country (Figure 1). Ages at the moment of sample collection ranged from 2 to 15 
years old, with a median age of 8 years. The majority of samples (90%) originated 
from male cats (Table 2). The infected cats were at different stages of infection, but all 
cats had clinical signs, covering a broad spectrum from mild, with fever, anorexia, 
stomatitis, and gingivitis, to severe malignancies (e.g. blood neoplasms). 
 
Figure 1: Geographic distribution of samples collected in Belgium and The Netherlands. The sample 





Table 2: Sample identification, origin, age and subtype assignment. All samples were named following 
Bachmann (Bachmann et al., 1997), the first two letters indicate the home country, followed by two letter indicating 
the province, the next four letters are based on the cat’s name and town. Gag and env genbank accession numbers 
are indicated for samples that generated new unique FIV sequences. 
Identification Location Age sex Clade gag Clade env Accession number 




BEWVdooo Oostkamp 8 M A A KM880118 KM880108 
BEWVkhde Deerlijk 6 M A A KM880119 
 
BEWVflpo Poelkapelle 5 M A A  
 
BEWVprpi Pittem 8 M A A  
 
BEWVslin Ingelmunster 12 M A A  
 
BEWVvisa Sint-Andries 8 M A A  
 
BEOVbaoo Oostakker 4 M A A  KM880105 
BEOVboze Zele 12 M A A  
 
BEOVmame Melsele 3 M A A  
 
BEOVmido Drongen 10 M A A  
 
BEOVvias Assenede 2 M A A  KM880106 
BEOVzwni Ninove 4 M A A  
 
BEANchgr Grobbendonk 8 M A A  
 
BEANcuhe Heist-op-den-berg 6 M A A  
 
BEANslbe Bevel 11 M A A KM880116 
 
BEANzwbo Boom 2 M A A  
 
BEVBcahe Hever 3 F A A  
 
BEVBfika Kampenhout 7 F A A  
 
BEVBozke Kessel-lo 15 M A A  KM880107 
BEVBshvi Vilvoorde 8 M A A KM880121 KM880109 
BEVBziel Elewijt 15 M A A  
 
BEANfrme Meulebeke 3 M A A  
 
BEHEramo Moeskroen 10 M A A KM880120 
 
BELIflzo Zonhoven 12 M A A  
 
BELIomst Sint-Truiden 4 M A A  
 
BELIpopa Paal 12 M A A  
 
NLFLsnal Almere 8 M A A  KM880113 
NLFRfrgr Grou 8 M A A  KM880114 
NLNBbrhe Helmond 8 M A A  
 
NLNBtahe Helmond 13 F A A  
 
NLNHpial Alkmaar 8 M A A  KM880115 
NLNHzwud Uden 8 M A A  
 
NLUTkuvi Vinkeveen 8 M A Unknown KM880117 KM880110 
NLUTpimi Mijdrecht 8 M A A  KM880112 
NLZEkowa Walcheren 8 F A A  KM880111 






3.3.2.  Phylogenetic analysis of gag sequences 
Sequences were aligned with FIV strains that represented clades A to E, additionally 
gag sequences from other EU countries were included as well. The 36 gag fragments 
sequenced in the present study clustered together with clade A reference strains 
(Figure 2). Only 4 gag fragments had an unique sequence, and represented 11% of the 
total sample size. They originated from geographically distinct parts of Belgium and 
The Netherlands. Two samples, BEWVkhde and BEHEramo, formed a cluster together 
with the French isolate Wo (Pancino et al., 1993). All other 32 samples had an 
identical gag sequence, and clustered together with the San Diego isolate FIV PPR 
(Phillips et al., 1990). These samples are represented in GenBank by the sample 
BEVBshvi. The mean genetic distance within these unique isolates was 4.3 ± 1%, which 
was close to the 4.4 ± 1.5% divergence seen within clade A reference sequences.  
3.3.3.  Phylogenetic analysis of env sequences  
With 11 new unique sequences, the env gene showed more genetic diversity than gag. 
From these 11 sequences, 6 came from The Netherlands and 5 from Flanders, this 
made 60% of the samples of the Netherland unique, while the samples from Flanders 
generated only 19% unique sequences. The other samples (n=25) that were analyzed, 
had an env sequence that was identical to FIV PPR. All new samples clustered together 
within clade A, except for NLUTkuvi (Figure 3). This sample from Utrecht, The 
Netherlands, formed a separate cluster with a significant bootstrap value together with 
DESLc08. The latter strain was first reported by Steinrigl and colleagues, and 
originated from a cat that was infected with FIV in Sri Lanka.  
Bootscan analysis of the gag-env concatenated sequences showed no recombination 
between different subtypes. Furthermore, none of the reference sequences for clades A 
to D formed a parental strain for env fragment of DESLc08, while the gag fragment 
was suggested to share a common ancestor with clade A viruses (Steinrigl et al., 2010). 
Hence, a bootscan analysis was performed on NLUTkuvi with reference strains for 
clade A (Petaluma), B (USIL2489_7B), C (BM3070), D (Fukuoka), and DESLC08 as 
potential parent sequences (Figure 4). The analysis revealed DESLc08 as the parental 
sequence for most of the env fragment of NLUTkuvi. The gag fragment, on the other 
hand, resembled the clade A reference sequence. This is no surprise, as NLUTkuvi 
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Figure 2: Unrooted maximum likelihood tree 
for gag sequences constructed under the 
Tamura 3-parameter model and tested by a 
1000 bootstrap iterations. Belgian sequences are 
indicated with black triangles, while samples from 
the Netherlands are indicated with an open triangle. 
The 36 samples generated 4 unique sequences 
(BEWVkhde, BEWVdooo, BEHEramo, BEANslbe), 
while all other sequences clustered together with the 
San Diego isolate FIV PPR. Bootstrap values above 
70 % are indicated at significant nodes. The origin of 
reference sequences are mentioned when not 
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Figure 3: Unrooted maximum likelihood tree 
for env sequences constructed under the 
Tamura 3-parameter model tested by a 1000 
bootstrap iterations. Belgian and Dutch 
sequences are indicated with black and open 
triangles respectively. Only 10 new env sequences 
were discovered, all other samples had an env 
sequence identical to FIV PPR. One of the samples, 
NLUTkuvi, formed a new cluster together with 
DESLc08. Bootstrap values above 70 % are indicated 
at significant nodes. The origin of reference 
sequences are mentioned when not apparent from 




Figure 4: Bootscan analysis performed with Simplot 3.5.1. The concatenated gag-env sequence of 
NLUTkuvi was tested against reference sequences of FIV subtypes A (orange), B (yellow), C (pink), and D (green) 
and against the German sample DESLc08 (Blue). The vertical dotted line indicates the transition from the gag to 
env fragment. The 70% bootstrap level is marked by the horizontal dotted line.  
Genetic distances between the env sequence of the newly formed cluster with 
NLUTkuvi and DESLc08 and the established clades A to E were calculated, and are 
shown in Table 3. Distances to these clades always exceeded 20%, therefore NLUTkuvi 
and DESLc08 could be considered a new env subtype. The distance between DESLc08 
and NLUTkuvi on the other hand was 9.5 ± 2.2%, representing an intra-clade variance 
(Sodora et al., 1994). The mean genetic distance between the generated clade A env 
fragments was 6.6 ± 2.4%, comparable to 7.9 ± 2.6 % between the clade A reference 
sequences. Two samples, NLZEkowa and NLUTpimi, formed a significant cluster with 
the older Dutch isolate Dutch4 (Rigby et al., 1993). NLFRfrgr and NLNHpial, two 
samples coming from the north of The Netherland, formed a bootstrap significant 
cluster together. Apart from BEWVdooo, none of the samples with a unique gag 
sequence presented an unique env sequence. 
Table 3: Mean genetic distance (± standard deviation) between the env fragments of samples 
NLUTkuvi, DESLc08 and BEVBshvi and the different FIV clades A to E based on the reference 
strains used for building the env phylogenetic tree.   
Clade 
Sample A B C D E 
DESLc08 27.6 ± 2.6 % 30.3 ± 3.5 % 34.3 ± 2.8 %  27.2 ± 2.0 % 29.6 ± 3.3 % 
NLUTkuvi 25.3 ± 2.8 % 35.8 ± 2.1 % 35.5 ± 3.2 % 30.1 ± 4.7 % 37.1 ± 4.0 % 







































Consistent with previous reports, the majority of the FIV infected samples were 
derived from male cats (Hayward et al., 2007; Hosie et al., 1989; Reggeti & Bienzle, 
2004). Territorial male behavior leads to a higher fighting incidence and, 
consequently, an increased risk for FIV infection (Natoli et al., 2005). The gag 
sequences from samples collected in Belgium and The Netherlands showed a low 
genetic diversity, although these cats lived in geographically distinct locations. Only 
14% of the samples generated a new unique gag sequence. Two Belgian samples, 
BEWVkhde and BEWVramo, clustered together with the French isolate Wo (Pancino 
et al., 1993). Although the branch did not have a significant bootstrap value, these 
samples did come from cats that live close to the French border. It is likely that cats 
living in that area cross the border more frequently, either as a stray or by movement 
upon purchase.  
The newly described sequences for the env gene showed a larger variation, with a total 
of 33% unique sequences. Surprisingly most of these unique sequences came from 
samples collected in The Netherlands, even though the sample size from that country 
was smaller. Chances of finding new sequences should increase with larger sample 
sizes, but this was not the case. A possible explanation for this bigger sequence 
variation, could be the presence of more physical borders in The Netherlands when 
compared to Belgium. The Netherlands are more compartmentalized by large rivers, 
lakes and the sea than Belgium, blocking free movement across these natural obstacles 
for stray and feral cats. These constrains on virus spread could lead to a more local 
evolution of virus strains. On two occasions, on the other hand, two strains that were 
not geographically related, did share a significant branch. In one of these cases, the 
significant branch was an older Dutch strain, Dutch4, originating from Amsterdam. It 
could be speculated, that there is a larger overall sequence variability in The 
Netherlands compared to Belgium, with occasional spread of local strains by 
movement of households. In contrast with other European countries (Duarte & 
Tavares, 2006; Samman et al., 2011; Steinrigl et al., 2010), FIV samples from Belgium 
and The Netherlands, show a low genetic diversity. All samples, besides one were 
subtyped as clade A FIV strains, confirming the observation made by Steinrigl et al., 
that genetic diversity is higher in Southern European countries (Austria, Italy and 
Portugal), compared with a more uniform variation found in Germany. The lower 
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variability, and the presence of clade A viruses only, may indicate a more recent 
introduction of FIV in the Northern European countries.  
One of the env sequences, NLUTkuvi, did not show any relationship to previously 
identified clades, either by phylogenetic tree building or bootscan analysis for 
recombination. The sequence clustered together with the German strain DESLc08, 
originating from a cat that was infected with an unknown subtype in Sri Lanka 
(Steinrigl et al., 2010). The genetic distance to known FIV subtypes indicates that 
these sequences might belong to a new env subtype. The gag fragment of NLUTkuvi 
belonged to the clade A FIV viruses. Therefore, it could be speculated that NLUTkuvi 
is a recombinant between clade A and the unknown clade to which DESLc08 belongs. 
Another explanation is that co-infection with both subtype A and the unkown subtype 
occurred in this cat and that the generated gag and env sequences are derived from 
separate viruses. Sequencing of the gag gene showed unambiguous results when 
repeated (data not shown), making co-infection a less likely conclusion.  
Unlike gag, env is under pressure from the humoral immune response (Seibert et al., 
1995), causing positive selection of escape mutants. This leads to a large sequence 
variability, especially in the variable loops. The FIV clade system is based on a highly 
variable region in the env gene, V3-V4. Several reports show that intragenic and 
intergenic recombination occurs in the different FIV genes, making it difficult to 
classify these strains in the clade system, as it is only based on env sequences 
(Bachmann et al., 1997; Carpenter et al., 1998; Hayward & Rodrigo, 2008; Kann et al., 
2007; Reggeti & Bienzle, 2004). In this report, the current clade system is also not well 
supported by significant bootstrap values in phylogenetic trees for gag and env, 
especially for clade B. To date, there is some evidence that the env subtyping  predicts 
pathogenicity and disease progression. Several authors have suggested that clade C 
FIV viruses are more pathogenic than clade A viruses (de Rozìeres et al., 2008; 
Pedersen et al., 2001), and for clade B viruses the opposite was proposed (Bachmann 
et al., 1997). However, classification to a FIV clade does not seem to predict good 
cross-protection in vaccination studies (Dunham et al., 2006). Therefore, it might be 
interesting to integrate other genetic regions into the current FIV clade system to 
improve correlations between virus subtyping and virus virulence, disease progression 
and cross-protection upon vaccination. Recently, it was shown that the genes vif and 
orfA are important determinants of replication rate in vitro, partly by interaction of Vif 
with the cellular protein APOBEC (Troyer et al., 2013). While env variability is an 
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important strategy of FIV to deceive the immune system, other proteins can play a 
major role in immune evasion and pathogenicity of a virus strain as well. 
Incorporation of these genes in phylogenetic analyses, and classification based on 
amino acid level may provide a better prediction on pathogenicity.  
In conclusion, a low genetic variability was seen for the FIV gag and V3-V4 env 
sequences from Belgium and The Netherlands. This is in accordance with a more 
uniform variability of FIV as already reported for Northern Europe. We reported one 
V3-V4 env sequence that did not match with any of the previously known FIV 
subtypes, but showed a large similarity to a strain that was first detected in a cat that 
was infected in Sri Lanka. As more FIV sequences from different regions become 
available, more new subtypes seem to emerge. Therefore, it would be interesting to 
generate more full genome FIV sequences or to look into additional regions in the 
genome to ameliorate classification of different FIV strains. This can help to improve 
correlations between virus subtyping and virus virulence, disease progression and 




3.5. Supplementary data 
Supplementary Table 4: FIV references for gag and env sequences used in the  alignments for 
phylogenetic analysis and neighbor-joining tree building.  
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Env and Gag are key components of the FIV virion that are targeted to the plasma 
membrane for virion assembly. They are both important stimulators and targets of 
anti-FIV immunity. To investigate the expression pattern and conformational changes 
of Gag and Env during FIV infection of feline PBMC (the natural FIV host cells) and 
GFox, and after FIV transfection of CrFK, FIV Env and Gag specific MAbs were used. A 
kinetic follow up of Gag and Env expression showed a polarization of both Gag and 
Env expression to specific sites at the plasma membrane of PBMC. In infected GFox 
and PBMC, Env showed antigenic changes during processing and trafficking which 
were not seen in transfected CrFK. Interestingly, mature trimeric Env expressed on the 
plasma membrane of CrFK and GFox was antigenically different from mature Env on 
PBMC. Epitopes available on intracellular immature Env of PBMC were masked on 
plasma membrane expressed Env. In conclusion, mature trimeric cell surface 
expressed Env is antigenically distinct from intracellular monomeric Env in PBMC and 
may mask cells from the feline humoral immunity; it is restricted to a small area on 
the plasma membrane and co-localizes with a large moiety of Gag, which may 
represent a preferred FIV budding site, or initiation of virological synapses with direct 





4.1. Introduction  
Feline immunodeficiency virus (FIV) is a member of the Retroviridae and belongs to 
the genus lentivirus. It is mainly transmitted through biting incidents between cats 
(Natoli et al., 2005). The virus has a broad cell tropism, since it replicates in cells of 
the monocyte/macrophage lineage, and in T- and B-lymphocytes (Beebe et al., 1994; 
Brown et al., 1991; Brunner and Pedersen, 1989; Dow et al., 1999; English et al., 1993). 
The effective immune-evasive properties of FIV allow the virus to cause a lifelong 
infection. After a long asymptomatic incubation phase, FIV infection can cause an 
AIDS-like disease, which is characterized by a depletion of CD4+ T-cells, an increase in 
plasma viral load, and severe immune suppression (Hartmann, 2012; Pedersen et al., 
1989; Tompkins and Tompkins, 2008). 
Lentiviruses are enveloped viruses that have only one heavily glycosylated envelope 
protein in their viral membrane. FIV Env is translated in the rough endoplasmic 
reticulum (ER) as a 150 kDa glycosylated polyprotein. After cleavage of the leader 
sequence, the protein is transported from the ER to the Golgi apparatus, where the 
protein is further processed and cleaved by furin into a surface protein (SU) of 95 kDa 
and a transmembrane protein (TM) of 36 kDa (Stephens et al., 1991; Verschoor et al., 
1993). The envelope surface and transmembrane part remain associated but are non-
covalently linked. Mature Env protein is transported towards the cell surface of 
infected cells and is finally incorporated into the FIV particle as a trimer. Sequence 
alignments showed that the viral envelope protein contains 8 hypervariable regions 
(V1-V9), of which 5 (V1-V6) can be found on SU and 3 on TM (V7-V9) (Pancino et al., 
1993). For infection, the surface protein sequentially interacts with the CD134 primary 
virus receptor and the secondary virus entry port, CXCR4 (de Parseval et al., 2004; 
Richardson et al., 1999; Shimojima et al., 2004; Willett et al., 1997). Conformation 
changes in SU result in the exposure of the extracellular portion of the TM protein that 
contains a hydrophobic fusion peptide, responsible for fusion between the viral 
envelope and the plasma membrane of the host cell (de Parseval et al., 2006; Garg et 
al., 2004). Subsequently, the virus core containing the viral genome is released into 
the host cell cytoplasm.  
Another important FIV structural protein is the Gag polyprotein, which contains the 
matrix (MA), capsid (CA) and nucleocapsid (NC) protein. After translation, the Gag 
polyprotein associates with the plasma membrane through a group of basic residues 
and by myristolyation of the MA part (Brown et al., 2015; Elder et al., 1993; Manrique 
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et al., 2001). The capsid protein ensures polymerization of the Gag polyprotein, which 
is required for particle formation (Serrière et al., 2013). Incorporation of the FIV RNA 
genome is mediated by the nucleocapsid that contains a packaging signal (Kemler et 
al., 2002; Moscardini et al., 2002). Only after budding, the Gag polyprotein is cleaved 
by the viral protease, giving rise to the mature virion core components: the MA 
underneath the envelope, the typical lentiviral cone shaped CA, and the NC that 
stabilizes the viral genome.  
FIV protein expression and conformational changes during viral replication have not 
been extensively studied in feline leukocytes, the natural host cells. Most information 
on FIV behaviour is derived from experiments with the adherent endothelial-like 
Crandell Rees feline kidney cell line (CrFK) transfected with an infectious clone of FIV, 
or GFox cells, which are CrFK cells that stably express the FIV receptor CD134, and 
hence can be infected with FIV (de Parseval et al., 2004). Because important 
differences may exist in the behaviour of viruses in these research cell lines in 
comparison with feline blood mononucleair cells, the information gathered from 
infection models in cell lines should be taken with caution. In the present study, we 
wanted to investigate if there are differences in expression pattern and conformational 
changes of FIV proteins Env and Gag between infected PBMC and infected/transfected 
cell lines.  
4.2. Materials and methods  
4.2.1.  Cells  
CrFK cells were grown in MEM (Gibco) supplemented with 5% fetal bovine serum 
(FBS), 2 % lactalbumine, 100 U/ml penicillin, 0.1 mg/ml streptomycin. GFox cells 
were a kind gift from Dr. J.H. Elder (The Scripps Research Institute). GFox were 
cultured in DMEM medium (Gibco) supplemented with 10% FBS, 100 U/ml penicillin, 
0.1 mg/ml streptomycin, 1% non-essential amino acids (100 x), and 2 mM sodium 
pyruvate. Peripheral blood mononuclear cells (PBMC) were collected from fresh blood 
obtained by venipuncture of the jugular vein of SPF cats (approved by the local ethical 
committee EC2015/79). PBMC were purified by density centrifugation of the blood 
over Ficoll Paque (GE Healthcare). Cells were kept in RPMI (Gibco), 10% FBS, 100 
U/ml penicillin, 0.1 mg/ml streptomycin, 1% non-essential amino acids (100 x), and 2 
mM sodium pyruvate. Following isolation and culture plastic adherence of monocytes 
for 24 h, suspension cells were stimulated for 3 days with 2.5 µg/ml concanavalin A 
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(Sigma), hereafter 100 U/ml interleukin 2 (IL2) (Roche) was added for the duration of 
the culture. 
4.2.2.  Virus  
FIV-PPR was obtained from Dr. J.H. Elder through the AIDS Reagent Program, 
Division of AIDS, NIAID, NIH (Phillips et al., 1990). Virus was grown and titrated by 
end-point dilution in GFox cells.  
4.2.3.  Infection and transfection 
IL2-stimulated PBMC were inoculated with FIV-PPR by spinoculation. Cells were 
washed and resuspended at a concentration of 500,000 cells/ml in virus inoculum 
containing 1000 TCID50/ml. Cells were centrifuged in a 6-well plate at 1200 xg for 90 
minutes at 32°C. Next, plates were incubated an additional half hour at 37°C and 5% 
CO2. For FIV-PPR infection in GFox, cells were seeded at 150,000 cells/ml in a 24-well 
plate on glass inserts. The next day, cells were inoculated with 200 μl virus suspension 
at 1000 TCID50/ml for 1 h. CrFK cells were transfected with the FIV-PPR infectious 
molecular clone. Briefly, CrFK cells were seeded in antibiotic-free medium at 150,000 
cells/ml in a 24-well plate on a glass coverslip. The next day, each well was transfected 
with 0.25 µg plasmid DNA pre-complexed with 0.25 µl PlusReagent® (Invitrogen) 
using 1.5 µl Lipofectamin-LTX® (Invitrogen). Cells were incubated with this 
transfection mix in MEM for 4 h; subsequently the medium was replaced with 
complete CrFK medium without antibiotics.  
4.2.4.  Antibodies 
Mouse monoclonal antibodies against FIV were provided by Custom Monoclonals Intl. 
Corp. (Sacramento, US). Two different antibodies against the FIV Gag polyprotein 
were used, PAK3-2 and P24CR1. The antibody PAK3-2C1 recognizes both the Gag 
polyprotein and the processed capsid protein and was designated αCA-gag, while 
P24CR1 only recognizes the processed FIV capsid protein and was designated αCA-
mature throughout the paper. The anti-FIV SU MAbs used in this paper target, amino- 
to carboy-terminal order, the V2 region (SU2-6, SU2-8, SU2-11 and SU1-12), the V3 
region (SU1-30, SU2-5, SU1-10 and SU1-7), and the V4 region (SU2-3). For clarity, the 
SU MAbs are named after the epitope they target, for instance the antibody SU2-6 




Figure 1: Diagram of the FIV-PPR SU protein with indication of the SU MAb epitopes. The V2 loop 
(blue) contains linear epitopes, V2-1 and V2-4, as well as conformational epitopes, V2-2 and V2-3. The V3 (red) 
contains the CXCR4 binding region. V3-1, V3-2 and V3-3 are linear epitopes with the latter being exposed only after 
SU-receptor interaction, while V3-4 is conformational. The V4 loop (green) contains only one linear epitope, V4-1.  
4.2.5. Immunocytochemistry 
Plasma membrane staining was performed at 4°C or after fixation with 1 % 
paraformaldehyde in PBS for 5 minutes at room temperature. For intracellular 
staining, the fixed cells were permeabilized with cold acetone/water 80% v/v for 5 
minutes at -20°C. Suspension cells were spun onto silicon coated microscopic slides 
prior to permeabilization. Cells were incubated with 20 µg/ml anti-FIV antibody or an 
isotype-matched control antibody in cold DMEM at 4°C or PBS containing 10% 
normal goat serum at 37°C for 1h. Primary antibodies were visible with a 
complementing fluorescently conjugated secondary antibody and nuclei with 
Hoechst33342 (ThermoFisher). Coverslips were mounted on microscopic slides with 
glycerin/PBS containing 2.5% 1,4-diazabicyclo(2,2,2)octane (Janssens). Samples were 
analyzed by confocal laser scanning microscopy (Leica TSC SPE system with Leica 
DM2500 CQS microcope). Pictures were taken with the Leica LAS X interface. 
Subsequent processing of the pictures was performed with ImageJ software (NIH). 
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4.2.6. Western blot for FIV proteins 
Cellular lysates were prepared from FIV transfected CrFK cells and infected GFox and 
PBMC by lysis in buffer containing 50mM TRIS-HCl, 150 mM NaCl, 1% Nonidet P-40, 
0.1% SDS, 5mM EDTA, and protease inhibitor cocktail (Roche) in water. Samples were 
diluted in loading buffer containing β-mercaptoethanol, boiled for 5 minutes and 
loaded on a 10% acrylamide (Biorad) gel. After electrophoresis, proteins were blotted 
on a PVDF-membrane (GE Healthcare). Remaining protein binding sites were blocked 
in a 5% milk solution in PBS containing 0.1% TWEEN-20 (Sigma) overnight. FIV 
protein detection was performed by overnight incubation with αV3-1 (SU1-30) and 
αCA-gag (PAK3-2C1). After washing, blots were incubated with goat-anti-mouse-HRP 
(Sigma) secondary antibodies for 1 h at room temperature. Viral proteins were 
detected with Amersham ECL Prime western blotting detection reagent (GE 
Healthcare) on a ChemiDoc MP System (Biorad).  
4.3. Results  
4.3.1.  Expression kinetics of the FIV structural proteins Env and Gag in 
PBMC, GFox and CrFK 
To get more insights into the FIV viral protein processing and trafficking during the 
replication cycle, the FIV structural proteins Gag and Env were stained at several time 
points (0, 3, 6, 9, 12, 18, 24 and 48 h) post inoculation (p.i.) or transfection. The 
results are summarized in Table 1. FIV virion formation by the different cells was 
confirmed by titration by end-point dilution of the cell culture medium that was 
collected prior to the staining experiments at 48 h p.i. (data not shown). 
After 12 h p.i., the first infected PBMC were detected by positive cytoplasmic Gag 
(stained with αCA-gag) and Env (stained with αV3-1) expression. Starting at 24 h p.i., 
28 ± 6% of the FIV+ cells showed an accumulation of Gag polyprotein in specific areas 
at the plasma membrane, as is shown in Figure 2a-2b. The amount of FIV+ cells 
showing this accumulation of Gag polyprotein remained around 30% during the 
following time points, and was also observed at later time points (7 days p.i.). At 36 h 
p.i., the accumulating Gag was accompanied by cell surface expression of FIV Env. The 
Env protein expressed on the cell surface of the infected PBMC was not distributed 
evenly, but concentrated in one or several clusters on the plasma membrane (Fig. 3a). 
These patches of envelope proteins showed a 100% co-localization with the 
accumulations of Gag polyprotein (Fig. 4a). The first giant cells, containing multiple 
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nuclei, were also detected 36 h p.i., confirming the appearance of Env on the plasma 
membrane and interaction between the Env and the FIV receptors on susceptible cells 
(Fig. 4b). Mature FIV capsid protein (stained with αCA-mature) was observed from 36 
h p.i.. Unlike its precursor, the Gag polyprotein, mature capsid protein was not found 
cytoplasmically, but only in protrusions connected to the plasma membrane (Fig. 2c).  
Figure 2: Expression of FIV Gag polyprotein and mature capsid protein in FIV infected PBMC, 
infected GFox and transfected CrFK. (a) Expression of Gag polyprotein in infected PBMC. (b) Accumulation 
of Gag polyprotein in infected PBMC (white box), starting 24 h p.i. and seen in 30% of FIV infected PBMC for the 
remainder of the culture. (c) Expression of mature capsid protein in infected PBMC, visible after 36 h p.i.. (d) 
Expression of Gag polyprotein in infected GFox. (e) Expression of mature capsid protein in infected GFox. (f) 
Expression of Gag polyprotein in transfected CrFK. (g) Expression of mature capsid protein in transfected CrFK.   
In GFox cells, the first intracellular FIV Gag polyprotein and Env expression was 
visualized at 24 h p.i.. Although cell surface expression of Env was not yet detected, the 
presence of syncytia indicated that Env was already expressed on the plasma 
membrane. Failure to detect Env by staining could be due to a low amount of protein 
on the plasma membrane. At later time points (36 h and 48 h p.i.) Env was clearly 
Chapter 4 
75 
detected on the cell surface of infected GFox cells. Unlike the infected PBMC, plasma 
membrane expressed Env was distributed evenly on the cell surface (Fig. 3b). Also, no 
accumulation of Gag polyprotein at the plasma membrane of FIV infected GFox was 
noticed at any given time point (Fig. 2d). In contrast with infected PBMC, mature 
capsid protein (stained with αCA-mature) was present in the cytoplasm of  FIV 
infected GFox, as can be seen in Figure 2e. 
Figure 3: Cell surface expression of FIV Env SU on (a) FIV infected PBMC, (b) infected GFox and (c) 
transfected CrFK. Plasma membrane expression of the FIV envelope protein stained with αV3-2 (Env SU V3 
region) on paraformaldehyde fixed cells.  
Figure 4: Co-localization of cell surface expressed FIV Env and accumulations of the FIV Gag 
polyprotein in infected PBMC. (a) Co-localization between FIV Gag polyprotein accumulations (stained with 
αCA-gag in green) and cell surface expressed Env protein (stained with αV3-1 in red), 48 h p.i.. (b) FIV infected 
syncytia (full arrow) interacting with non-infected cell (hollow arrow). Concentration of Env and Gag proteins can 
be seen at the contact site (box).  
In CrFK transfected with the FIV infectious clone, cytoplasmic expression of Env and 
Gag was noticeably faster, starting at 6 h post transfection. Three hours later (9 h post 
transfection), Env was also detected on the cell surface of CrFK. Figure 3c shows that 
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similar to the infected GFox cells, Env expression was uniformly scattered across the 
plasma membrane. Also like the infected GFox cells, there was no accumulation of the 
Gag polyprotein at the plasma membrane, while mature capsid protein was detected in 
the cytoplasm of FIV protein expressing CrFK cells (Fig. 2f-2g).  
Table 1: Summary of the kinetics of FIV Env and Gag expression in FIV infected PBMC, infected 
GFox and transfected CrFK.  
The expression and processing of the Gag polyprotein and Env protein in the different
cell types was also analyzed by western blot. In all cell types, the mature capsid protein
(a cleavage product of Gag) with a molecular weight of 24 kDa can be clearly seen (Fig.
5a). The band at 51 kDa represents the uncleaved Gag polyprotein. The larger band at
approximately 150 kDa, lane 1 (CrFK cells), represents the Gag-Pol chimera protein.
Also in lane 1, the cellular lysate of transfected CrFK cells shows more cleavage forms
of the Gag protein (Lin et al., 2006) compared to infected GFox and PBMC in lanes 2
and 3 respectively. Cellular lysate of transfected CrFK cells (Fig. 5b, lane 1) showed two
prominent bands for FIV Env protein at 130 kDa and 100 kDa. The upper band reflects
the Env precursor without the leader sequence of approximately 20 kDa (Verschoor et
al., 1993). The lower band is the SU part (gp95) of the cleaved FIV Env protein. Cell
lysates from infected GFox and PBMC initially showed only one band at 130 kDa, in
lanes 2 and 3 respectively. Longer exposure times (Fig. 5b, lanes 4-6) revealed a very
faint band at around 100 kDa in cellular lysate of PBMC. The Env staining results
already indicated a much higher FIV protein translation in transfected CrFK compared
to infected GFox and PBMC. The lower percentage of infected cells in PBMC compared
to GFox cells is reflected in a lower staining intensity on the blot, which was confirmed
by calculation after correction based on the tubulin staining intensity on the blot.
*Env in: in the cytoplasm, **Env out: on the plasma membrane, 1 Gag accumulation, 2 mature capsid, 3 localized, 4 syncytia present
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Figure 5: Western blot for FIV Gag and cleavage products, and FIV Env SU on cellular lysates of FIV 
infected PBMC, infected GFox and transfected CrFK. (a) Western blot for FIV Gag protein on cellular 
lysates from transfected CrFK (lane 1), infected GFox (lane 2), and infected PBMC (lane 3). (b) Western blot for FIV 
Env protein on cellular lysates from transfected CrFK (lane 1), infected GFox (lane 2), and infected PBMC (lane 3). 
Lanes 4-6 are long exposure pictures of lanes 1-3 respectively. 
4.3.2.  FIV envelope protein expression in CrFK, GFox and feline PBMC 
Expression of FIV envelope protein was assessed in more detail at the moment cell 
surface expression of Env was detectable in all cells used, 48 h p.i. or post transfection. 
By using antibodies that recognize epitopes on different variable loops of SU, 
trafficking and concomitant processing of Env was followed. Epitopes recognized by 
the anti-SU antibodies have previously been mapped (de Parseval et al., 2006; Elder et 
al., 2010; Hu et al., 2014; Sundstrom et al., 2008), and a diagram of the FIV SU 
protein with indication of SU MAb epitopes is pictured in Figure 1. Staining for FIV SU 
protein was performed both for intracellular expression on permeabilized cells, and for 
cell surface expression on live cells at 4°C and on fixed cells.  
4.3.2.1. Epitope availability on cytoplasmically expressed FIV Env 
Clear differences were seen in epitope availability of intracellular FIV Env expressed in 
infected PBMC or GFOx compared to transfected CrFK cells (Table 2). The FIV Env 
V2-loop epitopes (Fig. 6a) behaved similarly and were detected only in close proximity 
but not co-localizing with the Golgi apparatus. This may possibly represent transport 
vesicles that are leaving the Golgi complex. The single exception was the behaviour of 
V2-1. In infected PBMC this epitope was clearly better detected by staining compared 
to the other V2 epitopes, and in transfected CrFK αV2-1 (antibody SU2-6) which 
targets the amino-terminal linear epitope gave a very intense staining, making it 
difficult to distinguish cytoplasmic compartments. Cellular localization of the Env 
staining was confirmed by double staining with calnexin and 58K Golgi protein; 
representative pictures are given in Figure 7. 
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The V3 region contains three linear epitopes; V3-1, V3-2 and V3-3, of which the latter 
is exposed only after interaction between SU and CXCR4 (Grant CK, unpublished 
results). We were not able to map the αV3-4 (antibody SU1-7) binding peptide, 
because it is most likely a conformational epitope. Visualization of the linear epitopes 
V3-1 and V3-2 was similar in infected PBMC and GFOx, and transfected CrFK 
(Fig.6b). These V3 epitopes induced a strong Env staining, and clearly marked Env 
expression in the ER. The epitopes V3-3 and V3-4 delivered a distinct staining pattern 
compared to V3-1 and V3-2 in FIV infected PBMC and GFox, but not in transfected 
CrFK. In GFox, the V3-3 and V3-4 epitope were mainly detected in the Golgi apparatus 
but not in the ER. In PBMC, V3-3 and V3-4 were only seen at sites of cell contact as a 
discrete line. The V4 epitope (Fig. 6c) on Env was detected in transfected CrFK, at a 
lower level in infected PBMC, but never in GFox cells. Extracellular particles were 
found in infected GFox cell cultures stained against V4-1 . 
4.3.2.2. Cell surface accessibility of specific epitopes on FIV Env  
Cell surface expression of mature trimeric Env protein reveals large differences in 
availability of individual SU epitopes with all three cell types examined (Table 2). 
Expression of FIV SU was detected on living CrFK and GFox at 4°C with αV2-1, αV3-1, 
αV3-2, αV3-3, αV3-4, but not with αV2-2, αV2-3 and αV2-4. On CrFK, fixation of the 
cells led to detection of Env with αV2-4 as well, suggesting that fixation induced a 
change in the Env protein within the V2, thereby allowing the V2-4 epitope to be 
recognized. Detection of Env with the V4 epitope (V4-1) was only possible on CrFK 
cells. In sharp contrast with CrFK cells or GFox cells, all the FIV SU specific MAbs 
were negative against Env on live PBMC at 4°C. If PBMC were gently fixed (0.4 % 
paraformaldehyde), then the V3 epitopes V3-1 and V3-2 became available and were 









































































































































































































































































Figure 6: Cytoplasmic FIV Env SU epitope availability in infected PBMC, infected GFox and 
transfected CrFK. (a) Epitopes V2-1 to V2-4 on the FIV Env SU V2 region. (b) Epitopes V3-1 to V3-4 on the FIV 
Env SU V3 region. (c) Epitope V4-1 on the FIV Env SU V4 region.  
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Figure 7: Double staining of FIV Env and markers for the Golgi apparatus and the ER. FIV Env is 
stained with αV3-2, and the ER and Golgi are marked by antibodies against calnexin and 58K Golgi protein, 
respectively. (a) infected PBMC, (b) infected GFox, and (c) transfected CrFK 
4.4. Discussion 
Kinetic follow-up of FIV Gag and Env expression during the FIV life cycle allowed us 
to study the “when and where” of FIV protein expression in different cell types. The 
early onset of viral protein translation in transfected CrFK is no surprise, since the 
transfected proviral DNA does not need to be transcribed and integrated into the host 
chromatin before transcription and translation can occur, as is the case for the viral 
mRNA genome in the infection environment. 
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During the FIV expression kinetics experiments we noted a high concentration of both 
Gag and Env proteins at focal points in the plasma membrane of infected PBMC. After 
translation, Gag protein is targeted towards the plasma membrane by myristoylation 
involving a patch of basic residues (Manrique et al., 2001; Manrique et al., 2004). 
Recently, Brown and colleagues showed that depletion of PI(4,5)P2, a lipid that serves 
as a docking site for proteins, from the plasma membrane of FIV-infected CRFK cells 
inhibited production of FIV particles (Brown et al., 2015). Furthermore, the FIV Env 
protein has been shown to be palmitoylated, a protein modification that can target 
proteins to lipid rafts. Our results indicate that on PBMC FIV Env expression is 
targeted to specific sites at the plasma membrane. Taken together, these results are 
indicative that FIV proteins are targeted to specific microdomains in the plasma 
membrane of infected PBMC. We hypothesize that this polarization may indicate 
active cell sites preferred for virus budding, and/or be the prerequisite for the 
formation of virological synapses, similar to viral egress of HIV and murine leukemia 
virus (Fais et al., 1995; Jolly et al., 2004; Jolly et al., 2011; Owens et al., 1991). Unlike 
murine leukemia virus, FIV was not able to induce polarized expression of its viral 
proteins at cell contacts in CrFK or GFox, which are unpolarized cells. It is therefore 
reasonable that FIV, similar to HIV, can hijack the natural polarization of activated 
PBMC for its egress (Jolly et al., 2011; Miranda et al., 2002). Further research is 
needed to further elucidate these processes associated with FIV spread between 
PBMC. 
Processed Gag protein (mature capsid protein) was detected inside the cytoplasm of 
transfected CrFK and infected GFox, while only the Gag polyprotein could be detected 
in the cytoplasm of feline PBMC. Western blot also showed more cleavage variants of 
Gag in the CrFK cellular lysate compared to GFox and PBMC. Cleavage of the Gag 
polyprotein is believed to occur upon virion budding, and correct timing is essential to 
the production of infectious virus particles. Manrique and co-workers (2001) also 
showed that the Gag polyprotein is sensitive to cleavage by cellular proteases, which 
might also be the case in CrFK and GFox (Manrique et al., 2001). Possibly, a 
premature cleavage of the Gag polyprotein occurs in CrFK and GFox due to premature 
dimerization of the viral protease as a result of a higher viral protein production. 
Clear differences were seen in epitope availability of intracellular FIV Env expressed in 
transfected CrFK cells compared to infected GFOx or PBMC. Except for V2-4, antibody 
targeting of the V2 epitopes is highly dependent on correct N-linked glycosylation 
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(data not shown). In the Golgi complex the N-linked sugars on Env are further 
processed and the Env precursor is cleaved into the SU and TM part. These processing 
events may possibly induce important changes in the SU molecule, with increased 
accessibility of the V2 epitopes as a consequence. Aberrant Env folding may explain 
the availability of V2 epitopes in the ER under transfection conditions, and why 
brefeldin A treatment was able to induce V2 epitope availability in the ER of FIV 
infected cells (data not shown). The epitopes V3-3 and V3-4 delivered a distinct 
staining pattern compared to V3-1 and V3-2 in infected GFox and PBMC, but not in 
CrFK. All the V3 epitopes studied span the CXCR4 binding site that is located in a 
cryptic loop which is opened after interaction with the primary receptor CD134 (de 
Parseval et al., 2006). SU binding to the FIV receptors induces a series of 
conformational changes, which eventual lead to dissociation between SU and TM 
(Garg et al., 2004). Since the V3-3 epitope is exposed only after FIV receptor binding 
(Grant CK, unpublished results), it is possible that enough SU molecules in a post-
receptor interaction conformation are trapped in between cells to result in detection, 
as they would otherwise be discarded in the extracellular milieu. The same might be 
true for V3-4, which is most likely also a conformational epitope. Premature 
interaction between the SU molecule and FIV receptors in the Golgi complex may 
explain the accessibility of these epitopes in the Golgi complex of infected GFox. In 
PBMC, Env protein expression might be too low to detect the V3-3 and V3-4 epitopes 
in the Golgi apparatus. While the CD134 side of the FIV Env-CD134 binding is 
elucidated (de Parseval et al., 2005; Willett et al., 2006), the sites on FIV SU 
responsible for CD134 binding are not. Failure to detected the V4-1 epitope in 
CD134high GFox cells, and to a lower degree in CD134low PBMC, might be caused by 
interaction between V4-1 and CD134, blocking MAb binding. The V4 epitope was 
detected after processing in infected PBMC, but never in GFox cells. Detection of the 
V4 loop was not hampered by glycosylations, and is also not sensitive to ER stress 
induced (mis)folding like the V2 loop (data not shown). 
Env proteins on the cell surface of infected cells and on the virion are important 
targets for anti-viral immunity. Epitope availability and distribution of cell surface 
expressed Env trimers was similar between CrFK and GFox, with exception of the V2-1 
and V4-1 epitope. In contrast, the Env protein expressed on the cell surface of live 
PBMC could not be detected at all. Our results might indicate that the FIV Env trimers 
expressed on the plasma membrane of PBMC, like mature HIV Env, adopts a “closed” 
conformation, hiding the receptor binding site on V3 (Wyatt et al., 1998). The epitopes 
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on V2 may be protected V4 epitopes conformation occlusion and/or by glycosylation. 
It has been demonstrated that uncleaved Env precursor and monomeric Env proteins 
are present on the plasma membrane of infected cells (Celma et al., 2007; Dey et al., 
2008). Compared to normal trimeric Env, these aberrant proteins might not be able to 
conceal certain epitopes from antibody binding. Since Env production and expression 
seems more controlled in PBMC, the low amount of unprocessed gp130 and/or 
monomeric Env on the plasma membrane cells might not be detectable by staining. 
Our staining results of FIV Env on the plasma membrane of PBMC show that the 
epitopes that are preferentially targeted by sera of naturally FIV infected cats are not 
accessible for antibody binding on the cell surface expressed mature trimeric Env 
complexes (CK Grant,unpublished results; Bendinelli et al., 1995). This is in line with 
work by Richardson and coworkers who suggested that most linear B-cell epitopes are 
poorly exposed on functional trimeric FIV Env, and therefore do not contribute to 
virus neutralization (Richardson et al., 1996). Work on HIV proposed that most of the 
anti-Env response is directed against the unprocessed Env protein and/or against 
disassembled Env, that is released as cellular or viral debris (Parren et al., 1997). In 
light of these results it is probable that FIV Env expressed on infected cells or present 
on newly formed viral particles will not be recognized by the immune system, allowing 
them to escape from the humoral response so effectively mounted against them. 
In summary, our results show important differences between Env and Gag expression, 
processing and targeting between the natural host cells of FIV, the feline PBMC, and 
feline adherent cell lines infected or transfected with FIV that are often used. Env and 
Gag proteins seem to be transported towards specific sites at the plasma membrane of 
infected PBMC only, but further research is needed to establish if these events lead to 
synapses between cells and subsequently direct virus transmission from one cell to 
another. Epitopes on Env crucial for virus infectivity were carefully shielded from 
antibody recognition on PBMC, although these regions are immunodominant in sera 
from FIV infected cats.  
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Feline mesenchymal stromal cells were successfully isolated from red bone marrow, 
thymus, lymph nodes and spleen, and immortalized with SV40 large T-Ag. 
Characterization showed that these cells express typical mesenchymal markers, 
vimentin and smooth muscle actin, and produce the extracellular matrix protein 
fibronectin. The production of CCL19, CCL21, CXCL12 and IL7, important for 
lymphoid organ function, was demonstrated at the mRNA level. These cells may be 
useful for in vitro proliferation of hematopoietic stem cells (HSC) and differentiation 
into functional immune cells for research or therapy and for in vitro modeling of 






Feline immunodeficiency virus (FIV) targets multiple cell types of the immune system, 
including monocyte/macrophages, and T- and B-lymphocytes (Brown et al., 1991; 
Pedersen et al., 1987). Infection and death of these cells, especially CD4+ T-cells, 
ultimately lead to a profound dysregulation of the immune system. Furthermore, FIV 
can infect hematopoietic progenitor cells in the bone marrow, and cause involution 
and destruction of the thymus and lymph nodes (Beebe et al., 1992; Huisman et al., 
2004). Together, these phenomena lead to the inability of the cat’s immune system to 
respond to the invasion of pathogens, causing an acquired immunodeficiency 
syndrome (feline AIDS) (Callanan et al., 1992; O'Neil et al., 1996).  
To study the effects of FIV infection in the lymphoid organs, stromal cells that are 
responsible for the structure and function of these organs should get full attention. 
The lymphoid organs can be divided into primary and secondary lymphoid organs. 
The bone marrow and thymus are the primary organs, they are responsible for the 
production and maturation of functional immune cells that are able to respond to 
foreign organism and substances to protect the body from harmful effects. In the 
secondary lymphoid organs, like the lymph nodes, spleen and mucosa associated 
lymphoid tissues (MALT); the adaptive immune response is orchestrated. Professional 
antigen presenting cells encounter T- and B-cells in a controlled environment, 
allowing the generation and stimulation of an effective adapted immune response 
against pathogens detected in the body.  
Stromal cells shape the framework of tissues and produce extracellular matrix proteins 
in which the cells responsible for the function of the organ reside. In case of the 
lymphoid tissues these functional cells are the hematopoietic cells. The capillary 
network in the bone marrow ends in single walled sinuses with a discontinuous 
basement membrane. Reticular cells surround these sinuses and create a niche for 
hematopoiesis by producing reticular fibers, extracellular matrix, and growth factors 
(Nagasawa et al., 2011). Mesenchymal stem cells (MSC) that reside in the bone 
marrow are believed to be the precursor of these reticular cells. In adults, 
hematopoietic activity is reduced, and the red bone marrow transforms into yellow 
bone marrow as the reticular cells differentiate into adipocytes (Nombela-Arrieta et 
al., 2011). The thymus develops from an outgrowth of the endoderm originating from 
the third pharyngeal pouch of the embryo. The structural network of the thymus is 
composed of epithelial cells, divided into cortical and medullar thymic epithelial cells 
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(cTEC and mTEC, respectively). These cells are responsible for the guidance, selection 
and maturation of T-cells progenitors by expressing chemo- and cytokines, presenting 
self-antigens and interacting with the T-cell receptor (Derbinski et al., 2005; Gotter et 
al., 2004; Sanos et al., 2011; Takahama, 2006). The development, growth and 
differentiation of the epithelial network in the thymus depends on the presence of 
mesenchymal cells, that originate from the embryonic neural crest cells and are 
defined by platelet derived growth factor receptor (PDGFR) (Itoi et al., 2007; 
Jenkinson et al., 2007; Odaka, 2009)). The secondary lymphoid organs, lymph nodes, 
spleen and MALT, all have a similar composition.  T- and B-lymphocytes accumulate 
in T-cell zones and follicles, respectively. In the T-cell zone, a reticular fiber network is 
formed by reticular cells. B-cells gather in follicles populated with specialized reticular 
cells called follicular dendritic cells (Nairn & Helbert, 2006). Stromal cells in the 
lymph nodes of human and mice have already been described, and they can be 
differentiated based on the expression of podoplanin (gp38) and platelet/endothelial 
cell adhesion molecule 1 (PECAM1/CD31). Lymph node stromal cells comprise: gp38- 
CD31+ blood endothelial cells (BEC), gp38+ CD31+ lymphatic endothelial cells (LEC), 
gp38+/- CD31- follicular dendritic cells (FDC), gp38+ CD31- fibroblastic reticular cells 
(FRC), gp38- CD31- integrin α7+ pericytes (IAP), and a small proportion of undefined 
stromal cells (Chang & Turley, 2015; Seibert et al., 1995; Zotes et al., 2013). In the 
spleen FDC, FRC and BEC can also be found. In mice, the same markers can be 
applied as for the lymph nodes (Zotes et al., 2013), while in humans additional 
markers are needed (Steiniger et al., 2014).  
In this report, stromal cells from feline primary and secondary organs were isolated, 
cultured and immortalized for further use. A first characterization was performed by 
means of immunofluorescent staining for general lineage cell markers and through 
chemokine and cytokine mRNA profiling.  
5.2. Materials and Methods 
5.2.1.  Isolation and primary cell culture 
In veterinary practices, cats are euthanized regularly for various reasons. The use of 
tissues from these animals helps to reduce the number of laboratory animals. 
Therefore, tissues from euthanized conventional cats were used in this study, after 
informed consent of the owners. This study was approved by the ethical committee of 
the Faculty of Veterinary Medicine, Ghent University (EC2012/043). Eight weeks old 
cats were sedated by intramuscular injection of 0.1 mg/kg dexmedetomidine 
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hydrochloride (Dexdomitor, Orion Corporation) and 0.1 mg/kg ketamine (Anesketin, 
Dechra). Subsequently, the cats were euthanized with an overdose of 20% sodium-
pentobarital intracardially. Immediately after euthanasia, various lymphoid tissues 
were collected and kept on ice in PBS before further processing.  
5.2.2.  Red bone marrow 
Both the left and right femur and humerus were removed and rinsed in PBS 
containing 100 U/ml penicillin and 0.1 mg/ml streptomycin. All following procedures 
were performed in a laminar flow cabinet. The bones were cleared of any tissue 
remaining on the bone, and placed in a sterile bacterial plate. The ends of the bones 
were clipped with scissors, and the marrow was flushed out by insertion of a 18G 
needle and 5 ml syringe. Flushing was performed with ice cold RPMI containing 2 % 
fetal calf serum, 10 U/ml heparin, 100 U/ml penicillin and 0.1 mg/ml streptomycin. 
Following flushing, the marrow was broken down into little pieces by repeatedly 
sucking the pieces through the needle into the syringe. All cells were collected and 
placed in 50 ml tube on ice for 15 minutes to allow bone marrow fat to solidify. Next, 
the tissue mixture was strained over a 100 µm cell strainer, and centrifuged at 300 xg 
for 10 minutes. Contaminating red blood cells were lysed by resuspending the cell 
pellet in 10 ml of red blood cell (RBC) lysis buffer. Cells were seeded on fibronectin (10 
µg/cm2), gelatin (10 mg/ml), or in non-coated 24-well plates in DMEM supplemented 
with 10 % fetal bovine serum, 100 U/ml penicillin, 0.1 mg/ml streptomycin, 0.1 mg/ml 
gentamycin, 1 % non-essential amino acids 100 x, 2 mM sodium pyruvate (stromal cell 
medium). Cells were kept at 37°C in a humidified incubator with 5 % CO2.  
5.2.3.  Thymus and lymph nodes 
The isolation of stromal cells from the thymus and lymph nodes was based on the 
protocol described by Fletcher and colleagues (Fletcher et al., 2011). In young cats the 
thymus is a prominent organ in the chest. After excision, the attached blood vessels 
were removed. The tissue was minced with needles and washed to remove the loose 
thymocytes. Hereafter, the remaining tissue was incubated with 0.2 mg/ml 
collagenase IV in DMEM with continuous stirring for 30 minutes at 37 °C. The tissue 
was washed to collect lose cells. The residual pieces were incubated with 0.4 mg/ml 
collagenase IV for 30 minutes at 37 °C with regular agitation by pipetting. This step 
was repeated until all tissue was digested. The axillary, submandibular, and inguinal 
lymph nodes were collected, and kept in ice cold PBS. The complete lymph node was 
incubated for 20 minutes in an enzyme mix containing 0.2 mg/ml collagenase IV and 
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0.8 mg/ml dispase I in DMEM supplemented with 2 % fetal calf serum, 1.2 mM CaCl2, 
100 U/ml penicillin and 0.1 mg/ml streptomycin. Following this initial digest, the 
lymph nodes were aspirated to break the capsule. Large pieces were allowed to settle 
and supernatant was collected. The pieces of tissue were resuspended in the enzyme 
mixture and left to incubate for 10 minutes at 37 °C and mixed by pipetting every 5 
minutes. This step was repeated until all tissue was digested. The cells isolated from 
thymus and lymph node were strained over a 100 µm cell strainer and centrifuged at 
300 xg for 10 minutes. If cell pellets showed signs of contaminating RBC, a RBC lysis 
step was included. The isolated cells were seeded in stromal cell medium onto 
fibronectin (10 µg/cm2), gelatin (10 mg/ml), or non-coated 24-well plates. 
5.2.4. Spleen 
The spleen was excised, rinsed in PBS containing 100 U/ml penicillin and 0.1 mg/ml 
streptomycin and attached omentum was removed. The tissue was cut into small 
pieces (± 0.5 cm3). To remove lose cells, the pieces were shaken vigorously at 4 °C in 
ice cold DMEM supplemented with 100 U/ml penicillin and 0.1 mg/ml streptomycin. 
This step was repeated twice, after which the pieces were broken down to ± 0.2 cm2, 
and an additional shaking step was performed. The remaining tissue was digested with 
0.5 mg/ml collagenase I and 0.5 mg/ml collagenase IV for 20 minutes at 37 °C. After 
replacement of the enzyme mixture, the tissue was digested for an additional 20 
minutes at 37 °C with agitation by pipetting every 5 minutes. Because the spleen tissue 
seemed to be resistant to degradation with the collagenase mixture, after removal of 
lose cells, the remaining pieces of tissue were digested with DMEM containing 20 % 
trypsin for 40 min at 37 °C with regular agitation. The reaction was neutralized by the 
adding an excess of fetal calf serum. Cells detached by the collagenase and trypsin 
treatment were kept separately. The enzymatic washes were centrifuged at 300 xg for 
10 min, and red blood cells were removed by incubation with RBC lysis buffer. Cells 
were strained over a 100 µm cell strainer, and washed with DMEM. The isolated cells 
were seeded in stromal cell medium on fibronectin (10 µg/cm2) or gelatin (10 mg/ml) 
coated 24-well plates, or in non-coated 24-well plates. 
5.2.5.  Immortalization 
The primary cultures of the stromal cells (7 days after seeding) from various tissues 
were transduced with commercial recombinant lentiviruses (Gentaur) expressing the 
human telomerase reverse transcriptase (hTERT) or the simian vacuolating virus 40 
large T antigen (SV40 T-Ag), or a combination of these two lentiviruses. After 30 
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minutes of inoculation with 200 µl virus suspension, complete culture medium was 
added, and the cells were incubated overnight with the virus/medium (1:1) inoculum. 
The next day, the inoculum was removed, and replaced by complete culture medium. 
When reaching 80 % confluency, cells were trypsinized (0.25 % trypsin with 0.02 % 
EDTA), and seeded into 25 cm2 culture vessels. The clonal expansion of the cells was 
evaluated daily.  
5.2.6.  Immunofluorescent staining 
To investigate the origin of the isolated cells, immunofluorescence staining with 
different cell markers was performed on early passage (p5-10) immortalized cells. For 
staining, cells were seeded on glass coverslips and allowed to reach 70 % confluence. 
Cells were fixed with 1 % paraformaldehyde in PBS containing Ca2+ and Mg2+ (rPBS) 
for 10 minutes at room temperature, followed by permeabilization with 0.1 % Triton 
X-100 for 2 minutes at room temperature. Staining was performed against vimentin 
(Lab Vision Corporatio), desmin (Dako), cytokeratin (Dako), smooth muscle actin 
(Dako), fibronectin (Biorad) and PECAM-1/CD31 (LifeSpan Biosciences). Primary 
antibodies were visualized with appropriate fluorescently labeled secondary 
antibodies, and counterstained with a Hoechst 33342 (Molecular probes) nuclear 
staining. Coverslips were mounted on microscopic slides with glycerin/PBS containing 
2.5 % 1,4-diazabicyclo(2,2,2)octane (Janssens) and analyzed with a confocal laser 
scanning microscope (Leica TSC SPE system with Leica DM2500 CQS microcope). 
5.2.7.  Cytokine and chemokine mRNA RT-PCR 
Early passage (p5-10) immortalized lymphoid stromal cells and feline venous 
endothelial cells (Olyslaegers et al., 2013) were seeded in 25 cm2 culture vessels and 
allowed to reach 70 % confluency. Cells were collected by trypsinization and mRNA 
was isolated with the RNeasy mini kit (Qiagen). To remove any contaminating DNA, 
all samples were incubated with DNase I (NEB) for 15 min at 37 °C. The enzyme was 
inactivated prior to PCR at 70 °C for 10 minutes. The RNA was used as a template in a 
one-step reverse transcriptase PCR for different cyto- and chemokines (Table 1). In 
brief, a 25 µl reaction mix contained 1 µg of sample RNA mixed with 10µl reaction 
buffer 5 x, 2 µl dNTP mix, specific forward and reverse primers (Table 1), RNase free 
water and 2 µl of QIAGEN OneStep RT-PCR Enzyme Mix. The reverse transcription 
took place at 50 °C for 30 min, followed by an initial activation of the DNA polymerase 
at 95 °C for 15 minutes. Next, samples were temperature cycled for 30 times, with 
denaturation at 94 °C for 1 min, annealing at the primer specific temperature for 30 s, 
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and extension at 72 °C for 1 min. After cycling any unfinished products were extended 
at 72 °C for 10 min. The PCR product was separated on a 1.5 % agarose gel in 0.5 x 
TAE buffer for 35 min at 100 mV, and bands were visualized with ethidium bromide 
solution (Sigma). The absence of DNA in the samples was controlled by regular PCR. 
Table 1: Cytokine and chemokine mRNA RT-PCR primers presented in 5’ to 3’ orientation.  
Gene Forward primer Reverse primer 
GM-CSF CGG GGC AGC CTC ACC A GGC TCC CAG CAG TCA AAG 
CCL19 GAT GCT GAA GAC TGC TGC TCT GCA GTC TCC GGA TG 
CCL21 GAC CCA AGG CAG TGA TG CTC CTT TGT CCC TCT TAC AG 
CXCL12 (SDF1) CCG TGT GGC AGA TGG AAG GG CTA TAA ATG CGG GTG TCT ACG 
IL7 AAC AAG GAT CAG GGG AGG AAT AAA GAA CCA GCC GCA GAG ACC 
ICAM1b GTG AGC CAG AGG TCT CAG TTC CGC TGG CGG TTA T-AG 
5.3. Results and discussion 
5.3.1.  Primary and immortalized stromal cell culture 
5.3.1.1. Bone marrow 
One day after isolation, the seeded cells were washed gently to avoid disturbance of the 
attached cells. Independent of the used cell culture surface, a lot of cells remained in 
suspension after 24 h. Pictures of the primary bone marrow culture can be found in 
Figure 1. Overall, the adherent cells could be divided into two groups based on their 
morphology; (1) cells resembling monocytes, and (2) large spindle-like cells. 
Adherence of spindle-like cells was best on fibronectin, followed by gelatin. Cell 
culture grade plastic showed the worst performance but allowed stretching of 
macrophage-like cells. The spindle-like cells on fibronectin started to form clusters on 
day 2 and showed proliferation on day 3. The macrophage-like cells started to form 
giant cells that contained multiple nuclei. The spindle-like cells formed bundles, 
forming growth cavities around the giant cells. The culture showed contact inhibition 
and cells ceased to grow and started dying once confluency was reached. Six days post-
isolation, the cells seeded on fibronectin reached confluency and were split with 
0.025% trypsin and versene solution. The spindle-like cells loosened readily with this 
treatment, while the giant cells remained firmly attached to the coating. In this way, a 
first separation of the different cell types could be made. However, in the first passage 
culture vessels, some remaining macrophage-like cells were observed. 
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Figure 1: Primary bone marrow culture seeded on a fibronectin coated culture dish. (a.) Two days 
after isolation, non-adherent cells were washed away. The white arrow indicates a macrophage-like giant cell with 
multiple nuclei, surrounded by loosely adhering smaller cells. Firmly attached stretched out fibroblast-like cells are 
present in the black circle. 200 x magnification. (b.) On day 3, the clusters of fibroblastic cells started to expand and 
more giant cells appeared (white arrows). 200 x magnification. (c.) After 7 days in culture, the  fibroblast-like cells 
filled the culture dish, showing contact inhibition and leaving spaces for the giant cells (white arrows). 100 x 
magnification. 
Primary cells could be kept in culture for several passages. Cells cultured on cell 
culture plastic showed slower growth kinetics compared to cultures on fibronectin 
coated plates. On cell culture grade plastic, confluency could not be reached, and 
connected cell clusters were formed. On the other hand, cells seeded on fibronectin 
were able to form a monolayer that showed an organization and direction of cells in 
bundles and waves. However, in order to establish a stable cell line for further work, 
first passage cells were transduced using commercial lentiviruses that contained the 
SV40 T-Ag or hTERT gene, or a combination of both lentiviruses. Following 
transduction, only cells transduced with SV40 T-Ag or the hTERT/SV40 T-Ag 
combination could be maintained, with better survival and growth kinetics in the 
SV40 T-Ag only cells. Immortalized cells were morphologically similar to their primary 
counterparts, but cell lines lost contact inhibition, and reduced self-organization of the 
culture in bundles and waves during growth. In contrast to their primary counterparts, 
immortalized cells were able to form monolayers on uncoated culture surfaces. 
5.3.1.2. Thymus 
After washing away loose cells 24 h post-seeding, a small amount of cells had attached 
to the culture plates, but the majority stayed in suspension. It is not surprising that 
non-adherent cells were still present, since the seeded cell suspension probably still 
contained thymocytes, T-cell progenitor cells that were maturing in the thymus. T-
cells do not adhere to cell culture plastic and adhere only loosely to fibronectin. There 
was not a large difference in cell attachment between fibronectin and gelatin coated 
plates, but the coated plates performed better than non-coated plates.  
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Progression of the primary culture is shown in Figure 2. Among the adhered cells, 
three cell types could be distinguished morphologically; polygonal cells, spindle-like 
cells and macrophage-like cells. Some thymocytes remained in the culture dishes after 
gentle washing. Cells collected from the 24 h washing steps were seeded in non-coated 
culture plates and incubated for an additional two days. After this re-seeding more 
spindle-like cells were recovered, but also smaller polygonal cells. It is possible that 
washing 24 h after seeding was too early, and the stromal cells needed more time to 
adhere. Another explanation could be a too high cell number in the well, inhibiting 
contact between cells and the culture surface. The simultaneous isolation of small 
polygonal cell and fibroblast-like cells from thymus was already reported by 
Rzhaninova and colleagues for the human fetal thymus (Rzhaninova et al., 2005). 
Three days post-isolation, outgrowth could be seen of the spindle-like cell clusters in 
the fibronectin coated plates. Cells were split with a 0.025% trypsin and versene 
solution 7 days post-isolation. After passage, the groups of polygonal cells were not 
seen anymore, it is possible that individual polygonal cells were still present in the 
cultures.  
Figure 2: Primary thymus culture seeded on a fibronectin coated culture dish. (a.) Two days after 
isolation, non-adherent cells were washed away. Spindle-like cells were firmly attached and stretched out. Some 
thymocytes remained in the culture dish after washing (white arrow). 200 x magnification. (b.) On day 3, the 
fibroblastic cells started to expand, some cell clusters showed more polygonal cell bodies (black circle) compared to 
the more spindle like cells. There were still some thymocytes present (white arrow). 200 x magnification. (c.) After 
7 days in culture, the spindle-like cells filled the culture dish, showed contact inhibition and an organized growth 
pattern. 100 x magnification. 
Primary cells could be kept in culture for several passages, but cell growth was slow, 
independent of the culture substrate. In order to establish a stable cell line with better 
growth kinetics for future work, passage one cells were transduced using commercial 
lentiviruses that contained the SV40 T-Ag or hTERT gene, or a combination of both 
lentiviruses. As was noticed for the bone marrow stromal cell cultures, only thymus 
stromal cells transduced with the SV40 T-Ag and the SV40 T-Ag/hTERT combination 
survived. After immortalization, the growth rate was improved but still slow compared 
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to bone marrow stromal cells. Unlike immortalized bone marrow stromal cells, 
immortalized thymus stromal cells still needed fibronectin coating to be able to from a 
monolayer. On uncoated culture surfaces cells became large and stopped growing (Fig. 
5). Rzhaninova and colleagues reported that basic fibroblastic growth factor (bFGF) 
was needed for effective growth of mesenchymal cells isolated from the human thymus 
(Rzhaninova et al., 2005), although this growth factor is not required for bone marrow 
mesenchymal cells (Walsh et al., 2000). Hence, addition of bFGF might improve 
growth of the feline thymus mesenchymal cells as well.   
5.3.1.3. Lymph node 
Similar to cells isolated from the thymus, only few cells attached to the culture surface 
after 24 h. After washing, the loose cells were seeded again into new non-coated 
culture plates and incubated for two more days. Once more, this strategy allowed a 
larger quantity of primary cells to be isolated. Gelatin and fibronectin achieved better 
results than cell-culture plastic. Two cell types were observed; the spindle-like cells, 
and macrophage-like cells (Fig. 3). On day two, the first expansion of spindle-like cells 
was seen in the gelatin coated wells. The macrophage-like cells stretched out and 
started to form giant cells. Once full confluency was reached, cell growth stopped due 
to contact inhibition.  
Figure 3: Primary lymph node culture seeded on a fibronectin coated culture dish. (a.) Two days after 
isolation, non-adherent cells were washed away. Spindle-like cells were firmly attached and stretched out. Large 
macrophage-like cells were present in the culture (white arrows). 200 x magnification. (b.) On day 3, the 
fibroblastic cells started to expand. 200 x magnification. (c.) After 7 days in culture, the spindle-like cells filled the 
culture dish, showed contact inhibition and an organized growth pattern, but left spaces for macrophages (white 
arrows). 100 x magnification. 
The primary culture was split 7 days after seeding of the isolated cells with a 0.025% 
trypsin and versene solution. Similar to the bone marrow primary culture, spindle-like 
cells loosened easily, while the macrophage-like cells remained attached to the cell 
surface. Growth kinetics and patterns of the spindle-like cells from the lymph node 
were similar to those isolated from the bone marrow, and the primary cultures could 
be passaged several times without immortalization. Cells were only able to establish a 
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monolayer on fibronectin coated surfaces. On non-coated surfaces, cells formed an 
interconnected network of cell clusters that had the tendency to loosen due to tractive 
forces generated by the cells. In order to establish a stable cell line for future work, 
first passage lymph node stromal cells were transduced using commercial lentiviruses 
that contained the SV40 T-Ag or hTERT gene, or a combination of both lentiviruses. 
As was noticed for the bone marrow and thymus stromal cell cultures, only cells 
transduced with the SV40 T-Ag and the SV40 T-Ag/hTERT combination survived 
passaging. Growth of the immortalized cells on uncoated surfaces was possible but 
slow, and cells became large and stretched. Similar to immortalized thymus stromal 
cell cultures, immortalized cultures from the lymph nodes had better growth 
characteristics when seeded on fibronectin (Fig. 5).  
5.3.1.4. Spleen  
The tissue digested with collagenase or trypsin was seeded onto different culture 
plates, again containing the different surface coatings. One day after seeding, a lot of 
platelets and red blood cell-debris had attached to the culture surface. Most of the cells 
collected after collagenase digestion showed a macrophage-like morphology. Trypsin 
digestion, on the other hand, resulted in the collection of both macrophages and 
spindle-like cells. Like the stromal network in the lymph nodes, FRC in the spleen 
forme a network of reticular fibers and extracellular matrix. The FRC encapsulate 
these matrix proteins to from a conduit system. Apparently, in contrast to trypsin, the 
digestion with collagenase was not potent enough to detach the stromal cells from the 
extracellular matrix. The resident macrophages of the red pulp and cells of the white 
pulp, T- and B-cells, are not firmly attached to the extracellular matrix, but reside 
within the network shaped by the FRC and other stromal cells. On the fibronectin 
coated wells, outgrowth of fibroblastic cells from cell clusters was already seen one day 
post-isolation, but only for the trypsin digested tissue. Although some spindle-like 
cells could be seen on the other growth surfaces (gelatin and cell-culture plastic), they 
were less supportive for growth of the fibroblastic cells, and mainly contained 
macrophages. Two and three days after isolation, the platelets and debris were 
removed by actions of the macrophages, which also started to merge into giant cells 
(Fig. 4). As was seen in the primary bone marrow cultures, the spindle-like cells grew 
in bundles around the macrophages, leaving a niche. The growth kinetics of the 
isolated spindle-like cells was fast and subject to contact inhibition. Hence, on day 5 
post-isolation, the fibroblastic cells growing on fibronectin were split with 0.025% 
trypsin and versene, and seeded in fibronectin coated wells. As already explained 
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before, only the spindle-like cells loosened during trypsin treatment. The stromal cells 
organized themselves in waves when seeded on fibronectin, and showed heavily 
decreased growth kinetics when seeded on cell culture plastic.  
Figure 4: Primary spleen culture seeded on gelatin coated culture dish. (a.) Day 2 after isolation, non-
adherent cells were washed away. Spindle-like cells were firmly attached and stretched out. 200 x magnification. 
(b.) On day 3, the fibroblastic cells started to expand. Large macrophage-like cells were present in the culture 
(white arrows). (c.) After 5 days in culture, the spindle-like cells filled the culture dish, showed contact inhibition 
and an organized growth pattern. The spindle-like cells grew around the macrophage-like cells (white arrows). 100 
x magnification. 
First passage spleen stromal cells were transduced using commercial lentiviruses that 
contained the SV40 T-Ag or hTERT gene, or a combination of both lentiviruses. As for 
all other lymphoid stromal cell lines, only cells transduced with SV40 T-Ag or the 
hTERT/SV40 T-Ag combination could be maintained, with better survival and growth 
kinetics in the SV40 T-Ag only cells. Immortalized cultures behaved similar to primary 
cells, with fast growth on fibronectin coating a reduced growth on uncoated plastic 
(Fig.5). 
Figure 5: Immortalized lymphoid stromal cells cultures (a) on cell culture grade plastic and (b) on a 
fibronectin coating. (a) Passage 8 immortalized cell cultures seeded on cell culture plastic. (b) Passage 5 
immortalized cell cultures seeded on a fibronectin coated culture surface, forming a monolayer. 100 x magnification 
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5.3.2.  Characterization 
5.3.2.1. Marker staining 
The general structure of lymphoid organs is determined by a network of different 
stromal cells. Hematopoietic cells enter and exit the lymphoid organs via the blood 
and lymphoid vasculature, composed of specialized endothelial cells. Stromal cell 
cultures, both primary and immortalized, were analyzed for the expression of the 
epithelial cell marker, cytokeratin, and different mesenchymal markers, such as 
smooth muscle actin (SMA), vimentin, desmin and fibronectin. In humans and mice, 
cells in the secondary lymphoid organs are further characterized by the expression of 
podoplanin (gp38), a heavily glycosylated membrane protein; and platelet/endothelial 
cell adhesion molecule 1 (PECAM1/CD31). Unfortunately, no validated antibody is 
available to test podoplanin expression on feline cells. PECAM1 expression was tested 
with an antibody cross-reacting with feline cells. Results are summarized in Table 2.  
Table 2: Presence of different cellular markers in stromal cells isolated from bone marrow, 
thymus, lymph nodes and spleen.  
 Bone marrow Thymus Lymph node Spleen 
Cytokeratin - -/+ - - 
Vimentin + + + + 
Desmin - - - - 
Fibronectin + + + + 
Smooth muscle actin + + + - 
PECAM1 - - - - 
Immortalized stromal cell cultures from bone marrow, lymph node and spleen were 
consistently negative for cytokeratin expression (Fig. 6). Conversely, the stromal cell 
culture from the thymus showed smaller polygonal cells that were positive for 
cytokeratin expression (Fig. 6). These cells were already noticed morphologically via 
light microscopy. Therefore, it will be important to further clone the thymus stromal 
cell culture, in order to split the two different cell types.  
Vimentin, an intermediate filament characteristic of mesenchymal cells, was uniformly 
expressed by stromal cells of all the isolated lymphoid tissues (Fig. 6). The expression 
of vimentin confirms the mesenchymal origin of the isolated cells. This means that 
some cells isolated from the thymus express both the epithelial cell marker cytokeratin 
as well as the mesenchymal marker vimentin. Dual expression of cytokeratin and 
vimentin has been reported before in thymus epithelial cell lines from mouse and rat 
(Colić, 1991; Ehmann et al., 1986), and intestinal epithelial cell cultures (Desmarets et 
al., 2013). Epithelial cells can express mesenchymal markers as a result of epithelial-
mesenchymal transition (EMT) (Kalluri & Weinberg, 2009). EMT can be induced by 
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immortalization and culturing, but also occurs in the adult thymus. Current 
understanding of the fattening of the thymus indicates a role for EMT in the transition 
of thymus epithelial cell into fibroblasts that can commit to the adipocyte lineage 
(Dixit, 2010). Hence, the cytokeratin+ /vimentin+ cells in the feline thymus cell cultures 
represent most likely TEC that are undergoing partial EMT, either induced by 
immortalization and culture, or as a result of fattening of the post-natal thymus.  
None of the stromal cells isolated from the different lymphoid tissues showed 
expression of desmin, an intermediate filament found in muscle tissue (Fig. 6).  
Stromal cells from all selected tissues produced and excreted fibronectin (Fig. 6). 
Fibronectin is an important extracellular matrix component produced by 
(myo)fibroblasts and epithelial cells. It contains several binding sites for other 
extracellular matrix proteins like collagen, especially with type III collagens, also 
known as reticulin, the constituent of reticular fibers (Engvall et al., 1978). Apart from 
binding other matrix proteins, fibronectin also binds cell adhesion molecules, 
cytokines and growth factors. Furthermore, binding between the fibronectin receptor, 
integrin α5β1, and fibronectin induces cell signaling leading to actin cytoskeleton 
rearrangements, defining the orientation and migration of cells (Huttenlocher & 
Horwitz, 2011). Signaling induced by the fibronectin used to coat the culture vessels is 
most likely responsible for the organization of the mesenchymal cells in waves during 
culture as discussed above, and allowing for the formation of monolayers which was 
not seen on non-coated culture surfaces.  
Smooth muscle actin, a contractile element found in myofibroblasts and smooth 
muscle tissue, was highly expressed in non-confluent stromal cell cultures of the 
various lymphoid tissues, except for the spleen (Fig. 6). However, upon reaching 
confluency, SMA expression was downregulated or absent. Stiffness of cell culture 
surfaces can induce the expression of SMA and the production of stress fibers in 
fibroblasts, and is related to the physiological pathway seen during tissue repair after 
injury (Hinz, 2010). The expression of SMA and the concomitant ability of cells to 
generate tractive forces can be responsible for loosening of cells seen in stromal cell 
cultures in non-coated cell culture plates. Coating wells with extracellular matrix 
proteins gives contracting cells something to firmly adhere to, avoiding loosening of 
cells. In the lymph nodes and spleen, the expression of fibronectin and SMA are 
characteristic for FRC (Aguzzi et al., 2014; Malhotra et al., 2012).  
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In the lymph node, contractility of the reticular network is regulated by interaction 
between podoplanin expressed on FRC and C-type lectin 2 (CLEC-2) on dentritic cells, 
and is important during lymph node activation following an inflammatory response 
(Chang & Turley, 2015). In the thymus, expression of SMA actin has been shown 
around vascular structures, and may represent pericytes, a multipotent mesenchymal 
cell type also found in the bone marrow (Bianco et al., 2008; Odaka, 2009). 
Figure 6: Expression of mesenchymal and endothelial cell markers by cells isolated from feline 
bone marrow, thymus, lymph node and spleen (red and green). Immunofluorescent staining was 




5.3.2.2. mRNA profile 
The mRNA expression of chemokines and cytokines important for the function of 
lymphoid tissues was assessed via RT-PCR of early passage immortalized stromal cells 
(Fig. 7). RT-PCR products were verified by sequencing.  
CCL19 and CCL21 are chemokines produced in lymphoid tissues, with the former 
being the soluble form of the latter. CCL21 is immobilized on glycans present on cell 
surfaces or in the extracellular matrix. These chemokines are the ligands for CCR7, 
that is expressed on immune cells, and induce the chemotaxis of immune cells to the 
lymphoid organs (Chang & Turley, 2015). CCL19 mRNA was present in every 
lymphoid stromal cell culture, while CCL21 was not. It is known that CCL21 expression 
in lymphoid stromal cells is rapidly lost after in vitro culture. Expression can be 
restored by fluid flow over the cells, indicating that interstitial lymph flow in the 
organs is necessary for a complete differentiation and function of the reticular cells 
(Tomei et al., 2009). In the thymus expression of CCL19 and CCL21 by mTEC guide 
immature T-cells back from the thymic cortex to the medulla during their selection 
and maturation process (Bunting et al., 2011). It is possible that the detected CCL19 
mRNA originates from the cytokeratin+/vimentin+ cells found in the feline thymus 
stromal cell culture. Endothelial cells can be induced to produce CCL19, and play a 
role in attracting lymphocytes during inflammation (Alt et al., 2002; Yu et al., 2015). 
The production of these chemokines mainly by FRC in the secondary lymphoid organs 
is important for the generation of the T-cell zone (Cyster, 2000; Koning & Mebius, 
2012; Mebius & Kraal, 2005).  
CXCL12, also known as stromal derived factor 1 (SDF1), is an important lymphocyte 
homing factor that binds to the receptor CXCR4, that also functions as the FIV 
secondary receptor (Joshi et al., 2005). As can be seen in Figure 7, CXCL12 mRNA was 
present in all of the tested cell cultures. In the bone marrow CXCL12 is mainly 
produced by CXCL12-abdundant reticular cells (CAR cells), but also by other 
perivascular cells, endothelial cells and osteoblasts and is crucial to HSC maintenance 
and retention (Mercier et al., 2012; Sugiyama et al., 2006). Cortical thymus epithelial 
cells produce CXCL12 as a guide for the CXCR4-expressing T-cell progenitors to travel 
towards the cortex of the thymus during their maturation and selection (Plotkin et al., 
2003), and also provides survival signals (Bunting et al., 2011). In the spleen CXCL12 
signal is produced by stromal cells in the red pulp, marginal zone and white pulp by 
FRC, and is important for the migration of immune cells to their specific niche 
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(Hargreaves et al., 2001; Umemoto et al., 2012). The expression of CXCR4 on 
lymphocytes reassures recirculation of the lymphocytes from the blood through the 
lymph nodes, in which FRC are the main source of CXCL12 (Malhotra et al., 2012).  
Stromal cells from the bone marrow, thymus and spleen showed presence of IL7 
mRNA, as well as the feline venous endothelial cells. In the bone marrow IL7 is 
produced by stromal cells, and determines B-cell lineage commitment (Kikuchi et al., 
2005), while in the thymus production of IL7 in TEC and mesenchymal cells induces 
survival and maturation of T-cells (Kang et al., 1999). In the spleen IL7 aids in the 
organization of B-cells the marginal zone (Willems et al., 2011).  
Lymphocytes bind to endothelial cells and stromal cells through several adhesion 
molecules like intercellular adhesion molecule 1 (ICAM-1). ICAM-1 is constitutively 
expressed on endothelial cells and cell membrane expression of this molecule is 
increased during inflammation. It is an important factor for the extravasation and 
activation of blood leukocytes that enter tissues. Expression of ICAM-1 in the feline 
venous endothelial cells was previously shown by Olyslaegers and colleagues 
(Olyslaegers et al., 2013). FRC and FDC in the secondary lymphoid organs share a 
common ancestor, the lymphoid tissue organizer cells (LTo cells) that express ICAM-1 
among other adhesion factors to retain the hematopoietic cells at the place of lymph 
node development. Mature FRC and FDC retain the expression of adhesion molecules 
important for clustering and signal transduction in hemapoietic cells (Aguzzi et al., 
2014; Koning & Mebius, 2012).  
Figure 7: The mRNA expression of different cytokines and chemokines in immortalized lymphoid 
stromal cell cultures. Bone marrow (B), lymph node (L), spleen (S), thymus (T); and venous endothelial cells 
(E).  
Although the cells isolated from the different lymphoid tissues express markers typical 
for mesenchymal stromal cells, and express mRNA of cytokines essential to lymphoid 
tissue function, further characterization will be needed. Furthermore, reciprocal 
interaction with hematopoietic cells is essential for differentiation of the mesenchymal 
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cells into fully functional lymphoid tissue stromal cells (Koning & Mebius, 2012; 
Kumar et al., 2015). These interactions will enable us to validate the complete 
expression profile of the isolated and immortalized feline lymphoid tissue stromal 
cells. 
5.4. Conclusion 
Feline mesenchymal stromal cells were successfully isolated from bone marrow, 
thymus, lymph nodes and spleen. The cells were successfully immortalized with SV40 
T-Ag only. Immortalization induced loss of contact inhibition during growth. 
Characterization showed that these cells express the typical mesenchymal markers and 
produced the extracellular matrix protein fibronectin. The cells produced various 
cytokines important for lymphoid organ function at the mRNA level. 
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Feline immunodeficiency virus (FIV) has a broad tropism among cells of the immune 
system, infecting monocytes/macrophages, and both T- and B-lymphocytes. 
Replication in these cells takes a toll on the immune system, eventually leading to an 
acquired immunodeficiency. Important changes occur in lymphoid tissue organization 
during the FIV disease course, and recently it was shown that while FIV replication is 
absent in blood circulating leukocytes, replication is active in the lymph nodes. 
Recently, we isolated and characterized feline mesenchymal stromal cells from 
different lymphoid tissues. It was investigated if these cells influenced the 
susceptibility of leukocytes for FIV infection and if they altered FIV replication in these 
cells. Co-culture with lymphoid mesenchymal stromal cells induced expression of the 
FIV receptors, CD134 and CXCR4, on PBMC. Activated endothelium and lymph node 
mesenchymal cells were able to elevate FIV infection (percentage of infected cells) in 
PBMC. Furthermore, lymphoid stromal cells from bone marrow and lymph node were 




Worldwide, up to 30% of the cat population is infected with the feline 
immunodeficiency virus (FIV) (Yamamoto et al., 2007). This important pathogen is 
the feline homologue of the human immunodeficiency virus (HIV), and has a similar 
disease course. Following infection, flue-like symptoms may be observed for a short 
period of time. Hereafter, the disease goes silent, with a long asymptomatic phase that 
may last for many years. Eventually, the FIV infected cat will develop clinical signs of 
the acquired immunodeficiency, leading to secondary infections that are often the 
cause of death (O'Neil et al., 1996). Like HIV, FIV infects cells of the immune system 
including cells of the myeloid lineage, T-lymphocytes, and B-lymphocytes (Brown et 
al., 1991; Dow et al., 1999; English et al., 1993). FIV susceptible cells express the 
primary receptor CD134, an activation marker belonging to the tumor necrosis factor 
receptor superfamily, and the chemokine receptor CXCR4 (Pedersen et al., 1987; 
Shimojima et al., 2004). Under the influence of neutralizing antibodies, FIV may 
develop escape mutants with reduced need for CD134-binding to induce infection 
(Hartmann et al., 2012). 
Early in FIV infection, secondary lymphoid tissues show signs of a boosted immunity, 
with an increased influx of leukocytes around the high endothelial venules (HEV) and 
the development of numerous germinal centers (Bach et al., 1994; Huisman et al., 
2004). Heavy FIV infection is observed in the thymus, causing disappearance of the 
cortical thymocytes, and concomitant involution of the thymic cortex (Huisman et al., 
2004; Orandle et al., 1997). Active FIV replication in the thymus leads to the influx of 
immune cells that form follicles and germinal centers in the thymic medulla (Huisman 
et al., 2004; Woo et al., 1997). FIV infection also causes alterations in the bone 
marrow, an increased cellularity as a result of myeloid hyperplasia is detected, and 
hematopoietic precursor cells may also be infected (Beebe et al., 1992; Huisman et al., 
2004; Shelton et al., 1990). When the cat’s body can no longer resupply immune cells 
that are depleted due to direct FIV replication and bystander apoptosis, an involution 
and depletion of the immune cells in the secondary lymphoid organs is seen (Rideout 
et al., 1992). Furthermore, the functional organization of these organs by stromal cells 
is lost as well. T-cell numbers decline rapidly, while plasma viremia becomes 
detectable once again. At this stage, severe immunodeficiency causes rapid disease 
progression, leading to death by secondary infections.  
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The lymphoid tissue stromal cells shape the network in which hematopoietic cells 
reside. They create a microenvironment needed for proper function and organization 
of the different lymphoid tissues. Stromal cells produce extracellular matrix proteins, 
communicate with the hematopoietic cells through cytokine production and contact, 
and lay chemotactic tracks for compartmentalization of the different cell types in these 
tissues (Bunting et al., 2011; Mebius & Kraal, 2005; Mercier et al., 2012; Seibert et al., 
1995). Recently it was shown by Eckstrand and colleagues that FIV replication is silent 
in leukocytes circulating in blood, but active in leukocytes in the lymph nodes of FIV-
infected cats during the asymptomatic phase (Eckstrand et al., 2016). This raises the 
hypothesis that lymphoid organs may serve as a viral replication reservoir during FIV 
infection. The lymphoid micro-milieu may activate and/or support FIV replication in 
leukocytes. Previously, we have isolated, cultured and characterized lymphoid stromal 
cells from feline bone marrow, thymus, lymph nodes, and spleen (Roukaerts et al., 
2016). In the present study we investigated if stromal cells from these organs can 
influence the sensitivity of leukocytes for FIV infection, and if these cells influence FIV 
replication in FIV infected leukocytes.  
5.2. Materials and Methods 
5.2.1.  Cells 
Feline mesenchymal stromal cells from lymph node and bone marrow (Roukaerts et 
al., 2016), and feline endothelial cells from vena cava (Olyslaegers et al., 2013) were 
maintained in DMEM supplemented with 10 % fetal bovine serum (FBS), 100 U/ml 
penicillin, 0.1 mg/ml streptomycin, 0.1 mg/ml gentamycin, 1 % non-essential amino 
acids 100 x, 2 mM sodium pyruvate.  
Peripheral blood mononuclear cells (PBMC) were collected from fresh blood obtained 
by venipuncture of the jugular vein from 3 male neutered specific pathogen free cats 
(EC2015/79). PBMC were purified by density centrifugation on Ficoll Paque (GE 
Healthcare). PBMC cultures were established by stimulation for 3 days with 2.5 µg/ml 
concanavalin A (Sigma-Aldrich), after which 100 U/ml interleukin 2 (IL2) (Roche) was 
added for the duration of the culture. PBMC cultures were kept in lymphocyte medium 
containing RPMI (Gibco BRL), 10% FBS, 100 U/ml penicillin, 0.1 mg/ml 




5.2.2.  Virus  
Virus was grown by transfecting GFox cells with a plasmid containing the FIV-PPR 
provirus and allowing virus replication for 2 days. Stocks were titrated by end-point 
dilution on GFox cells. Virus material was obtained through the AIDS Reagent 
Program, Division of AIDS, NIAID, NIH: FIV-PPR  from Dr. Elder JH (Phillips et al., 
1990). 
5.2.3.  Co-culture of venous endothelial cells or lymphoid mesenchymal 
cells with PBMC 
Endothelial cells and mesenchymal cells were seeded at 25,000 cells/ml in 24-well 
plates in double. Freshly isolated PBMC were co-cultured with these cells at a density 
of 250,000 PBMC/ml 12h prior to FIV inoculation. PBMC that had attached to the 
endothelial cells or mesenchymal stromal cells were inoculated by adding 200 μl of 
103.28 TCID50/ml FIV inoculum for 1.5 h to the wells. PBMC that had not attached 
during co-culture or were inoculated prior to co-culture, were inoculated by 
spinoculation. Briefly, PBMC were collected by centrifugation and resuspended in 
virus inoculum containing 103.28 TCID50/ml at a concentration of 1,000,000 cells/ml 
inoculum. The PBMC inoculum mixture was transferred to 6-well plates and spun at 
1200 xg for 1h at 32°C. After centrifugation, the plates were incubated at 37°C for an 
additional 30 min. Following inoculation, all cells were washed, and co-culture was 
continued for 48h, samples were collected at indicated time points.  
5.2.4. Immunofluorescence staining 
5.2.4.1. Cell markers 
The different cell types in the PBMC culture were stained with markers against  CD3 
(Nishimura et al., 2004) for T-lymphocytes, CD21 (clone CA2.1D6, Biorad) for B-
lymphocytes and CD13 (clone 25-2B, VMRD) for myeloid cells. Staining was 
performed either on glass inserts for cells that adhered during the first 24 h post 
inoculation, or in suspension just after isolation and of the population that remained 
in suspension during culture. Adherent cells were fixed with 1% paraformaldehyde and 
washed with phosphate buffer saline containing Mg2+ and Ca2+ (rPBS) and 300mM 
glycine. Next, the cell marker antibodies were diluted in rPBS with 10 % normal goat 
serum (NGS) and incubated with the cells for 1 h at 37°C. After washing, the primary 
antibodies were visualized with fluorescently labeled goat-anti-mouse polyclonal 
antibodies for 1 h at 37°C, and nuclei were counter-stained with Hoechst (Molecular 
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Probes). Cells in suspension were fixed in 1% paraformaldehyde and washed with 
regular PBS. They were incubated with the primary antibodies diluted in PBS with 10 
% NGS at 37°C for 1 h with gentle shaking. Primary antibodies were labeled with 
matching fluorescent conjugated goat-anti-mouse polyclonal antibodies (Invitrogen), 
and nuclei were labeled with Hoechst. Following staining, the suspension cells were 
cytospined onto microscope slides for analysis by fluorescent microscopy.  
5.2.4.2. FIV receptors 
FIV receptor staining was performed on life cells at 0°C (on ice). Briefly, cells were 
incubated for 1.5 h in ice cold PBS containing 10 μg/ml anti-CXCR4 (IgG2a, clone 
374606, R&D Systems) and 20 μg/ml anti-CD134 (IgG1, clone 7D6, AbD Serotec), 
with gentle shaking. After incubation with the primary antibody mix, cells were 
washed and fixed with 1% paraformaldehyde in PBS for 10 minutes at room 
temperature. The primary antibody mix was visualized with isotype specific goat anti-
mouse secondary antibodies, GαM-IgG2a-AF488 and GαM-IgG1-AF594, respectively.  
5.2.4.3. FIV infection staining 
PBMC were stained for FIV infection after fixation with 1 % paraformaldehyde in PBS 
for 10 minutes at room temperature. Next, cells were spun onto silicon coated 
microscope slides and permeabilized with 0.5 % triton-X100 for 15 minutes at 37°C. 
The samples were incubated with 13.3 µg/ml anti-FIV Gag (PAK3-2C1, CMI) or 13.3 
ug/ml anti-FIV Env (SU1-30, CMI) in PBS containing 10 % normal goat serum at 37°C 
for 1,5 h. The primary antibody was visualized with a goat anti-mouse IgG1-AF594 
conjugated antibody. Samples were counterstained with Hoechst nucleus staining. All 
stainings were analyzed by confocal laser scanning microscopy (Leica TSC SPE system 
with Leica DM2500 CQS microcope). Pictures were taken with the Leica LAS 
X interface. Subsequent processing of the pictures was performed with the ImageJ 
software (NIH). 
5.2.5.  FIV gag qPCR 
Supernatant from FIV infected cells was analyzed at various time point post infection 
for the amount of viral RNA using an FIV gag qPCR. A one step quantitative real-time 
RT-PCR with SYBR Green detection was performed with primers for the FIV capsid 
protein (forward primer gag-1356bp: AAC AAG CAG AAS CWA GAT T; reverse primer 
gag-1455bp: CGA GGA GAT TTA GCC TTT). Synthetic FIV standard RNA was 
produced in vitro, as follows. Viral RNA was isolated from FIV-PPR stock using the 
QIAamp Viral RNA Mini Kit (Qiagen). From this viral RNA, cDNA was made using the 
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SuperScriptTM III First-Strand Synthesis System for RT-PCR (Invitrogen). For this 
reaction, 5 ng viral RNA was incubated with 2 µM reverse primer for FIV gag and 10 
mM dNTP mix for 5 min at 65°C. After cooling on ice, an equal amount of cDNA 
synthese mix containing 10x RT buffer, 25 mM MgCl2, 100 mM DTT, 40 U RNase OUT 
and 200 U Superscript II RT was added and incubated at 50°C for 50 min. The 
reaction was terminated by heating at 85°C for 5 min. RNA was cleared from the 
produced cDNA by incubation with RNase H for 20 min at 37°C. The produced cDNA 
was amplified with Heculase II polymerase (Agilent Technologies Inc.) in a reaction 
with the FIV gag forward primer extended with a T7-promotor and FIV gag reverse 
primer. The reaction was cycled with an initial denaturation at 98°C for 1 min, after 
which 30 cycles of 95°C for 20 s, 50°C for 20 s and 68°C for 1 min followed. A final 
extension took place for 4 min at 68°C. The 50 µl reaction mix contained 5x Herculase 
II buffer, 25 mM dNTP mix, 1.25 µl forward and reverse primer, 0.5 µl Herculase II 
polymerase, and 2 µl cDNA template. From this FIV gag cDNA, the synthetic FIV 
mRNA standard was transcribed. The cDNA was transcribed for 1 h at 37°C in a 
reaction mix containing 10x transcription buffer, 500 mM rNTP, and 20 U T7 RNA 
polymerase-Plus Enzyme Mix. The template cDNA was removed by incubation with 2 
U DNAse for 15 min at 37°C. The DNAse was inactivated at 70°C for 10 min. The 
amount of synthetic FIV Gag RNA was determined by spectroscopic measurement 
with the Nanodrop 2000 system.  
RNA was extracted from cell culture medium using the QIAamp Viral RNA Mini Kit 
(Qiagen). To 17 µl of One step Precision Master Mix (Primer Design), 3 µl of sample 
was added for a final reaction volume of 20 µl. The One step Precision Master Mix 
contains SYBR® Green and ROX for detection of amplification, and was cycled on a 
Step One PlusTM  real-time PCR system (Applied Biosystems). Reverse transcription 
took place at 55°C for 10 min, followed by an inactivation of the reverse transcriptase 
and activation of the DNA polymerase at 98°C for 10 min. Next, amplification was 
allowed for 40 cycles of 10 s at 95°C and 1 min at 56°C, fluorescence was detected 
every cycle. A first-derivative melting curve analysis was performed by heating the 
reaction to 95 °C for 15 s, cooling to 60 °C for 1 min and reheating to 95°C at 0.3°C 
increments. The standard curve was set-up by a serial ten-fold dilution of the synthetic 






5.3.1.  Influence of lymphoid mesenchymal cells on FIV susceptibility of 
PBMC 
The PBMC fraction of the blood consists of monocytes and B- and T-lymphocytes; 
RBC, platelets and granulocytes (mast cells, neutrophiles and eosinophiles) are 
removed by density centrifugation. The amount of monocytes, B-cells and T-cells in 
the PBMC fraction was determined immediately after isolation for each cat (Figure 1a). 
Myeloid cells (monocytes and remaining granulocytes) were identified by the 
expression of aminopeptadase N (CD13), and represented 16 ± 3% of the PBMC. B-
lymphocytes are characterized by the expression of complement receptor 2 (CD21), 
and corresponded to 12 ± 4 % of the isolated PBMC. T-lymphocytes can be recognized 
by expression of the T-cell receptor complex (CD3), with a total of 56 ± 10 %.  
Immediately after isolation, PBMC did not express the FIV receptors CD134 and 
CXCR4 (Fig. 1b). Culturing PBMC in vitro is enough to trigger the recruitment of 
intracellular pools of CXCR4 to the plasma membrane (Troth et al., 2008). Culturing 
cells for 24 h while allowing plastic adherence resulted in more than 85% of the PBMC 
expressing CXCR4, both on suspension cells and adhered cells (Fig. 1b). To stimulate 
in vitro proliferation and induce expression of the FIV receptors, PBMC are usually 
stimulated with concanavalin A (conA), a plant lectin that induces mitoses, for 3 days. 
This initial stimulation is followed by interleukin 2 (IL2), a cytokine important for T-
lymphocyte survival, for duration of the culture. After stimulation with conA and IL2, 
the expression of CXCR4 declined, and stabilized at around 30% CXCR4+ cells. Unlike 
CXCR4, CD134 was not yet expressed on PBMC 24 h post isolation (without 
stimulation), but was up-regulated to 16 ± 3% after 3 days of conA stimulation. Four 
days of IL-2 incubation further boosted CD134 expression, reaching maximum levels 
of 33 ± 4% (Fig. 1b). The mitogenic stimuli also altered the phenotype of the T-cells 
from small and round to cells with an increased size, extended cytoplasm, and the 
appearance of plasma membrane protrusions. When culturing PBMC in presence of 
conA and IL2, monocytes and B-lymphocytes were not maintained in the culture, with 
numbers declining steeply resulting in 5% B-cells. Monocytes are partially lost due to 
adherence to the culture plastic, less than 1% monocytes were found in PBMC cultures 




Figure 1: Change in cell-types present in the PBMC culture and expression of the FIV receptors 
CXCR4 and CD134 over time in presence of conA and IL2 stimulation. (a) PBMC cell-type composition; 
myeloid cells as detected with CD13 (white), B-lymphocytes as detected with CD21 (grey), T-lymphocytes as 
detected with CD3 (dark grey). (b) Expression of the FIV receptors CXCR4 (white) and CD134 (grey) in PBMC 
cultures under influence of conA and IL2 stimulation, initiated after plastic adherence. *Stained both on cells that 
have adhered to the culture plastic and cells that remained in suspension after 1 day of culture. Subsequent time 
points were stained on suspension cells only.  
To be able to influence the susceptibility of feline PBMC for FIV, lymphoid 
mesenchymal stromal cells should be able to induce CD134 and CXCR4 expression. 
Feline endothelial cells are used as a control, representing the blood vessel wall, since 
no FIV replication is detected in blood. Freshly isolated cells were co-cultured for 12 h 

































































stromal cells from bone marrow and lymph node. To simulate an inflammatory 
environment, the endothelial and mesenchymal cells were incubated with 1 ng/ml 
TNF-α for 12 h prior to co-culture with PBMC. Cell membrane expressed CXCR4 
reached levels above 80% for all three cats with every cell type after the 12 h 
incubation period. Co-culture with the different cells also induced expression of CD134 
on the PBMC, reaching 11-28% after 12 h. Freshly isolated PBMC and PBMC in culture 
for 24 h without stimulation (Fig. 1b), can be used as a baseline control for these 
results. No significant difference (kruskal-wallis test) was found between the different 
cell-types with or without TNF-α pre-incubation (Fig. 2). Also, no difference was found 
between venous endothelial cells and lymphoid mesenchymal cells.  
Figure 2: Expression of CXCR4 and CD134 on PBMC after a 12 h co-culture with lymphoid 
mesenchymal cells and endothelial cells. B: bone marrow mesenchymal cells, L: lymph node mesenchymal 
cells, E: venous endothelial cells. Cells were pre-treated with TNF-α for 12 h prior to PBMC co-culture (+) or 
untreated (-).   
Since mesenchymal cells from lymphoid tissues and venous endothelial cells were able 
to induce the expression of the FIV receptors, it was tested if these cells could alter FIV 
sensitivity of PBMC. After a 12 h co-culture period, PBMC were inoculated with FIV, 
and further cultured together with venous endothelial cells or lymphoid mesenchymal 
cells. Samples were taken at 12, 36 and 48 h post inoculation, covering one replication 
cycle. After 12 h, viral proteins expression was barely detectable. Infection percentages 
remained low, but detectable at 36 (not shown) and 48 h (Fig. 3). No statistical 
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difference (kruskal-wallis test) was found between the FIV infection percentages in 
PBMC co-cultured with the different cell types. This lack of significance is partly due to 
the great variance in infection percentage between PBCM isolated from cat 1 and 2, 
and cat 3. Overall the infection percentage was much lower in cat 3 compared to the 
other cats, except for PBMC co-cultured with mesenchymal cells of the lymph nodes. 
Here FIV infection percentages increased in cat 3, but are lower compared to co-
culture with bone marrow mesenchymal cells or endothelial cells for cat 1 and 2. 
Although not statistically different, FIV infection percentages in PBMC co-cultured 
with endothelial cells stimulated with TNF-α are higher for cat 1 and 2. Virion 
production was measured at the different time points by RT-qPCR, but did not reach 
levels higher than those measured at 0 h post inoculation, representing remaining 
inoculation virus (data not shown).  
Figure 3: Percentage of FIV infected cells in PBMC co-cultured with lymphoid mesenchymal cells 
and venous endothelial cells for 48 h. Cells were pre-treated with TNF-α for 12 h prior to PBMC co-culture 
(+) or untreated (-). Results are presented for every cat; cat 1 (white), cat 2 (grey), cat 3 (dark grey).  
5.3.2.  Influence of lymphoid mesenchymal cells on FIV replication in FIV 
infected PBMC 
Next, it was tested if the mesenchymal stromal cells could influence FIV replication in 
PBMC already infected with FIV. PBMC (cat 1) were artificially stimulated with conA 
and IL2, and inoculated with FIV immediately prior to co-culture with mesenchymal 
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control for inflammatory conditions. Infection percentages were determined on one 
and four days post-inoculation. Already on day 1, infection percentages were much 
higher in PBMC stimulated with LPS or co-cultured with the lymphoid mesenchymal 
cells compared to control PBMC in regular lymphocyte medium. The effect was even 
more prominent on day 4 post inoculation.  
The amount of virus in the cell culture medium was determined by RT-qPCR. After 4 
days of co-culture, a one log10 increase was measured compared to day 1, but no 
difference was observed between the different culture conditions.  
Figure 4: Percentage of FIV infected cells in PBMC inoculated with FIV prior to co-culture with 
lymphoid mesenchymal cells and the amount of virus particles shed in the medium. (a) Percentage of 
FIV infected cells in FIV inoculated PBMC co-cultured with bone marrow or lymph node mesenchymal stromal 
cells, or cultured in presence of LPS. IL2 stimulated inoculated PBMC were used as a control. Infection percentages 
were determined on day 1 (white) and day 4 (grey) post co-culture. (b) Amount of FIV virus particles in culture 
medium of FIV inoculated PBMC co-cultured with bone marrow or lymph node mesenchymal stromal cells, or 
cultured in presence of LPS. IL2 stimulated inoculated PBMC were used as a control. An FIV qPCR on the culture 
medium was performed on  day 1 (white) and day 4 (grey) post co-culture. 
5.4. Discussion 
FIV affects the structure and function of both primary and secondary lymphoid organs 
in infected cats. Recently, active replication of FIV was found in the lymph nodes, 
while this is absent in blood. Therefore it was investigated whether lymphoid stromal 




















































cells are able to influence the susceptibility of PBMC for FIV infection and if they could 
alter FIV replication in these cells.  
The expression of the FIV receptors, CD134 and CXCR4, was absent on freshly isolated 
feline PBMC, and was up-regulated after artificial stimulation or co-culture with 
venous endothelial cells and mesenchymal stromal cells originating from bone marrow 
and lymph nodes. CD134 is up-regulated after initial stimulation of immune cells, and 
provides additional stimulation signaling securing prolonged proliferation, survival 
and expression of cytokines (Salek-Ardakani & Croft, 2006). Willett and colleagues 
described that CD134 expression is predominant on feline CD4+ T-lymphocytes, but 
also occurs to a lesser extent on CD8+ T-lymphocytes, B-cells and macrophages 
(Willett et al., 2007). Expression of CD134 on macrophages can be up-regulated after 
LPS stimulation (Willett et al., 2007). On naïve cells, induction of CD134 expression is 
slow, and onset may take from 12 h up to 5 days. Memory cells, on the other hand, can 
show expression as early as 1 h post activation (Croft, 2010). Our results also show that 
CD134 expression on PBMC is slow after artificial stimulation, and is dependent on 
activation signaling provided by conA and IL-2 stimulation. It has been shown before 
that IL2 can enhance and prolong CD134 expression (Croft, 2010). After co-culture 
with lymphoid mesenchymal cells and venous endothelial cells, comparable levels of 
CD134 were detected already after 12 h of co-culture. This shows that the co-culturing 
provides stimulation, either direct or indirect, that causes rapid CD134 expression. 
Surprisingly no difference was found between the blood vessel wall control (venous 
endothelial cells) and the lymphoid mesenchymal cells. Although these immortalized 
endothelial cells seem phenotypically unaltered, it is possible that they do produce 
different cytokines in vitro compared to the in vivo situation. Furthermore, it is likely 
that they are able to communicate with the PBMC that are added during co-culture. 
Although CXCR4 expression is absent on freshly isolated cells, culture of PBMC was 
enough to induce CXCR4 expression as has been shown before (Saleh et al., 2007; 
Troth et al., 2008). The increased expression of CXCR4 ex vivo might be due to the 
absence of its ligand stromal derived factor-1 (SDF1/CXCL12) that induces 
internalization of the receptor after binding. However, CXCR4 is down-regulated after 
mitogenic stimulation of PBMC with conA, as was shown here, or phytoheamaglutinin 
(Bermejo et al., 1998). It can thus be concluded that lymphoid stromal cells are more 
potent inducers of CD134 expression on PBMC, while maintaining CXCR4 expression.  
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Because the lymphoid mesenchymal cells and endothelial cells were able to induce FIV 
receptor expression, their influence on FIV infection sensitivity of PBMC was tested. 
Although there were no statistical significant differences in FIV sensitivity of PBMC 
co-cultured with the different cell-types, some promising observations were made. 
One cat (cat 3) showed much lower infection percentages compared to the other two 
(cat 1 & 2). When looking at the composition of the PBMC population upon isolation, 
this cat has a lower proportion of T-cells and monocytes compared to the other cats. It 
is known for HIV that multiple host factors influence the susceptibility to the virus and 
the progression of the disease (Lama & Planelles, 2007). This probably holds true for 
cats as well. For instance, the long-term FIV infection study by the group of Murphy B 
recently demonstrated the existence of a long-term nonprogressor cat  (Eckstrand et 
al., 2016). Although overall infection percentages were low in PBMC of cat 3, upon co-
cultured with mesenchymal cells of the lymph nodes, infection percentages matched 
those of the other cats. It has been shown that while CXCR4 expression is absent on 
freshly isolated feline PBMC, it is high on cells residing in lymphoid tissues (Troth et 
al., 2008). The FIV isolate used for inoculation, FIV-PPR, uses both CD134 and 
CXCR4 to establish infection. However, it has been shown that in cells expressing high 
levels of CXCR4, the CD134 interaction becomes dispensable (de Parseval et al., 
2004). Thus, co-culture with mesenchymal cells from the lymph node might increase 
CXCR4 concentrations on the cell surface of PBMC, leading to higher FIV infection 
percentages.  
An elevated FIV infection percentage in PBMC of cat 1 and 2 when co-cultured with 
TNF-α treated venous endothelial cells was observed. Stimulation of these endothelial 
cells with TNF-α induces the expression of several leukocyte adhesion factors 
(Olyslaegers et al., 2013), allowing leukocytes to actively interact with these cells. 
Furthermore, TNF-α can induce the expression of CD134 ligand (CD134L/CD252) on 
the cell surface of vascular endothelial cells (Imura et al., 1996), and thereby adhere 
activated leukocytes and induce CD134/CD134L signaling on both sides. CD134L 
exists as a membrane anchored and soluble form, and signaling through the 
cytoplasmic tail of membrane bound CD134L is believed to increase cytokine 
production in vascular endothelium (Kotani et al., 2002). For HIV it was shown that 
stimulation of resting CD4+ T-cell with CCL19/21, a cytokine expressed by lymphoid 
tissues and activated endothelium to attract leukocytes (Chang & Turley, 2015; Yu et 
al., 2015), can increase integration of the HIV provirus upon infection (Saleh et al., 
2007). Activation causes upregulation of both FIV receptors on lymphocytes and 
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macrophages, and increases signaling that actives transcription factors that can bind 
the FIV promoter region enhancing transcription of FIV mRNA (Busillo & Benovic, 
2007; Croft, 2010; Sparger et al., 1992). Activation of leukocytes via direct cellular 
interactions and indirectly through cytokines might create a favorable environment for 
FIV infection at inflammatory sites, but further research will be needed.  
Results might suggest that FIV susceptibility and replication in PBMC of cat 1 and 2 
relies on different processes compared to cat 3. Cat 1 and 2 showed increased FIV 
infection percentages in the activated endothelium environment, while cat 3 showed 
increased FIV infection in the CXCR4 inducing lymph node environment.  
Preliminary results suggest that mesenchymal cells from bone marrow and lymph 
node can enhance FIV replication efficiency in infected PBMC (cat 1), at least for some 
cats. Co-culture of inoculated PBMC with mesenchymal stromal cells was even more 
potent in increasing the number of infected PBMC than an artificial stimulus with LPS. 
Further work, involving a greater number of cats and a more fine-tuned lymphoid 
tissue model, is needed to confirm these first results. This will allow us to confirm if 
and how lymphoid tissues sustain ongoing FIV replication, and which factors and 
processes are involved. Additionally, results from more cats could also shed some light 
on reasons for the differences in FIV progression between cats. Recent work showed 
active FIV replication in lymph nodes even in the asymptomatic phase of the FIV 
disease course (Eckstrand et al., 2016). It will be interesting to investigate if 
mesenchymal stromal cells from lymphoid tissue are able to reactivate FIV replication 
in latently infected cells, and by doing so assure replenishing the FIV reservoir.  
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Twenty years ago, the human immunodeficiency virus was discovered in patients 
that presented an acquired immunodeficiency resulting in the development of 
numerous secondary and opportunistic infections. Shortly after HIV, feline 
immunodeficiency virus (FIV) was discovered in cats with similar symptoms that 
were negative for feline leukemia virus infection (Pedersen et al., 1987). Twenty 
years of feline retroviral research taught us a lot about the viral proteins, genome 
and the anti-FIV immune response, but nonetheless left major questions about the 
viral replication cycle and pathogenesis. There is no antiretroviral therapy 
commercially available for cats and a positive FIV diagnosis is often a death 
sentence. An FIV vaccine was developed, but efficacy of the vaccine is currently 
still a matter of debate. Therefore, the vaccine is not available in Europe and the 
use of this vaccine is not recommended. 
This thesis aimed to shed some new light on open questions in the FIV 
pathogenesis: (1) how does FIV survive and cause a lifelong infection while the 
generated immune response is vigorous, and (2) how can the disease progress in 
the asymptomatic phase with no apparent viral replication. Before trying to 
answering these questions the strains that are circulating in Belgium and The 
Netherlands were genetically characterized.  
6.1. Low genetic variability between FIV strains in Belgium and The 
Netherlands.   
FIV is divided into five different clades (A to E), based on phylogenetic analyses of 
variable regions 3 to 5 in the env gene (Kakinuma et al., 1995; Sodora et al., 1994). 
Overall, a low genetic variability was found between env and gag gene fragments 
of FIV field strains collected in Belgium and The Netherlands (Chapter 3). Except 
for one unknown virus, all viruses (n= 36) belonged to clade A FIV viruses. Clade A 
and B are found worldwide and might be considered as the general subtypes, while 
other clades are only found in geographic isolated regions (Yamamoto et al., 
2007). For example, subtype E has been found only in South-America and subtype 
D only in Japan (Kakinuma et al., 1995; Pecoraro et al., 1996). In Europe, clades A 
and B are most prevalent, followed by some reports of clade C virus in Germany 
and a new subtype in Portugal (Duarte & Tavares, 2006; Hosie et al., 1989; 
Steinrigl et al., 2010). This could mean that FIV viruses change locally, and might 
be spread again to other parts of the world by movement of FIV infected animals. 
FIV is a lentivirus that infects members of the Felidae and Hyenidea, and each host 
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harbors their own FIV variants (Brown et al., 1994; Carpenter et al., 1996; Troyer 
et al., 2005). One might speculate that virus variance can also arise from 
recombination with FIV strains from other species. While such cross-over 
infections have been reported in captivity, these infections are very rare in the wild 
and often restricted due to incompatibility of the virus and the host (Troyer et al., 
2008; VandeWoude et al., 2010). The lack of genetic variation between strains 
collected in Belgium and The Netherlands (Chapter 3) most likely indicates a 
relatively recent introduction of the virus in the region.  
While this locally low variability might be encouraging to consider vaccination to 
prevent infection, caution is needed. Numerous vaccination trails have reported 
enhancement of disease upon challenge, and this enhancement seems to be 
attributed to anti-FIV Env antibodies (Haseltine, 1991; Miyazawa et al., 1991; 
Rigby et al., 1993; Zhu et al., 1996). In addition, the generation of broad-
neutralizing antibodies against FIV by vaccination has been proven to be an 
unsuccessful strategy (Bęczkowski et al., 2015). Presence of broad-neutralizing 
antibodies against FIV in naturally infected cats did not correlate to slower disease 
progression or improved health status (Westman et al., 2016). This is not that 
surprising since we and others have shown that neutralization sensitive epitopes 
are inaccessible on the mature FIV Env protein expressed on PBMC (chapter 4) 
(Richardson et al., 1996), as will be discussed below. Furthermore, it has been 
proposed that vaccination may create FIV responsive memory cells that are rapidly 
activated upon challenge. Activated memory cells have accelerated CD134 
expression (FIV primary receptor) kinetics upon activation and can cause a rapid 
expansion of the FIV target cells (Lecollinet & Richardson, 2008).  
6.2. Hide and seek: FIV proteins on top of the game 
All viruses in the genus Lentivirus are able to infect monocytes/macrophages. 
Equine infectious anemia virus (EAIV), caprine arthritis and encephalitis virus 
(CAEV) and maedi-visna virus (MVV) mainly infect monocytes and macrophages, 
and attract lymphocytes to the site of virion replication (Cheevers & McGuire, 
1985; Larruskain & Jugo, 2013; Sellon et al., 1992). Human, simian, bovines and 
feline immunodeficiency viruses, have evolved further and do not only infect 
monocytes/macrophages and attract lymphocytes, but also infect these bystander 
lymphocytes (Barré-Sinoussi et al., 1983; Daniel et al., 1985; Pedersen et al., 1987; 
Whetstone et al., 1997). The viruses are often studied in in vitro culture systems 
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with cell-free virus, although it has been known for some time now that cell-free 
lentivirus is poorly efficient in infecting new cells compared to cell-to-cell spread 
(Carr et al., 1999; Dimitrov et al., 1993; Phillips, 1994). The term “cell-to-cell” 
spread encompasses two different strategies. First, virus can spread directly from 
one cell to another by cell fusion and the formation of syncytia. Secondly, it may 
also refer to the formation of a virological synapse, a transient tight contact 
between two cells, in which virus can safely cross from one cell to the other, 
without interception by the immune system. The formation of the virological 
synapse has already been described for a number of retroviruses, like human T-
lymphotropic virus (HTLV), HIV, and murine leukemia virus (MLV) (Bangham, 
2003; Jin et al., 2009; Jolly et al., 2004).  
In chapter 4 we showed that FIV infected PBMC show a high concentration of 
both Gag and Env proteins in restricted areas at the plasma membrane. After 
translation, Gag polyprotein is targeted towards the plasma membrane by 
myristoylation and a patch of basic residues in the matrix protein (Manrique et al., 
2001; Manrique et al., 2004). Furthermore, the FIV Env protein has been shown 
to be palmitoylated, a protein modification that can target proteins to lipid rafts 
(González et al., 2012). Recently, Brown and colleagues showed that depletion of 
PI(4,5)P2, a lipid that serves as a docking site for proteins, from the plasma 
membrane of FIV-infected CrFK cells inhibited production of FIV particles (Brown 
et al., 2015). The remarkable accumulation of Env and Gag in restricted areas in 
the plasma membrane raises the hypothesis that FIV proteins are targeted to 
specific micro-domains in the plasma membrane of infected PBMC, and that this 
polarization may be indicative for the existence of active cell sites for virus 
budding, and/or be the prerequisite for the formation of virological synapses, 
similar to what is described for HIV and MLV (Fais et al., 1995; Jolly et al., 2004; 
Jolly et al., 2011; Jouvenet et al., 2006; Owens et al., 1991; Perotti et al., 1996). 
Unlike MLV, FIV was not able to induce a polarized expression of its viral proteins 
at cell contacts in CrFK or GFox, which are unpolarized cells (Jin et al., 2011; Li et 
al., 2013). It is therefore reasonable to believe that FIV, similar to HIV, can hijack 
the natural polarization of activated PBMC for its egress (Jolly et al., 2011; 




Virological synapses used by retroviruses that replicate in immune cells are related 
to, but distinct from immunological synapses (Fig. 1). The virological synapses 
described for HIV are initiated by contacts between the HIV envelope protein on 
the infected cell and the HIV receptors on the contact cell (Groot et al., 2008; Jolly 
et al., 2004). The immunological synapse, on the other hand, is initiated by contact 
between an MHC molecule loaded with antigen and the T-cell receptor complex. 
While the immunological synapse is strictly limited to an antigen presenting cell 
(APC) and T-cells, the virological synapse can also exist between T-cells. Both 
types of synapse are stabilized by adhesion molecule/integrin interactions. To 
create and maintain the interaction between cells and ensure proper activation, 
cytoskeleton dynamics are required. Upon formation of the immunological 
synapse, the MTOC is reorientated towards the contact site (important for directed 
vesicle transport) and actin polymerizes (formation of signaling platforms) 
(Billadeau et al., 2007). At the virological synapse, the MTOC is reorientated 
towards the cell-cell contact area only in infected cells (Jolly, 2010). For HTLV, it 
has been shown that the viral transactivator protein Tax, an accessory protein, 
accumulates at the microtubule organizing center (MTOC), thereby sensitizing the 
cell for ICAM-1 induced MTOC polarization upon formation of the virological 
synapse. 
Figure 1: Composition of the virological synapse and the immunological synapse. The virological 
synapse (left) is initiated by interaction between the viral envelope protein and its receptors. The synapse is 
stabilized by interactions between adhesion molecules and integrins. The immunological synapse (right) is 
initiated by recognition of an antigen bound on a MHC-II molecule on an antigen presenting cell (APC) and 
the T-cell receptor (TCR) complex. Co-stimulatory signals are provided to the T-cell by interaction between 
CD80/CD86 and CD28. The synapse is stabilized by a ring of adhesion molecule-integrin interactions.  
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Several mechanisms of virus transmission at the virological synapse have been 
observed or hypothesized for other lentiviruses. For the interaction between an 
infected macrophage and uninfected T-cell, it is proposed that HIV particles are 
dumped into the synapse from an internal HIV compartment (Waki & Freed, 
2010). Cell-free particles may also be released into the synapsic cleft and interact 
with their receptors on the uninfected cell. Another phenomenon is the virus 
transport across filopodia-like cell protrusions. These so called “tunneling 
nanotubes” (TNT), are shown to form between T-cells after close cell contact 
(Sowinski et al., 2008), and are also induced by infected macrophages (Eugenin et 
al., 2009), and transport virus to the uninfected cell. These nanotubes are not 
open-ended tunnels and do not allow membrane or cytoplasm exchange, the virus 
spread remains receptor dependent. These filopodial bridges have been shown for 
MLV and HIV (Lehmann et al., 2005; Sherer et al., 2007). Further research is 
needed to further elucidate if the observed polarization of FIV proteins leads to the 
formation of an active virological synapse between cells during FIV infection.  
The expression of the envelope protein on the plasma membrane of an infected cell 
can be a major recognition antigen for the immune system, and may lead to 
cytolytic attacks from α-FIV cytotoxic T-cells or by the complement system. We 
have shown that FIV Env adopts a number of antigenically different conformations 
during its intracellular processing and trafficking. Furthermore, we have shown 
that upon cell surface expression of the mature trimeric Env protein, the protein 
was unrecognizable by Env-specific monoclonal antibodies (Chapter 4). Our 
results with the anti-V3 antibodies support the finding that the FIV secondary 
receptor (CXCR4) binding-epitope is located in a crypt that is only opened after 
interaction with the primary FIV receptor (CD134) (Egberink et al., 1994; Pedersen 
et al., 1987). Other regions (V2 and V4) on FIV Env remain hidden for other 
reasons, possibly as a result of steric occlusion or glycosylation, like has been 
shown for HIV and SIV Env (Chen et al., 2002; Kwong et al., 1998). This means 
that mature trimeric FIV Env expressed on the cell surface of infected cells, or 
incorporated in FIV virions might not by recognized by the mounted humoral 
antiviral response. This is in line with work by Richardson and colleagues who 
showed that B-cell epitopes are poorly recognized on mature Env, and do not 
contribute to virus neutralization (Richardson et al., 1996). For HIV it was 
suggested that most of the anti-Env response is directed against the unprocessed 
Env protein and/or against disassembled Env that is released as cellular or viral 
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debris, and hence is not effective against the mature Env protein (Parren et al., 
1997).  
A hypothetical model of the processing, trafficking and cell surface expression of 
the FIV Env protein, and of the viral protein polarization in PBMC, based on the 
results of Chapter 4 is summarized in Figure 2, and discussed below. The 
envelope protein is translated in the rough ER as a polyprotein, in which the V3 
loop has not yet adopted a closed conformation, and hence CXCR4-binding 
epitopes in the crypt are accessible (Fig. 2 (1)). After cleavage of TM and SU, and 
further adaptation of the sugar trees in the Golgi complex, the V2 and V4 loop 
acquire the right conformation, and can be recognized by their respective 
antibodies (Fig. 2 (2)). Processed Env is transported to the plasma membrane via 
vesicular transport, however, it remains to be investigated if Env is expressed on 
the plasma membrane continuously or if these vesicles are recruited after signaling 
and/or formation of the virological synapse (Fig. 2 (3)), like suggested for HIV 
(Jolly et al., 2011; Miranda et al., 2002). It is unclear if Gag associates with Env on 
the membrane of cytoplasmic vesicles and/or at the plasma membrane (Fig. 2 (4)). 
As described before, both proteins are modified in such a way that ensures 
association with lipid bilayers, and more specifically with lipid rafts (González et 
al., 2012; Manrique et al., 2001). Receptor interaction causes a series of 
conformational changes in FIV Env (Pedersen et al., 1987). Antibodies that target 
SU in a post-receptor conformation generated positive staining at close cell 
contact, another indication for the existence of the FIV virological synapse. After 
secondary receptor binding, SU dissociates from TM, and the fusion peptide of TM 
can insert into the target cell (Gallo et al., 2003; Hosie et al., 2009), causing fusion 
of the membranes and release of viral capsid into the target cell. It is not known if 
the conformational changes in SU also cause liberation of SU from the FIV 
receptors. If SU remains bound to the receptors, complexes that stay behind on the 
cell surface after infection may be extruded from the cell surface, or get 
internalized for degradation to clear the newly infected cell from FIV antigens that 
may be recognized by the immune system. Cross-linking of CD134 by antibodies at 
37°C causes formation and extrusion of CD134-antibody caps, while CXCR4 gets 
internalized (Roukaerts ID, unpublished results). Further research will show 
which strategy is used by FIV SU. Both phenomena have been described before in 
our lab for other viruses (Dewerchin et al., 2014; Favoreel et al., 1999; Favoreel et 
al., 1997).  
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More information about the formation of the virological synapse might allow the 
development of new therapeutic strategies against synapse-inducing viruses. Not 
only viral proteins associated with the process might be targeted, but also cellular 
proteins involved in trafficking of the viral protein and stabilization of the synapse. 
Another strategy that may be proposed is the treatment with CD134-peptides that 
open the SU molecule and render it more susceptible to V3-loop neutralizing 
antibodies. However, if FIV makes use of the virological synapse for spread, 
CD134-peptides might not be able to reach most of the SU molecules during FIV 
infection of a new cell. This problem might be solved by developing small 
molecules that can target the Env protein and open up its structure. For this 






Figure 2 (next page): Hypothetical model of the processing, trafficking and cell surface 
expression of the FIV Env protein, and the polarization of viral proteins in PBMC. (1) FIV Env 
(red) is translated by ribosomes that are associated with the ER. In the ER the leader sequence is still attached, 
and SU and TM are not separated. The CXCR4 receptor binding epitope on V3 (orange) is exposed. (2) After 
cleavage of the leader sequence the Env protein is transported towards the Golgi complex for further 
processing. the surface part (SU)  and the transmembrane part (TM) are separated through cleavage by furin, 
but stay non-covalently associated. The SU protein takes shape and epitopes on the V2 and V4 loop take form. 
The TM protein is palmitoylated. The processing of Env generates a molecule that is protected from antibodies 
by a glycan shield. (3) It is unclear at the moment if the majority of Env is stored in secretory vesicles, or is 
continuously transported to the plasma membrane. Further research will be needed to elucidate if FIV Env 
(3a) is stored in secretory vesicles that get recruited after contact, or (3b) is present on the membrane and 
polarizes to the contact site upon interaction between the FIV infected (left) and uninfected cell (right). 
Trimerization of the Env protein, in vesicles or on the cell membrane may provide sterical hindrance for 
antibody binding. (4) FIV Gag is translated in the cytoplasm by free ribosomes. The matrix part is 
myristoylated and associated with lipids through a patch of basic residues. For FIV it has not been investigated 
if Gag associates with Env (4a) on intracellular membranes of vesicles, and/or (4b) at the plasma membrane. 
FIV Gag might be transported to the trailing edge of activated leukocytes by interaction between the capsid 
protein and the actin network. (5) FIV Env is expressed as a trimer on the cell surface of infected cells. Env 
interacts with its primary receptor CD134, which is also expressed as a trimer. Interaction with the primary 
receptor induces a conformational change that exposes the CXCR4-binding V3 crypt (orange). After binding to 
CXCR4 a secondary conformational change leads to the dissociation between SU and TM, and allows TM to 
insert its fusion peptide into the plasma membrane of the target cell. It is unsure if SU remains associated to 





6.3. FIV finds a sanctuary in the lymphoid tissues 
Based on these results generated in Chapter 5 and results from others we propose 
a model for the early dissemination of FIV upon infection, and the progression of 
the disease during the asymptomatic phase (Fig. 3). Cats are infected by biting 
incidents, transferring the virus from the saliva of an infected cat into the wound of 
the bitten cat. The exact mechanism of primary infection is still not elucidated. 
Cell-free virus or cell-associated virus might infect resident macrophages or 
dendritic cells at the biting wound, or the virus might get drained directly to the 
lymph nodes. Our results might suggest that activated endothelial cells that line 
blood vessels at the site of inflammation elevate the susceptibility of leukocytes for 
FIV infection (Chapter 5b). Destruction of tissue and micro-organisms in the 
saliva of animals will induce an inflammatory response at the bite wound inflicted 
by the FIV positive cat. It can be speculated that in the presence of FIV susceptible 
leukocytes might induce a first replication round at the site of the bite wound, 
before FIV infected cells or dendritic cells loaded with virus move to the lymph 
nodes. For HIV it has been shown that phagocytosis of HIV infected T-
lymphocytes can cause infection of macrophages (Baxter et al., 2014). If this is true 
for FIV as well, phagocytosis of non-self infected cells that are present in the saliva 
might cause infection of the opsonizing macrophage. 
From the draining lymph node, FIV is rapidly distributed to other lymphoid organs 
by infected leukocytes (Huisman et al., 2004). After this acute phase, 
seroconversion will take place, and the infection is partially controlled leading to 
an asymptomatic phase with low to undetectable virus titers in the blood. Although 
virus titers are extremely low, and cats present no symptoms of disease, over the 
course of time a severe dysregulation of the immune system takes place, and 
eventually CD4+ T-cell counts plummet (Lerner et al., 1995; Ohno et al., 1994; 
Shelton et al., 1990). Recently, it was shown that viral mRNA, viral proteins and 
newly produced virus can be found in lymph nodes, whereas viral mRNA 
expression is absent in blood leukocytes (Eckstrand et al., 2016). This was not only 
shown for FIV, but also for HIV infected humans, even when they are treated with 
highly active antiretroviral therapy (HAART) (Lorenzo-Redondo et al., 2016; 
Pantaleo et al., 1993a). It can thus be hypothesized that lymph nodes are 
preferential sites of lentiviral replication, and that while replication is blocked in 
blood leukocytes it can be activated once these cells enter lymph nodes.  
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In chapter 5 we provided the first evidence that stromal mesenchymal cells from 
lymphoid tissues might increase susceptibility of naïve PBMC for FIV infection, 
and might enhance FIV replication and spread in already infected PBMC. For HIV 
it has been proposed that follicular dendritic cells (FDC), a specialized stromal 
mesenchymal cell type in the follicles of secondary lymphoid organs, can capture 
FIV particles, store them for several months and present them to leukocytes, 
causing infection of the latter (Burton et al., 1997; Pantaleo et al., 1993b). 
Maturation of monocytes into macrophages increases susceptibility of these cells 
for lentiviral infection and also activates replication in these cells (Dow et al., 1999; 
Gendelman et al., 1986; Narayan et al., 1983; Rich et al., 1992). Furthermore, for 
HIV it has been shown that FDC directly interact with infected 
monocytes/macrophages and activate HIV replication at the transcriptional level 
in these cells (Ohba et al., 2009). The long terminal repeats (LTR) that enclose the 
FIV provirus in the genome of the infected cell contain a number of signaling 
sequences for the binding of transcription factors and enhancers. A number of 
these sites are conserved between FIV isolates, like the TATA-box, AP4, AP1 and 
ATF/CREB sites (Sparger et al., 1992; Talbott et al., 1989). Some viruses may also 
contain additional sites to bind transcription factors like NF-κB, NF-1, C/EBP and 
LBP-1 (Sparger et al., 1992; Thompson et al., 1994). Signaling induced by 
chemokines or other molecules produced by / or present on mesenchymal stromal 
cells in these organs may activate these transcription factors and lead to FIV 
transcription. For instance, signaling via chemokine receptors and activation via 
the T-cell receptor activate NF-κB. Besides transcriptional activation and storage 
of infectious particles, the densely packed leukocytes in the lymphoid tissues 
constantly interact with each other. Since leukocytes can also adhere to the stromal 
network, the mesenchymal stromal cells might stabilize or enhance these leukocyte 
interactions. In this way, these cells may also aid in the formation of the virological 
synapse between an FIV infected cell and a target cell, and increase cell-to-cell 
spread of FIV.  
Infected cells will also travel to the bone marrow, possibly infected memory cells 
that home in the bone marrow (Alexaki & Wigdahl, 2008; Tokoyoda et al., 2009). 
Myeloid precursor cells (i.e. myeloblasts) can become infected (Beebe et al., 1992), 
giving rise to a persistent pool of latent provirus-carrying offspring. Monocytes 
may also become infected de novo, resulting in a non-productive infection until 
they become activated and differentiate. Provirus-containing monocytes that give 
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rise to tissue resident macrophages may cause local damage upon activation of FIV 
replication. This is for instance the cause of damage to the central nervous system 
in FIV infected cats (Hein et al., 2005; Ryan et al., 2005). FIV positive tissue 
macrophages may also drain to the lymph nodes after encountering other 
pathogens. Last but not least, pro-virus containing monocytes may recirculate to 
the lymph nodes, where they may become activated by antigens, pathogens or 
inflammatory signals, and pass the virus to T- and B-lymphocytes. Recent work at 
the University of Glasgow (Dr. Hosie M, unpublished) identified the existence of 
tissue compartment specific FIV variants, with differential use of the FIV 
receptors. More information on these variants and their circulation may lead to a 
better understanding of the  FIV tissue reservoirs (Techakriengkrai et al., 2014).   
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Figure 3: Hypothetical model for initial dissemination of FIV, and sites of ongoing FIV 
replication during the asymptomatic phase. (1) Cell-free or cell-associated FIV in saliva enters the cat at 
a bite wound inflicted during fights. Macrophages may become infected by phagocytosis of FIV+ cells or by up-
take of FIV virions. Activation of infiltrating leukocytes by the local blood vessel endothelium may increase 
FIV susceptibility of these cells. Activated leukocytes can support a local FIV replication round before draining 
to the lymph nodes. (2) During acute infection, FIV infected cells may spread from the draining lymph node 
and disseminate the virus to other lymphoid tissues, like the spleen, thymus and bone marrow. (3) While FIV 
replication is ongoing in the lymph nodes, no active replication can be detected in infected blood leukocytes 
during the asymptomatic phase. (4) FIV can infect myeloid progenitor cells in the red bone marrow, which will 
pass the integrated provirus to their progeny, creating FIV-carrying monocytes. These FIV+ monocytes will 
spread once again across the cat, inducing replication when they mature into macrophages. (5) Extravasation 
of FIV+ monocytes in the brain can cause inflammation because of FIV replication, leading to FIV induced 
damage.  
Conclusions 
 There is a low genetic variability of FIV in Belgium and The Netherlands
and clade A is the most prevalent subtype, but caution is needed since new
introductions and recombination can increase this variability (Chapter 3).
 FIV Env and Gag polarize towards specific sites at the plasma membrane in
infected PBMC, which may indicate a preferred budding site or induction of
the virological synapse. Cell-to-cell spread via the virological synapse can
hide FIV from the immune system (Chapter 4).
 FIV Env adopts a closed conformation upon expression of the functional
protein on the plasma membrane of infected cells, and may be protected
from antibody binding by a glycan shield and steric hindrance. This way FIV
infected cells and free FIV virions may evade the mounted anti-FIV
response (Chapter 4).
 Mesenchymal stromal cells from lymph nodes and activated endothelium
may increase susceptibility of PBMC for FIV infection (Chapter 5b).
 Lymph nodes and bone marrow mesenchymal stromal cells may augment
FIV replication in PBMC. This may explain why the lymphoid organs are a





Alexaki, A. & Wigdahl, B. (2008). HIV-1 infection of bone marrow hematopoietic progenitor 
cells and their role in trafficking and viral dissemination. PLoS Pathog 4, e1000215. 
Bangham, C. R. (2003). The immune control and cell-to-cell spread of human T-lymphotropic 
virus type 1. J Gen Virol 84, 3177-3189. 
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., 
Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W. & 
Montagnier, L. (1983). Isolation of a T-lymphotropic retrovirus from a patient at risk for 
acquired immune deficiency syndrome (AIDS). Science 220, 868-871. 
Baxter, A. E., Russell, R. A., Duncan, C. J., Moore, M. D., Willberg, C. B., Pablos, J. L., 
Finzi, A., Kaufmann, D. E., Ochsenbauer, C., Kappes, J. C., Groot, F. & Sattentau, Q. J. 
(2014). Macrophage infection via selective capture of HIV-1-infected CD4+ T cells. Cell Host 
Microbe 16, 711-721. 
Beebe, A. M., Gluckstern, T. G., George, J., Pedersen, N. C. & Dandekar, S. (1992). 
Detection of feline immunodeficiency virus infection in bone marrow of cats. Vet Immunol 
Immunopathol 35, 37-49. 
Billadeau, D. D., Nolz, J. C. & Gomez, T. S. (2007). Regulation of T-cell activation by the 
cytoskeleton. Nat Rev Immunol 7, 131-143. 
Brown, E. W., Yuhki, N., Packer, C. & O'Brien, S. J. (1994). A lion lentivirus related to 
feline immunodeficiency virus: epidemiologic and phylogenetic aspects. J Virol 68, 5953-5968. 
Brown, L. A., Cox, C., Baptiste, J., Summers, H., Button, R., Bahlow, K., Spurrier, V., 
Kyser, J., Luttge, B. G., Kuo, L., Freed, E. O. & Summers, M. F. (2015). NMR structure of 
the myristylated feline immunodeficiency virus matrix protein. Viruses 7, 2210-2229. 
Burton, G. F., Masuda, A., Heath, S. L., Smith, B. A., Tew, J. G. & Szakal, A. K. (1997).  
Follicular dendritic cells (FDC) in retroviral infection: host/pathogen perspectives. Immunol Rev 
156, 185-197. 
Bęczkowski, P. M., Harris, M., Techakriengkrai, N., Beatty, J. A., Willett, B. J. & 
Hosie, M. J. (2015). Neutralising antibody response in domestic cats immunised with a 
commercial feline immunodeficiency virus (FIV) vaccine. Vaccine 33, 977-984. 
Carpenter, M. A., Brown, E. W., Culver, M., Johnson, W. E., Pecon-Slattery, J., 
Brousset, D. & O'Brien, S. J. (1996). Genetic and phylogenetic divergence of feline 
immunodeficiency virus in the puma (Puma concolor). J Virol 70, 6682-6693. 
Carr, J. M., Hocking, H., Li, P. & Burrell, C. J. (1999). Rapid and efficient cell-to-cell 
transmission of human immunodeficiency virus infection from monocyte-derived macrophages to 
peripheral blood lymphocytes. Virology 265, 319-329. 
Cheevers, W. P. & McGuire, T. C. (1985). Equine infectious anemia virus: 
immunopathogenesis and persistence. Rev Infect Dis 7, 83-88. 
Chen, J. J., Huang, J. C., Shirtliff, M., Briscoe, E., Ali, S., Cesani, F., Paar, D. & Cloyd, 
M. W. (2002). CD4 lymphocytes in the blood of HIV(+) individuals migrate rapidly to lymph 
nodes and bone marrow: support for homing theory of CD4 cell depletion. J Leukoc Biol 72, 271-
278. 
Daniel, M. D., Letvin, N. L., King, N. W., Kannagi, M., Sehgal, P. K., Hunt, R. D., 
Kanki, P. J., Essex, M. & Desrosiers, R. C. (1985). Isolation of T-cell tropic HTLV-III-like 
retrovirus from macaques. Science 228, 1201-1204. 
Dewerchin, H. L., Desmarets, L. M., Noppe, Y. & Nauwynck, H. J. (2014). Myosins 1 and 
6, myosin light chain kinase, actin and microtubules cooperate during antibody-mediated 
internalisation and trafficking of membrane-expressed viral antigens in feline infectious peritonitis 
virus infected monocytes. Vet Res 45, 17. 
Dimitrov, D. S., Willey, R. L., Sato, H., Chang, L. J., Blumenthal, R. & Martin, M. A. 




Dow, S. W., Mathiason, C. K. & Hoover, E. A. (1999). In vivo monocyte tropism of 
pathogenic feline immunodeficiency viruses. J Virol 73, 6852-6861. 
Duarte, A. & Tavares, L. (2006). Phylogenetic analysis of Portuguese Feline Immunodeficiency 
Virus sequences reveals high genetic diversity. Vet Microbiol 114, 25-33. 
Eckstrand, C. D., Hillman, C., Smith, A. L., Sparger, E. E. & Murphy, B. G. (2016). Viral 
Reservoirs in Lymph Nodes of FIV-Infected Progressor and Long-Term Non-Progressor Cats 
during the Asymptomatic Phase. PLoS One 11, e0146285. 
Egberink, H., Keldermans, L., Schuurman, N., Stam, J., Hesselink, W., van Vliet, A., 
Verschoor, E., Horzinek, M. & de Ronde, A. (1994). Monoclonal antibodies to 
immunodominant and neutralizing domains of the envelope surface protein of feline 
immunodeficiency virus. J Gen Virol 75 ( Pt 4), 889-893. 
Eugenin, E. A., Gaskill, P. J. & Berman, J. W. (2009). Tunneling nanotubes (TNT) are 
induced by HIV-infection of macrophages: a potential mechanism for intercellular HIV trafficking. 
Cell Immunol 254, 142-148. 
Fais, S., Capobianchi, M. R., Abbate, I., Castilletti, C., Gentile, M., Cordiali Fei, P., 
Ameglio, F. & Dianzani, F. (1995). Unidirectional budding of HIV-1 at the site of cell-to-cell 
contact is associated with co-polarization of intercellular adhesion molecules and HIV-1 viral 
matrix protein. AIDS 9, 329-335. 
Favoreel, H. W., Nauwynck, H. J., Halewyck, H. M., Van Oostveldt, P., Mettenleiter, 
T. C. & Pensaert, M. B. (1999). Antibody-induced endocytosis of viral glycoproteins and major 
histocompatibility complex class I on pseudorabies virus-infected monocytes. J Gen Virol 80 ( Pt 
5), 1283-1291. 
Favoreel, H. W., Nauwynck, H. J., Van Oostveldt, P., Mettenleiter, T. C. & Pensaert, 
M. B. (1997). Antibody-induced and cytoskeleton-mediated redistribution and shedding of viral 
glycoproteins, expressed on pseudorabies virus-infected cells. J Virol 71, 8254-8261. 
Gallo, S. A., Finnegan, C. M., Viard, M., Raviv, Y., Dimitrov, A., Rawat, S. S., Puri, A., 
Durell, S. & Blumenthal, R. (2003). The HIV Env-mediated fusion reaction. Biochim Biophys 
Acta 1614, 36-50. 
Gendelman, H. E., Narayan, O., Kennedy-Stoskopf, S., Kennedy, P. G., Ghotbi, Z., 
Clements, J. E., Stanley, J. & Pezeshkpour, G. (1986). Tropism of sheep lentiviruses for 
monocytes: susceptibility to infection and virus gene expression increase during maturation of 
monocytes to macrophages. J Virol 58, 67-74. 
González, S. A., Paladino, M. G. & Affranchino, J. L. (2012). Palmitoylation of the feline 
immunodeficiency virus envelope glycoprotein and its effect on fusion activity and envelope 
incorporation into virions. Virology 428, 1-10. 
Groot, F., Welsch, S. & Sattentau, Q. J. (2008). Efficient HIV-1 transmission from 
macrophages to T cells across transient virological synapses. Blood 111, 4660-4663. 
Haseltine, W. A. (1991). Molecular biology of the human immunodeficiency virus type 1. FASEB 
J 5, 2349-2360. 
Hein, A., Martin, J. P. & Dörries, R. (2005). Early pathological changes in the central 
nervous system of acutely feline-immunodeficiency-virus-infected cats. Virology 343, 162-170. 
Hosie, M. J., Addie, D., Belak, S., Boucraut-Baralon, C., Egberink, H., Frymus, T., 
Gruffydd-Jones, T., Hartmann, K., Lloret, A., Lutz, H., Marsilio, F., Pennisi, M. G., 
Radford, A. D., Thiry, E., Truyen, U. & Horzinek, M. C. (2009). FELINE 
IMMUNODEFICIENCY ABCD guidelines on prevention and management. Journal of Feline 
Medicine and Surgery 11, 575-584. 
Hosie, M. J., Robertson, C. & Jarrett, O. (1989). Prevalence of feline leukaemia virus and 
antibodies to feline immunodeficiency virus in cats in the United Kingdom. Vet Rec 125, 293-297. 
Huisman, W., Schrauwen, E. J., Pas, S. D., Karlas, J. A., Rimmelzwaan, G. F. & 
Osterhaus, A. D. (2004). Antibodies specific for hypervariable regions 3 to 5 of the feline 
immunodeficiency virus envelope glycoprotein are not solely responsible for vaccine-induced 
acceleration of challenge infection in cats. J Gen Virol 85, 1833-1841. 
Jin, J., Li, F. & Mothes, W. (2011). Viral determinants of polarized assembly for the murine 
leukemia virus. J Virol 85, 7672-7682. 
Chapter 6 
148 
Jin, J., Sherer, N. M., Heidecker, G., Derse, D. & Mothes, W. (2009). Assembly of the 
murine leukemia virus is directed towards sites of cell-cell contact. PLoS Biol 7, e1000163. 
Jolly, C. (2010). T cell polarization at the virological synapse. Viruses 2, 1261-1278. 
Jolly, C., Kashefi, K., Hollinshead, M. & Sattentau, Q. J. (2004). HIV-1 cell to cell transfer 
across an Env-induced, actin-dependent synapse. J Exp Med 199, 283-293. 
Jolly, C., Welsch, S., Michor, S. & Sattentau, Q. J. (2011). The regulated secretory pathway 
in CD4(+) T cells contributes to human immunodeficiency virus type-1 cell-to-cell spread at the 
virological synapse. PLoS Pathog 7, e1002226. 
Jouvenet, N., Neil, S. J., Bess, C., Johnson, M. C., Virgen, C. A., Simon, S. M. & 
Bieniasz, P. D. (2006). Plasma membrane is the site of productive HIV-1 particle assembly. 
PLoS Biol 4, e435. 
Kakinuma, S., Motokawa, K., Hohdatsu, T., Yamamoto, J. K., Koyama, H. & 
Hashimoto, H. (1995). Nucleotide sequence of feline immunodeficiency virus: classification of 
Japanese isolates into two subtypes which are distinct from non-Japanese subtypes. J Virol 69, 
3639-3646. 
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J. & Hendrickson, W. 
A. (1998). Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and 
a neutralizing human antibody. Nature 393, 648-659. 
Larruskain, A. & Jugo, B. M. (2013). Retroviral infections in sheep and goats: small ruminant 
lentiviruses and host interaction. Viruses 5, 2043-2061. 
Lecollinet, S. & Richardson, J. (2008). Vaccination against the feline immunodeficiency 
virus: the road not taken. Comp Immunol Microbiol Infect Dis 31, 167-190. 
Lehmann, M. J., Sherer, N. M., Marks, C. B., Pypaert, M. & Mothes, W. (2005). Actin- 
and myosin-driven movement of viruses along filopodia precedes their entry into cells. J Cell Biol 
170, 317-325. 
Lerner, D. L., Wagaman, P. C., Phillips, T. R., Prospero-Garcia, O., Henriksen, S. J., 
Fox, H. S., Bloom, F. E. & Elder, J. H. (1995). Increased mutation frequency of feline 
immunodeficiency virus lacking functional deoxyuridine-triphosphatase. Proc Natl Acad Sci U S A 
92, 7480-7484. 
Li, F., Jin, J., Herrmann, C. & Mothes, W. (2013). Basic residues in the matrix domain and 
multimerization target murine leukemia virus Gag to the virological synapse. J Virol 87, 7113-7126. 
Lorenzo-Redondo, R., Fryer, H. R., Bedford, T., Kim, E. Y., Archer, J., Kosakovsky 
Pond, S. L., Chung, Y. S., Penugonda, S., Chipman, J. G., Fletcher, C. V., Schacker, T. 
W., Malim, M. H., Rambaut, A., Haase, A. T., McLean, A. R. & Wolinsky, S. M. (2016). 
Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530, 51-56. 
Manrique, M. L., Celma, C. C., González, S. A. & Affranchino, J. L. (2001). Mutational 
analysis of the feline immunodeficiency virus matrix protein. Virus Res 76, 103-113. 
Manrique, M. L., González, S. A. & Affranchino, J. L. (2004). Functional relationship 
between the matrix proteins of feline and simian immunodeficiency viruses. Virology 329, 157-167. 
Miranda, L. R., Schaefer, B. C., Kupfer, A., Hu, Z. & Franzusoff, A. (2002). Cell surface 
expression of the HIV-1 envelope glycoproteins is directed from intracellular CTLA-4-containing 
regulated secretory granules. Proc Natl Acad Sci U S A 99, 8031-8036. 
Miyazawa, T., Fukasawa, M., Hasegawa, A., Maki, N., Ikuta, K., Takahashi, E., 
Hayami, M. & Mikami, T. (1991). Molecular cloning of a novel isolate of feline 
immunodeficiency virus biologically and genetically different from the original U.S. isolate. J Virol 
65, 1572-1577. 
Narayan, O., Kennedy-Stoskopf, S., Sheffer, D., Griffin, D. E. & Clements, J. E. (1983). 
Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to 
macrophages. Infect Immun 41, 67-73. 
Ohba, K., Ryo, A., Dewan, M. Z., Nishi, M., Naito, T., Qi, X., Inagaki, Y., Nagashima, 
Y., Tanaka, Y., Okamoto, T., Terashima, K. & Yamamoto, N. (2009). Follicular dendritic 
cells activate HIV-1 replication in monocytes/macrophages through a juxtacrine mechanism 
mediated by P-selectin glycoprotein ligand 1. J Immunol 183, 524-532. 
Chapter 6 
149 
Ohno, K., Okamoto, Y., Miyazawa, T., Mikami, T., Watari, T., Goitsuka, R., Tsujimoto, 
H. & Hasegawa, A. (1994). Induction of apoptosis in a T lymphoblastoid cell line infected with 
feline immunodeficiency virus. Arch Virol 135, 153-158. 
Owens, R. J., Dubay, J. W., Hunter, E. & Compans, R. W. (1991). Human 
immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial 
cells. Proc Natl Acad Sci U S A 88, 3987-3991. 
Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., 
Orenstein, J. M., Kotler, D. P. & Fauci, A. S. (1993a). HIV infection is active and progressive 
in lymphoid tissue during the clinically latent stage of disease. Nature 362, 355-358. 
Pantaleo, G., Graziosi, C. & Fauci, A. S. (1993b). The role of lymphoid organs in the 
pathogenesis of HIV infection. Semin Immunol 5, 157-163. 
Parren, P. W., Burton, D. R. & Sattentau, Q. J. (1997). HIV-1 antibody--debris or virion? 
Nat Med 3, 366-367. 
Pecoraro, M. R., Tomonaga, K., Miyazawa, T., Kawaguchi, Y., Sugita, S., Tohya, Y., 
Kai, C., Etcheverrigaray, M. E. & Mikami, T. (1996). Genetic diversity of Argentine isolates 
of feline immunodeficiency virus. J Gen Virol 77 ( Pt 9), 2031-2035. 
Pedersen, N. C., Ho, E. W., Brown, M. L. & Yamamoto, J. K. (1987). Isolation of a T-
lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235, 
790-793. 
Perotti, M. E., Tan, X. & Phillips, D. M. (1996). Directional budding of human 
immunodeficiency virus from monocytes. J Virol 70, 5916-5921. 
Phillips, D. M. (1994). The role of cell-to-cell transmission in HIV infection. AIDS 8, 719-731. 
Rich, E. A., Chen, I. S., Zack, J. A., Leonard, M. L. & O'Brien, W. A. (1992). Increased 
susceptibility of differentiated mononuclear phagocytes to productive infection with human 
immunodeficiency virus-1 (HIV-1). J Clin Invest 89, 176-183. 
Richardson, J., Fossati, I., Moraillon, A., Castelot, S., Sonigo, P. & Pancino, G. (1996).  
Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline 
immunodeficiency virus envelope. J Gen Virol 77 ( Pt 4), 759-771. 
Rigby, M. A., Holmes, E. C., Pistello, M., Mackay, A., Brown, A. J. & Neil, J. C. (1993). 
Evolution of structural proteins of feline immunodeficiency virus: molecular epidemiology and 
evidence of selection for change. J Gen Virol 74 ( Pt 3), 425-436. 
Ryan, G., Grimes, T., Brankin, B., Mabruk, M. J., Hosie, M. J., Jarrett, O. & Callanan, 
J. J. (2005). Neuropathology associated with feline immunodeficiency virus infection highlights 
prominent lymphocyte trafficking through both the blood-brain and blood-choroid plexus barriers. 
J Neurovirol 11, 337-345. 
Sellon, D. C., Perry, S. T., Coggins, L. & Fuller, F. J. (1992). Wild-type equine infectious 
anemia virus replicates in vivo predominantly in tissue macrophages, not in peripheral blood 
monocytes. J Virol 66, 5906-5913. 
Shelton, G. H., Linenberger, M. L., Grant, C. K. & Abkowitz, J. L. (1990). Hematologic 
manifestations of feline immunodeficiency virus infection. Blood 76, 1104-1109. 
Sherer, N. M., Lehmann, M. J., Jimenez-Soto, L. F., Horensavitz, C., Pypaert, M. & 
Mothes, W. (2007). Retroviruses can establish filopodial bridges for efficient cell-to-cell 
transmission. Nat Cell Biol 9, 310-315. 
Sodora, D. L., Shpaer, E. G., Kitchell, B. E., Dow, S. W., Hoover, E. A. & Mullins, J. I. 
(1994). Identification of three feline immunodeficiency virus (FIV) env gene subtypes and 
comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol 68, 
2230-2238. 
Sowinski, S., Jolly, C., Berninghausen, O., Purbhoo, M. A., Chauveau, A., Köhler, K., 
Oddos, S., Eissmann, P., Brodsky, F. M., Hopkins, C., Onfelt, B., Sattentau, Q. & 
Davis, D. M. (2008). Membrane nanotubes physically connect T cells over long distances 
presenting a novel route for HIV-1 transmission. Nat Cell Biol 10, 211-219. 
Chapter 6 
150 
Sparger, E. E., Shacklett, B. L., Renshaw-Gegg, L., Barry, P. A., Pedersen, N. C., Elder, 
J. H. & Luciw, P. A. (1992). Regulation of gene expression directed by the long terminal repeat 
of the feline immunodeficiency virus. Virology 187, 165-177. 
Steinrigl, A., Ertl, R., Langbein, I. & Klein, D. (2010). Phylogenetic analysis suggests 
independent introduction of feline immunodeficiency virus clades A and B to Central Europe and 
identifies diverse variants of clade B. Vet Immunol Immunopathol 134, 82-89. 
Talbott, R. L., Sparger, E. E., Lovelace, K. M., Fitch, W. M., Pedersen, N. C., Luciw, P. 
A. & Elder, J. H. (1989). Nucleotide sequence and genomic organization of feline 
immunodeficiency virus. Proc Natl Acad Sci U S A 86, 5743-5747. 
Techakriengkrai, N., Logan, N., Willett, B. & Hosie, M. (2014). Tissue 
compatmentalization in feline immunodeficiency virus infection. In International feline retrovirus 
research symposium. Niagara-on-the-lake, Canada. 
Thompson, F. J., Elder, J. & Neil, J. C. (1994). Cis- and trans-regulation of feline 
immunodeficiency virus: identification of functional binding sites in the long terminal repeat. J Gen 
Virol 75 ( Pt 3), 545-554. 
Tokoyoda, K., Zehentmeier, S., Hegazy, A. N., Albrecht, I., Grün, J. R., Löhning, M. & 
Radbruch, A. (2009). Professional memory CD4+ T lymphocytes preferentially reside and rest 
in the bone marrow. Immunity 30, 721-730. 
Troyer, J. L., Pecon-Slattery, J., Roelke, M. E., Johnson, W., VandeWoude, S., 
Vazquez-Salat, N., Brown, M., Frank, L., Woodroffe, R., Winterbach, C., Winterbach, 
H., Hemson, G., Bush, M., Alexander, K. A., Revilla, E. & O'Brien, S. J. (2005). 
Seroprevalence and genomic divergence of circulating strains of feline immunodeficiency virus 
among Felidae and Hyaenidae species. J Virol 79, 8282-8294. 
Troyer, J. L., Vandewoude, S., Pecon-Slattery, J., McIntosh, C., Franklin, S., Antunes, 
A., Johnson, W. & O'Brien, S. J. (2008). FIV cross-species transmission: an evolutionary 
prospective. Vet Immunol Immunopathol 123, 159-166. 
VandeWoude, S., Troyer, J. & Poss, M. (2010). Restrictions to cross-species transmission of 
lentiviral infection gleaned from studies of FIV. Vet Immunol Immunopathol 134, 25-32. 
Waki, K. & Freed, E. O. (2010). Macrophages and Cell-Cell Spread of HIV-1. Viruses 2, 1603-
1620. 
Westman, M. E., Malik, R., Hall, E., Harris, M. & Norris, J. M. (2016). The protective 
rate of the feline immunodeficiency virus vaccine: An Australian field study. Vaccine 34, 4752-
4758. 
Whetstone, C. A., Suarez, D. L., Miller, J. M., Pesch, B. A. & Harp, J. A. (1997). Bovine 
lentivirus induces early transient B-cell proliferation in experimentally inoculated cattle and 
appears to be pantropic. J Virol 71, 640-644. 
Yamamoto, J. K., Pu, R., Sato, E. & Hohdatsu, T. (2007). Feline immunodeficiency virus 
pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine. AIDS 21, 
547-563. 
Zhu, Y. Q., Remington, K. M. & North, T. W. (1996). Mutants of feline immunodeficiency 














7.1. Summary  
The feline immunodeficiency virus is the causing agent of feline aids, an incurable 
disease that eventually leads to death. The virus has been known for almost 20 years 
and a lot of progress has been made in understanding the replication cycle and disease 
progression. However, there is no treatment available for infected cats, they are 
treated symptomatically. 
In chapter 1 an in depth introduction is given on the FIV genome structure, proteins 
and replication cycle. The anti-viral response is discussed and the known 
countermeasures FIV employs to escape from this immune response. Because more 
and more evidence is indicating a central role for the lymphoid tissues in the FIV 
pathogenesis, the second part of the introduction focuses on the structure of the 
lymphoid tissues and how FIV infection affects these organs.  
The aims of this work are explained in chapter 2.  
When starting the current work on FIV in Belgium no information existed on the 
circulating strains in the area. An up-to-date overview of FIV field strains in Belgium 
and the Netherlands is presented in Chapter 3. Viruses from naturally infected FIV 
positive cats were genotyped and their similarity was tested. Since cats can be infected 
with more than one FIV strain due to low cross-protection, recombinant viruses 
belonging to more than one subtype exist. Therefore, collected strains were genotyped 
for two regions in the FIV genome (the gag and env gene). Phylogenetic trees were 
assembled for both genes together with reference strains from all over the world. 
Except for one, all viruses collected in Belgium and the Netherlands clustered together 
with known clade A FIV viruses. One sample originating from a cat living in the 
Amsterdam region in the Netherlands had a clade A gag gene, but the env gene could 
not be matched to any known FIV subtype. Recombination analysis was performed to 
find out if the env gene was the product of inter-gene recombination. This analysis 
showed that the env gene partially matched other clade A FIV env genes, and the other 
part resembled a sequence reported in a cat infected with FIV in Sri Lanka, and 
belonged to an unknown FIV subtype. Based on the strains found in Belgium, further 
work was conducted with a clade A FIV virusstrain called FIV-PPR.  
Once FIV is contracted, it establishes a lifelong infection of its host and causes a severe 
immunodeficiency that eventually leads to death. The FIV envelope protein (Env) and 
Gag protein are major stimulators of the anti-FIV response. Although infected cats 
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develop a strong antiviral response, FIV is not cleared. In Chapter 4 the expression of 
FIV Env and Gag, and the availability of different epitopes on these viral proteins 
during replication were investigated in commonly used feline cell lines and feline 
PBMC. Large differences were found between the cell lines and PBMC. One of the 
most remarkable observations was the total lack of recognition of epitopes on the FIV 
envelope proteins when expressed on the cell surface of PBMC, but not on the feline 
adherent cell lines. Testing of the studied epitopes against sera from naturally infected 
cats showed that all cats developed a strong response against the conserved FIV 
receptor binding site. However, since these epitopes were shielded on mature envelope 
protein they probably don’t contribute to anti-FIV immunity. A second phenomenon 
was the polarization of both Gag and Env towards specific sites in the plasma 
membrane at the end of the FIV replication cycle in PBMC. Again, this was not 
observed in the feline cell lines. The polarization of viral protein may indicate a 
preferred composition of the plasma membrane for virion budding in this region, but 
may also be the perquisite to the formation of viral synapses between cells. In 
virological synapses virus transfer from cell-to-cell takes place hidden from the 
immune system.  
Another aspect of the FIV pathogenesis is the absence of FIV replication in leukocytes 
circulating in blood while the disease is asymptomatic but nonetheless progressing. 
Recently, it was shown that FIV replication is active in lymphoid tissues during the 
asymptomatic phase. Stromal cells of the lymphoid tissues not only shape the matrix 
framework of the organ in which the hematopoietic cells reside, they also provide 
signaling essential for the correct functioning of the organ. Chapter 5a focused on the 
isolation, characterization and immortalization of feline stromal cells from primary 
lymphoid tissues (bone marrow and thymus) and secondary lymphoid tissues (lymph 
nodes and spleen). Characterization showed that these cells express typical 
mesenchymal markers, vimentin and smooth muscle actin, and produce the 
extracellular matrix protein fibronectin. Production of various cytokines important for 
lymphoid organ function was demonstrated on the mRNA level. These cells were used 
in Chapter 5b to study the influence of lymphoid organ stromal cells on the 
sensitivity of peripheral blood mononuclear cells for FIV infection. Lymphoid 
mesenchymal stromal cells were able to induce expression of the FIV receptors, CD134 
and CXCR4, on PBMC. Activated endothelium and lymph node mesenchymal cells 
elevated FIV infection percentages in PBMC. Furthermore, lymphoid stromal cells 
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from bone marrow and lymph node enhanced spread of FIV infection in PBMC 
cultures.  
In Chapter 6 all results generated during this PhD are combined and placed in a 
broader perspective.  
7.2. Samenvatting 
Het feline immunodeficiëntie virus veroorzaakt aids in katten, een ongeneesbare 
ziekte die de dood tot gevolg heeft. Het virus werd 20 jaar geleden ontdekt niet veel na 
de ontdekking zijn menselijke tegenhanger het humaan immunodeficiëntie virus. In 
de loop der jaren werd er reeds veel vooruitgang geboekt in het begrijpen van de FIV 
replicatiecylus en de pathogenese veroorzaakt door het virus. Tot op heden is er voor 
katten echter nog geen behandeling beschikbaar en worden de geïnfecteerde dieren 
enkel symptomatisch behandeld.  
In Hoofdstuk 1 word een diepgaande inleiding gegeven omtrent de FIV genoom 
structuur, de virale proteïnen en de replicatiecyclus. Er wordt besproken hoe het 
immuunsysteem reageert op een FIV infectie en hoe het virus deze immuun respons 
weet te omzeilen. Omdat er steeds meer bewijzen zijn die een centrale rol voor de 
lymfoïde weefsels binnen de FIV pathogenese aangeven, wordt in een tweede deel de 
structuur van deze weefsels besproken, alsook hoe een FIV infectie deze organen 
aantast.  
Het tweede hoofdstuk verduidelijkt de doelen die gesteld werden voor dit 
doctoraatsproefschrift.  
Bij de aanvang van dit doctoraat was er geen informatie over de FIV veldstammen die 
circuleren in België en Nederland. Een actueel overzicht van de FIV stammen in België 
en Nederland wordt gegeven in Hoofdstuk 3. Uit het bloed van FIV positieve katten 
werd het virus geïsoleerd en er werd een genotypering uitgevoerd. De gelijkenis tussen 
al deze stammen werd bestudeerd. Omdat katten met meerdere FIV virussen 
tegelijkertijd kunnen worden geïnfecteerd, doordat er maar weinig kruisbescherming 
bestaat, geeft dit de kans aan FIV virussen om met elkaar te recombineren. Om die 
reden werden twee regio’s uit het FIV genoom getypeerd, met name het gag en env 
gen. De resultaten van deze twee genen werden samen met referentie stammen van 
over de hele wereld fylogenetisch geanalyseerd. Alle stalen verzameld in België en 
Nederland buiten één behoorden tot de clade A FIV virussen. Eén kat afkomstig uit 
Amsterdam was besmet met een FIV virus waarvoor de sequentie het env gen niet kon 
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worden ondergebracht bij de gekende clades, terwijl de gag sequentie tot de clade A 
virussen behoorde. Een recombinatie analyse toonde aan dat het eerste deel van de 
env sequentie grote gelijkenis vertoonde met de clade A virussen, maar dat het tweede 
deel leek op de env sequentie van een kat die geïnfecteerd werd met FIV in Sri Lanka. 
Het is nog maar de tweede keer dat deze sequentie werd teruggevonden en ze behoort 
tot een ongekende FIV subgroep. Omdat FIV virussen van subtype A de meest 
voorkomende zijn in België werd verder werk ook uitgevoerd met een FIV virus van dit 
subtype, met name FIV-PPR.   
Eens een kat geïnfecteerd is met FIV, zal ze levenslang drager zijn van dit virus. Het 
virus veroorzaakt net zoals bij de mens een verworven immunodeficiëntie die de dood 
tot gevolg heeft. Het FIV envelop en Gag eiwit zijn de belangrijkste mikpunten van de 
anti-FIV immuniteit. Hoewel een kat een sterke antivirale respons kent, wordt een FIV 
infectie niet opgeruimd. In Hoofdstuk 4 wordt de expressie van de Env en Gag 
eiwitten tijden de FIV replicatie in feliene cellijnen en PBMC in detail bestudeerd. Er 
werden grote verschillen gevonden tussen de vaak gebruikte feliene cellijnen en 
PBMC. Een van de belangrijkste waarnemingen was het gebrek aan herkenning van 
specifieke epitopen op het envelop eiwit wanneer het op het celmembraan van PBMC 
zit. Dit was niet zo op de celmembranen van de cellijnen waar deze epitopen wel 
werden gebonden door antistoffen. Uit een analyse van de sera van natuurlijk 
geïnfecteerde FIV katten bleek dat katten een sterke immuun respons hebben tegen de 
geconserveerde FIV receptorbindingsplaats, maar omdat deze verborgen zit op het 
eiwit dragen antistoffen hiertegen wellicht niet bij aan de anti-FIV immuniteit. Een 
tweede fenomeen dat werd geobserveerd, was de polarisatie van zowel Gag als Env 
naar specifieke zones van het plasmamembraan aan het einde van de FIV 
replicatiecyclus. Deze polarisatie van virale eiwitten kunnen wijzen op de 
aanwezigheid van een specifieke samenstelling van het plasmamembraan die wordt 
verkozen voor virusvorming. Het kan ook een voorstadium zijn van een virussynaps 
die wordt gevormd tussen twee cellen. In zo een virussynaps kunnen virussen zich 
verspreiden van cel naar cel zonder gezien te worden door het immuunsysteem.  
Wanneer een kat geïnfecteerd is met FIV worden er slechts zeer weinig leukocyten in 
het bloed teruggevonden die FIV eiwitten tot expressie brengen. De ziekte is 
asymptomatisch maar toch verslechtert de toestand van het immuunsysteem 
geleidelijk aan. Het werd recent aangetoond dat ook in de asymptomatische fase er 
actieve FIV replicatie kan worden teruggevonden in leukocyten die zich in de lymfoïde 
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weefsels bevinden. De stromale cellen die de lymfoïde weefsels vorm geven door de 
productie van extracellulaire matrix produceren ook signaalmoleculen essentieel voor 
de functie van deze weefsels. In Hoofdstuk 5a wordt beschreven hoe cellen van de 
primaire lymfoïde weefsels (beenmerg en thymus) en van de secundaire lymfoïde 
weefsels (lymfeknopen en milt) werden geïsoleerd, geïmmortaliseerd en 
gekarakteriseerd. Deze cellen brengen merkers die typisch zijn voor mesenchymale 
cellen tot expressie, zijnde vimentine, gladde spiercel actine en het extracellulaire 
matix eiwit fibronectine. De productie van cytokinen werd aangetoond op mRNA 
niveau. Deze mesenchymale cellen van de lymfoïde weefsels werden gebruikt in 
Hoofdstuk 5b om te bestuderen of zij een effect hebben op de gevoeligheid van 
PBMC voor FIV. Deze cellen konden PBMC stimuleren om de FIV receptoren CD134 
en CXCR4 tot expressie te brengen. Aanwezigheid van geactiveerde vasculaire 
endotheelcellen en mesenchymale cellen van de lymfeknopen leidden tot een verhoogt 
FIV infectiepercentage in PBMC. Verder zorgde de aanwezigheid van mesenchymale 
cellen van de lymfeknopen en het beenmerg tot een betere verspreiding van FIV in een 
PBMC cultuur.  
In Hoofdstuk 6 worden alle resultaten die werden bekomen tijdens dit doctoraat 
samengevoegd en in een breder perspectief geplaatst.  
   
 Curriculum Vitae  
Inge Roukaerts werd op 27 september 1987 geboren te Genk. In 2005 behaalde zij het 
getuigschrift middelbaar onderwijs aan het Sint-Jan Bergmanscollege te Genk in de 
richting Wetenschappen-Wiskunde. Ze studeerde verder aan de Vrije Universiteit 
Brussel en Universiteit Hasselt waar ze in 2010 het diploma Master in de Biomedische 
Wetenschappen (afstudeerrichting klinische moleculaire wetenschappen) met 
onderscheiding behaalde. In maart 2011 kreeg zij de kans het onderzoek naar het 
felien immunodeficiëntie virus op te starten in de vakgroep Virologie, Immunologie en 
Parasitologie aan de faculteit Diergeneeskunde van de Universiteit Gent onder 
begeleiding van Prof. Dr. Hans Nauwynck. In datzelfde jaar verwierf zij een 
doctoraatsbeurs van het Agentschap voor Innovatie door Wetenschap en Techniek 
Vlaanderen (IWT) om het onderzoek naar de immuno-evasieve strategieën van het 
felien immunodeficiëntie virus verder te zetten.  
  
 160 
List of publications & conference abstracts
Publications in international peer reviewed journals (including submitted papers) 
 Roukaerts I, Grant C, Theuns S, Christiaens I, Acar D, Van Bockstael S, 
Desmarets L, Nauwynck H. Differences in Env and Gag protein expression patterns 
and epitope availability in feline immunodeficiency virus infected PBMC compared 
to infected and transfected feline model cell lines. Vir Res. 2016 accepted. 
 Acar D, Olyslaegers D, Dedeurwaerder A, Roukaerts I, Baetens W, Van Bockstael 
S, De Gryse G, Desmarets L, Nauwynck H. Upregulation of endothelial cell 
adhesion molecules characterizes veins close to granulomatous infiltrates in the 
renal cortex of cats with feline infectious peritonitis and is indirectly triggered by 
feline infectious peritonitis virus infected monocytes in vitro. Gen Virol. 2016 Aug 
19. Epub ahead of print. 
  Theuns S, Conceic  a o-Neto N, Heylen E, Zeller M, Roukaerts I, Desmarets L, Van 
Ranst M, Nauwynck H, Matthijnssens J. Characterization of a genetically 
heterogeneous porcine rotavirus C, and other viruses present in the fecal virome of 
a non-diarrheic Belgian piglet. Infect Genet Evol. 2016 Sep 43:135-45. 
 Theuns S, Vyt P, Desmarets L, Roukaerts I, Heylen E, Zeller M, Matthijnssens J, 
Nauwynck H. Presence and characterization of pig group A and C rotaviruses in 
feces of Belgian diarrheic suckling piglets. Virus Res. 2016 Feb 2;213:172-83. 
 Desmarets L, Vermeulen B, Theuns S, Conceição-Neto N, Zeller M, Roukaerts I, 
Acar D, Olyslaegers D, Van Ranst M, Matthijnssens J, Nauwynck H. Experimental 
feline enteric coronavirus infection reveals an aberrant infection pattern and 
shedding of mutants with impaired infectivity in enterocyte cultures. Sci Rep. 2016 
Jan 29;6: 20022.  
 Theuns S, Vyt P, Desmarets L, Roukaerts I, Heylen E, Zeller M, Matthijnssens J, 
Nauwynck H. Presence and characterization of pig group A and C rotaviruses in 
feces of Belgian diarrheic suckling piglets. Virus Res. 2015 Dec 8;213:172-183. 
 Reddy V, Theuns S, Roukaerts I, Zeller M, Matthijnssens J, Nauwynck H. Genetic 
Characterization of the Belgian Nephropathogenic Infectious Bronchitis Virus 
(NIBV) Reference Strain B1648. Viruses. 2015 Aug 7;7(8):4488-506.  
 Theuns S, Conceição-Neto N, Christiaens I, Zeller M, Desmarets L, Roukaerts I, 
Acar D, Heylen E, Matthijnssens J, Nauwynck H. Complete genome sequence of a 
Publications & Abstracts 
159 
porcine epidemic diarrhea virus from a novel outbreak in belgium, january 
2015.Genome Announc. 2015 May 21;3(3).  
 Roukaerts I, Theuns S, Taffin E, Daminet S, Nauwynck H. Phylogenetic analysis
of feline immunodeficiency virus strains from naturally infected cats in Belgium
and The Netherlands. Virus Res. 2015 Jan 22;196:30-6.
 Theuns S, Heylen E, Zeller M, Roukaerts I, Desmarets L, Van Ranst M,
Nauwynck H, Matthijnssens J. Complete genome characterization of recent and
ancient Belgian pig group A rotaviruses and assessment of their evolutionary
relationship with human rotaviruses. J Virol. 2015 Jan 15;89(2):1043-57.
 Desmarets L, Theuns S, Roukaerts I, Acar D, Nauwynck H. Role of sialic acids in
feline enteric coronavirus infections. J Gen Virol. 2014 Sep;95(Pt9):1911-8.
 Theuns S, Desmarets L, Heylen E, Zeller M, Dedeurwaerder A, Roukaerts I, Van
Ranst M, Matthijnssens J, Nauwynck H. Porcine group A rotaviruses with
heterogeneous VP7 and VP4 genotype combinations can be found together with
enteric bacteria on Belgian swine farms. Vet Microbiol. 2014 Aug 6;172(1-2):23-34.
 Dedeurwaerder A, Olyslaegers D, Desmarets L, Roukaerts I, Theuns S, Nauwynck
H. ORF7-encoded accessory protein 7a of feline infectious peritonitis virus as a
counteragent against IFN-α-induced antiviral response. J Gen Virol. 2014
Feb;95(Pt 2):393-402.
 Desmarets L, Theuns S, Olyslaegers D, Dedeurwaerder A, Vermeulen B,
Roukaerts I, Nauwynck H. Establishment of feline intestinal epithelial cell
cultures for the propagation and study of feline enteric coronaviruses. Vet Res.
2013 Aug 21;44:71.
Abstracts at international conferences 
 Roukaerts I, Van Bockstael S, Acar D, Desmarets L, Nauwynck H. Newly
established lymphoid organ-derived mesenchymal cell cultures enhance FIV
replication in lymphocytes. Joint Symposium of the International Society for
Companion Animal Infectious Diseases and the International Feline Retrovirus
Research Symposium 2016. Bristol, United Kingdom. (Poster)
 Acar D, Olyslaegers D,  Dedeurwaerder A, Roukaerts I, Baetens W, Van
Bockstael S, De Gryse G, Desmarets L, Nauwynck H. Upregulation of
endothelial adhesion molecules by the feline infectious peritonitis virus. Joint
Publications & Abstracts 
160 
Symposium of the International Society for Companion Animal Infectious 
Diseases and the International Feline Retrovirus Research Symposium 2016. 
Bristol, United Kingdom.  
 Theuns S, Desmarets L, Roukaerts I, Christiaens I, Heylen E, Zeller M, Van 
Ranst M, Matthijnssens J, Nauwynck H. Successive subclinical group A and C 
rotavirus infections in piglets after weaning on a closed Belgian pig farm. 3rd 
Belgian Society for Virology meeting, 2015, Brussels, Belgium. 
 Desmarets L, Vermeulen B, Theuns S, Conceição-Neto N, Zeller M, Roukaerts 
I, Acar D, Olyslaegers D, Van Ranst M, Matthijnssens J and Nauwynck H. 
Experimental feline enteric coronavirus infection reveals an aberrant infection 
pattern and shedding of mutational variants with impaired enterocyte tropism. 
3rd Belgian Society for Virology meeting, 2015, Brussels, Belgium. 
 Theuns S, Conceic  a o-Neto N, Heylen E, Zeller M, Roukaerts I, Desmarets L, 
Van Ranst M, Nauwynck HJ, Matthijnssens J. The fecal virome of a Belgian 
non-diarrheic piglet contains group A and C rotaviruses, and an astro- and 
enterovirus. Twelfth International Double-Stranded RNA Virus Symposium 
2015, Goa, India. 
 Theuns S, Desmarets L, Roukaerts I, Christiaens I, Heylen E, Zeller M, Van 
Ranst M, Matthijnssens J, Nauwynck HJ. Successive subclinical rotavirus A and 
C infec4ons in pigs a7er weaning on a closed Belgian pig farm. Twelfth 
International Double-Stranded RNA Virus Symposium 2015, Goa, India. 
 Roukaerts I, Grant C, Desmarets L, Theuns S, Christiaens I, Acar D, 
Nauwynck H. Staining and expression kinetics of the feline immunodeficiency 
virus envelope glycoprotein. Xth Conference of the European Society of 
Veterinary Virology 2015, Montpelier, France. (oral presentation) 
 Desmarets L, Theuns S, Conceição-Neto N, Roukaerts I, Acar D , 
Matthijnssens J, Nauwynck H. Clinical, virological, and immunological 
parameters during experimental feline enteric coronavirus infection. Xth 
Conference of the European Society of Veterinary Virology 2015, Montpelier, 
France. 
 Theuns S, Heylen E, Zeller M, Roukaerts I, Desmarets L, Van Ranst M, 
Nauwynck H, Matthijnssens J.  Complete genome characterization of recent 
and ancient Belgian pig group A rotaviruses and assessment of their 
Publications & Abstracts 
161 
evolutionary relationship with human rotaviruses. Xth Conference of the 
European Society of Veterinary Virology 2015, Montpelier, France.   
 Christiaens I, Conceição-Neto N, Theuns S, Zeller M, Desmarets L, Roukaerts 
I, Heylen E, Matthijnssens J, Nauwynck H. Genetic characterization of porcine 
epidemic diarrhea virus strains isolated from novel outbreaks in the European 
Union, Belgium. Xth Conference of the European Society of Veterinary Virology 
2015, Montpelier, France. 
 Theuns S, Vyt P, Desmarets L, Roukaerts I, Heylen E, Zeller M, Van Ranst M, 
Matthijnssens J, Nauwynck H. Rotavirus A and C infections in Belgian 
Diarrheic suckling pigs. Xth Conference of the European Society of Veterinary 
Virology 2015, Montpelier, France.  
 Theuns S, Heylen E, Zeller M, Roukaerts I, Desmarets L, Van Ranst M, 
Nauwynck H, Matthijnssens J. Complete genome characterization of recent and 
ancient Belgian pig group A rotaviruses and assessment of their evolutionary 
relationship with human rotaviruses. 6th European Rotavirus Biology Meeting, 
2015, Dijon, France. 
 Theuns S, Vyt P, Desmarts L, Roukaerts I, Heylen E, Zeller M, Van Ranst M, 
Matthijnssens J, Nauwynck H. Circulation of pig group A and C rotaviruses in 
Belgian diarrheic suckling piglets and its impact on veterinary diagnostical 
analyses. 6th European Rotavirus Biology Meeting, 2015, Dijon, France. 
 Roukaerts I, Theuns S, Taffin E, Daminet S, Nauwynck H. Phylogenetic 
analysis of FIV strains from naturally infected cats in Belgium and The 
Netherlands. 2nd Belgian Society for Virology meeting, 2014, Brussels, Belgium. 
 Theuns S, Heylen E, Zeller M, Roukaerts I, Desmarets L, Van Ranst M, 
Nauwynck H, Matthijnssens J. Complete genome characterization of recent and 
ancient Belgian pig group A rotaviruses and assessment of their evolutionary 
relationship with human rotaviruses. 2nd Belgian Society for Virology meeting, 
2014, Brussels, Belgium. 
 Roukaerts I, Theuns S, Taffin E, Daminet S, Nauwynck H. Phylogenetic 
analysis of FIV strains from naturally infected cats in Belgium and the 
Netherlands. 12th International Feline Retrovirus Research Symposium 2014, 
Niagara-on-the-lake, Canada. (oral presentation) 
Publications & Abstracts 
162 
 Desmarets L, Theuns S, Roukaerts I, Acar D, Nauwynck H. Role of sialic acids 
in feline enteric coronaviruses infections. XIIIth International Nidovirus 
Symposium, 2014, Salamanca, Spain. 
 Desmarets L, Theuns S, Olyslaegers D, Dedeurwaerder A, Vermeulen B, 
Roukaerts I, Nauwynck H. Establishment of feline intestinal epithelial cell 
cultures for the propagation and study of feline enteric coronaviruses. XIIIth 
International Nidovirus Symposium, 2014, Salamanca, Spain. 
 Dedeurwaerder A, Acar D, Olyslaegers D, Desmarets L, Roukaerts I, Theuns 
S, Nauwynck HJ. ORF7-encoded accessory protein 7a of feline infectious 
peritonitis virus as a counteragent against interferon-alpha induced antiviral 
response. XIIIth International Nidovirus Symposium, 2014, Salamanca, Spain. 
 Theuns S, Desmarets L, Heylen E, Zeller M, Dedeurwaerder A, Roukaerts I, 
Van Ranst M, Matthijnssens J, Nauwynck HJ. Unraveling the role of porcine 
group A rotaviruses in the pathogenesis of piglet diarrhea and their 
evolutionary relationship with human rotaviruses. 11th International Rotavirus 
Symposium, 2014, New Delhi, India. 
 Roukaerts I, Olyslaegers D, Desmarets L, Theuns S, Dedeurwaerder A, 
Nauwynck H. Feline peripheral blood mononuclear cell cultivation: cell 
population evolution, FIV receptor expression & FIV replication. 1st Belgian 
Society for Virology meeting, 2013, Brussels, Belgium.  
 Desmarets L, Theuns S, Olyslaegers D, Dedeurwaerder A, Vermeulen B, 
Roukaerts I, Nauwynck H. Establishment of feline intestinal epithelial cell 
cultures for the propagation and study of feline enteric coronaviruses. 1st 
Belgian Society for Virology meeting, 2013, Brussels, Belgium. 
 Dedeurwaerder A, Olyslaegers D, Desmarets L, Roukaerts I, Theuns S, 
Nauwynck H. The ORF7-encoded accessory protein 7a of feline infectious 
peritonitis virus as a counteragent against interferon-alpha induced antiviral 
response. 1st Belgian Society for Virology meeting, 2013, Brussels, Belgium. 
163 
Dankwoord / Acknowledgements 
Alle technische details en bevindingen die te maken hadden met dit proefschrift zijn 
geschreven, rest alleen nog het dankwoord. Iedereen die mij een beetje kent weet dat 
ik geen dichterlijk of literair talent ben. Toch zal ik hier nog een woordje richten aan 
iedereen die een bijdrage heeft geleverd aan het voltooien van dit werk.  
Geen kansen, geen doctoraat. Ongeveer 6 jaar geleden reageerde ik op een vacature 
binnen de FIP-groep van het labo virologie. Het moet zijn dat jullie (Hans en Hannah) 
toch iets in mij zagen want nog geen 10 dagen later was ik aan de slag. Hannah, 
bedankt voor de intense begeleiding van het IWT project en de vele uren oefening voor 
de verdediging! Zonder jouw jarenlange ervaring in het virologisch onderzoek was dat 
nooit gelukt. Ook zette je me op de rails in het onderzoek met protocols en praktische 
tips. Hans, jij nam het promotorschap van mijn doctoraat op je. Ik wil je bedanken 
voor je niet aflatend enthousiasme, met daarbij horend een onuitputtelijke bron aan 
nieuwe (niet altijd even conventionele) hypothesen en zienswijzen. Verder moet het 
ook gezegd dat je gave om bij tegenslag een goede “peptalk” te geven zoals een echte 
top-coach behoort zeker een steun was! Ik denk dat je wel kan zeggen dat “dat meisje 
uit Limburg” met heel wat meer levenswetenschap je labo verlaat.  
Finding the right reagents for our FIV research was not an easy task. Luckily, some guy 
in the States was willing to send me some antibody samples. Chris Grant, if it wasn’t 
for you, much of my research would simply not exist! Thank you for your excitement 
when I sent you the first microscopy pictures, and your interest and support along the 
way! I will never forget! 
Aan de leden van de examenjury een dankjewel voor de tijd die ze genomen hebben 
om mijn werk grondig door te nemen en de opmerkingen die dit werk merkelijk 
hebben verbeterd.  
Ik kwam binnen in een labo waar twee “top-tjoolders” druk in de weer waren met 
darmen allerlei. Het ene idee was al zotter als het andere :D. Lowiese-ken en Bassie, 
die darmen hebben voor jullie beiden tot een super doctoraat en ook een mooie post-
doc carrière geleid. Ik zal die eerste zotte jaren dat we samen in het labo zaten nooit 
vergeten! De vrijdagfilmkes, de telkamer, de goed gezekerde gasfles, kattenvangen, 
kaka-score lijsten, llama’s, zijprojecten allerhande, vroege ochtend experimenten, 
opkuisacties, koffietassen, meer kaka en darmen, ozewiezewoze, banaan stickertjes, 
ikea-shopping, en zo kan ik nog even doorgaan… Alle gekheid op een stokje, Lowiese 
Dankwoord/Acknowledgements 
164
een hele dikke merci voor de vele hypothesen en experiment besprekingen, en voor het 
nalezen, verbeteren, meer nalezen en meer verbeteren, en nog meer nalezen van al 
mijn gekribbel. Nu nog ozewiezewoze uit mijn hoofd krijgen :p. Bassie, naast serieuze 
zaken kon ik bij jou ook terecht om eens goed te zagen of onnozel te doen, of nog beter 
om onze fantasie de vrije loop te laten. Een welgemeende dank je wel en… never let 
your inner child die ;), BAZINGA!!  
Naast deze tjoolders liepen er nog enkele figuren rond op “het eerste verdiep” die ik 
zeker moet bedanken. Ben, wanneer Hannah mij niet kon helpen werd ik aan jou 
overgeleverd want jij wist hoe lymfocyten moesten worden behandeld. Van jou leerde 
ik een hoop technieken die onmisbaar zouden blijken tijdens mijn doctoraat. 
Dominique en Annelike, toen ik binnen kwam op het labo waren jullie voor mij de 
geroutineerde doctoraatsstudenten. Van jullie expertise en doorzettingsvermogen 
(want het ging niet altijd van een leien dakje) daar konden wij nog iets van leren!! 
Allebei merikes voor de fijne babbels, FIP-meetingen, protocols, enz… en om ons af en 
toe eens een hart onder de riem te steken!  
Isaura, eerst zagen we elkaar vooral aan de bushalte, maar na een tijdje kwamen we 
elkaar meer tegen in het (moleculair) labo en uiteindelijk verhuisde je zelfs naar “het 
eerste verdiep”. Als mede-biomedische tussen die vele dierenartsen kon ik met jou al 
eens brainstormen over welke strategie het beste was op moleculair vlak. Ik vond het 
altijd fijn om ons kritisch oog op allerhande zaken te laten schijnen, met 
onverbloemde meningen. Maar onder die ruwe bolster, misschien toch ook een blanke 
pit, jij was altijd daar met steun of een bemoedigend woord wanneer nodig, waarvoor 
waarlijk dank! Zoals dat gaat in een labo komt er altijd maar vers bloed binnen 
wanneer anderen verdere horizonten opzoeken. Zo kwam er één binnen die in de 
eerste week al op de werkbank zat om de hele FIP-hypothese uit te tekenen. Delphine, 
dierenarts eerste klas, jij bracht een frisse wind in het labo. Af en toe op je gezicht 
gaan, daar trek jij je niets van aan. Je maakte ook onmiddellijk aanspraak op een 
plaats in team onverbloemd ;). Raak nooit die wilde haren kwijt, de onderzoeks- en 
academische wereld kunnen dat goed gebruiken!! In mijn laatste jaar verraste Hans 
me met een student, die zowaar het hele jaar zou blijven! Dankzij een gelukkig toeval, 
zoals dat wel vaker gaat in het onderzoek, hadden we plots toch een project voor jou. 
Sebastiaan, Sebas, Bockie, Ryan, ondertussen heb je al vele namen, maar eigenlijk blijf 
je gewoon mijn duckling. Jou nieuwsgierigheid en verwondering brachten ook bij mij 
de zin en plezier om onderzoek te doen terug, iets wat je (geloof mij) wel kan 
Dankwoord / Acknowledgements 
165 
gebruiken in die laatste loodjes van een doctoraat!! Ik vond het heel plezierig om voor 
jou de deuren van de “niet zo suffe ;)” onderzoekswereld (en dan vooral de FACS 
blijkbaar) te openen!! Nu op naar nieuwe horizonten en nog meer flowcytometrie, het 
ga je goed ;). p.s. hoe zit het nu eigenlijk met die dans-moves op Little Apple... Gaetan, 
Wendy, Eleni en Kasper, jullie vervolledigen de nieuwe charge in de bureau(s). Gaetan, 
we adopteerden jou uit de kelder als onze eigenste Shrimpie. Allemaal nieuw die 
garnalen toestanden, we overlaadden je dan ook met de meest uiteenlopende vragen. 
Nu hoef je niet meer alleen rond te zwerven naar god weet waar om gekke 
experimenten te doen, want nu ben je een team met Kasper. Ik wens jullie het 
allerbest, en als ik een scampi (aka een gamba zonder kop) eet, zal ik altijd even aan 
jullie denken. Met Lowiese soon on the move, werd er versterking voor het FIP-team 
gezocht. Een gekke biologe uit het Brusselse vervulde de eer. Wendy, ik er zeker van 
dat je samen met Delphine de eer van het FIP onderzoek in Gent hoog kunt houden. 
Eleni, “a woman’s touch” dat kon de georganiseerde chaos van Bassie wel gebruiken. 
Daar mocht er ene zijn pollekes kussen met jou komst om al die biggen op te volgen en 
te helpen met extracties en qPCR’s. TingTing, you are another asset of the Rota group. 
In the beginning a bit shy, but now on the road to success. I hope you and your 
husband will have some more beautiful years in Belgium, with two nice PhD’s in the 
end! Every once in a while I will listen to some Chinese pop music to remember you ;).  
Ytse, dat zootje ongeregeld dat ik hierboven het beschreven wandelt voortdurend in en 
uit “jouw labo” en zet ook soms (lees: vaak) de boel op stelten. Gelukkig hebben we 
daar een kordate West-Vlaamse om alles een beetje in de gaten te houden. Een hele 
dikke merci voor de vele fantastische kleuringen en andere experimenten die ik met 
een gerust hart aan je kon toevertrouwen!! Wat zouden we daar toch zonder jou doen!  
FIP-ers en aanverwanten…het was een genoegen!!! 
Het mag gezegd dat het labo staat of valt met de kwaliteit van de technische crew. Wel 
nu mogen wij van geluk spreken dat we kunnen rekenen op een fantastisch team 
laboranten. Carine, Lieve, Nele, Melanie en Chantal, dankjewel voor al de adviezen, 
antwoorden en experimentele ondersteuning, alsook de leuke babbels tussendoor!! Op 
een faculteit diergeneeskunde zijn ook altijd veel dieren aanwezig dus wat zouden we 
zijn zonder professionele verzorging. Een dikke merci aan Zeger en Magda voor het 
onderhoud v an het labo, de stallen en de dieren.  
Dankwoord/Acknowledgements 
166
Buiten het labo was er natuurlijk ook nood aan verstrooiing en eveneens een vangnet, 
want zo een doctoraat, dat krijg je niet zomaar cadeau. Aan mijn familie en in het 
bijzonder oma en opa, een dikke merci omdat jullie altijd nieuwsgierig waren naar wat 
ik daar in het verre Gent allemaal uitspookte. Mama en papa dankjewel voor de 
kansen die geleid hebben tot het aanvangen en voltooien van dit proefschrift, voor de 
niet aflatende steun wanneer het even moeilijker ging en voor de grote tuin waar ik 
altijd mijn zinnen kon verzetten. Ik kan dat niet in woorden uitdrukken hoezeer jullie 
mij geholpen hebben. Mijn lieve kleine broerke Arnout, die jeneverkes op de 
kerstmarkt na het afleggen van de IWT-verdediging, dat was een moment dat me altijd 
zal bijblijven. Met jou kon ik het al eens hebben over het wel en wee van de 
doctoraatsstudent of de aanpak van een artikel bespreken. Bedankt voor het relaxte 
tegengewicht voor mijn soms overspannen ziel :).  
Chris, waar te beginnen… :), ik hoef je hier niet te vertellen wat we allemaal hebben 
meegemaakt, want je was er altijd bij, je volgde me zelfs tot in Gent en weer terug! 
Niemand heeft alles van zo nabij meegemaakt als jij, maar er is ook niemand die nu zo 
veel in mijn vreugde kan delen!  
Inge 
To infinity… and beyond!!! 

